Headquarters, Department of the Army, Washington, DC 20310-2300 10 July 2006

Army Medical Department Supply Information

DISTRIBUTION STATEMENT A: Approval for public release; distribution is unlimited.

DEPARTMENT OF THE ARMY SUPPLY BULLETIN

SB 8-75-MEDCASE

Table of Contents Page

Overview Of and Customer Feedback Sheet For SB 8-75 MEDCASE .................................................... i

Chapter 1 - Medical Care Support Equipment (MEDCASE) and Super Capital Expense Equipment

 Program (SuperCEEP) General Information ........................................................... 1-1

Chapter 2 - MEDCASE/SuperCEEP Program Policies...................................................................... 2-1

Chapter 3 - Development of MEDCASE/SuperCEEP Requirements ................................................. 3-1

Chapter 4 - Approval of MEDCASE/SuperCEEP Requirements ........................................................ 4-1

Chapter 5 - Execution of MEDCASE/SuperCEEP Requirements....................................................... 5-1

Chapter 6 - Wholesale Supply System (Requisitions) ................................................................... 6-1

Chapter 7 - Local Purchase and Letters of Authority (LOA) ........................................................... 7-1

Chapter 8 - Alternate Acquisition Activity..................................................................................... 8-1

Chapter 9 - Processing of Urgent and Emergency MEDCASE/SuperCEEP Requirements ................... 9-1

Chapter 10 - The WEB MEDCASE Requirements and Execution (WEBMRE) System ......................... 10-1

Chapter 11 - Medical MILCON Projects (BLIC NF and MB Requirements) ........................................ 11-1

Chapter 12 - Diagnostic Imaging and Radiation Therapy Requirements ........................................ 12-1

Chapter 13 - Administrative and Information Management .......................................................... 13-1

Chapter 14 - Competition in Contracting Requirements ............................................................... 14-1

Chapter 15 - Special MEDCASE/SuperCEEP Program Considerations ............................................ 15-1

Chapter 16 - Equipment Replacement Reports ........................................................................... 16-1

Chapter 17 - Technology Assessment and Requirements Analysis (TARA) ..................................... 17-1

Appendix A - IDCs and Standard Item Descriptions ...................................................................... A-1

Appendix B - MEDCASE/SuperCEEP Forms: DA Form 5027-R (MPR) and DA Form 5028-R (MSTF) ........ B-1

Appendix C - Letters of Authority (LOAs) ...................................................................................... C-1

Appendix D - MEDCASE/SuperCEEP Requisition (Example) ............................................................. D-1

Appendix E - Diagnostic Imaging and Therapeutic Equipment ........................................................ E-1

Appendix F - Total Case Analysis (TCA) Format............................................................................. F-1

Appendix G - WEBMRE Access - User ID Request Form (MM260) ..................................................... G-1

Glossary - ............................................................................................................................GL-1

Index - ............................................................................................................................ IN-1

Effective until rescinded or superseded

SPECIAL NOTICE

THIS SUPPLY BULLETIN IS DEDICATED ENTIRELY TO THE PROCEDURES USED FOR THE

MEDICAL CARE SUPPORT EQUIPMENT (MEDCASE)/SUPERCEEP PROGRAM

THIS EDITION SUPERSEDES IN ITS ENTIRETY SB 8-75-MEDCASE DATED 10 MARCH 2004

Printing of this information does not constitute endorsement of the product, manufacturer, or the use

of any related item thereof by the U. S. Army.

 REPORTING ERRORS AND RECOMMENDING IMPROVEMENTS

You can improve this publication. If you find any mistakes, or you know a way to improve it, please

let us know. Mail your letter or DA Form 2028 (Recommended Changes to Publications and Blank

Forms) directly to the U. S. Army Medical Materiel Agency, ATTN: MCMR-MMO-A, Fort Detrick, MD

21702-5001. If you prefer using email, please address it to usammacrm@amedd.army.mil.
SB 8-75-MEDCASE 

i 

AN OVERVIEW OF THE MEDCASE/SUPERCEEP PROGRAM 

The Medical Care Support Equipment (MEDCASE)/Super Capital Expense 

Equipment Program (SuperCEEP) is a centralized funding program providing 

the investment and high-dollar value capital expense equipment required for 

Army health care activities at fixed Army Medical Treatment Facilities (MTFs) 

throughout the world. 

The MEDCASE/SuperCEEP is centrally managed and funded through the U. S. 

Army Medical Command (USAMEDCOM) and administered by the U. S. Army 

Medical Materiel Agency (USAMMA). The MEDCASE utilizes Defense Health 

Program (DHP), Other Procurement, Defense (OPD) funds to acquire 

investment equipment. The SuperCEEP utilizes DHP, Operations and 

Maintenance, Defense (OMD) funds to acquire capital expense equipment. 

Equipment requirements originate at the activity level. They are reviewed and 

approved depending on the dollar value, at the following levels: 

 (1) Activity 

 (2) Regional Medical Command (RMC) 

 (3) The USAMMA 

 (4) The USAMEDCOM 

 (5) Office of the Surgeon General (OTSG) Clinical Consultants and/or the 

Technology Assessments and Requirements Analysis (TARA) team. 

Approved and disapproved requirements are recorded in the Army Medical 

Department (AMEDD) central database (the MRE system at https://usammaextranet.detrick.army.mil/MRE/) maintained by the USAMMA. 

The USAMMA receives MEDCASE/SuperCEEP funds from the USAMEDCOM. 

MEDCASE/SuperCEEP funds are managed and controlled in the Web MEDCASE 

Requirements and Execution (WebMRE) System for participating RMCs, their 

regional activities, and Major Subordinate Commands (MSCs). 

The USAMEDCOM is the proponent of the MEDCASE/SuperCEEP program. The 

USAMMA is the proponent for the WebMRE system as well as technical 

consultant services to the Army Medical Department. 
SB 8-75-MEDCASE 

ii 

MEDCASE/SUPERCEEP Customer Feedback Sheet

This Supply Bulletin is produced to provide guidance to Logistics Personnel and other 

MEDCASE/SuperCEEP program customers on establishing MEDCASE/SuperCEEP 

requirements to support Army health care activities at fixed Army MTFs throughout the 

world. 

The feedback sheet below requests your proposals for improving the next edition of this 

Supply Bulletin. It also serves as a vehicle for submitting questions, problems and 

proposed solutions pertaining to the MEDCASE/SuperCEEP program. The goal is to 

make future editions of this Supply Bulletin as informative and effective as possible. 

CUSTOMER FEEDBACK For SB 8-75-MEDCASE Dated 10 March 2006 

Response From: 

_____________________________________________________ 

_____________________________________________________ 

_____________________________________________________ 

_____________________________________________________ 

Telephone: ________________________ FAX: ___________________ 

E-mail: ______________________________________________________ 

To the USAMMA Website: http://www/usamma.army.mil

FEEDBACK (Please provide any constructive criticism about this edition): 

_______________________________________________________________ 

_______________________________________________________________ 

_______________________________________________________________ 

_______________________________________________________________ 

_______________________________________________________________ 

_______________________________________________________________ 

_______________________________________________________________ 

Send this sheet with comments to: 

United States Army Medical Materiel Agency 

ATTN: MCMR-MMO-AT 

1432 Sultan Drive, Suite 100 

Fort Detrick, MD 21702-5001 

DSN 343-6984 / commercial 301-619-6984 

OR 

Contact our Customer Relationship Management Office (MCMR-MMO-PO) from our website 

at http://www.usamma.army.mil, select CONTACT US. Or from the homepage, under 

Contact USAMMA, click on the website and either send any additional feedback through 

the website facility or call us at the phone number shown. 

We look forward to hearing from you. 
SB 8-75-MEDCASE 

1-1 

CHAPTER 1. MEDICAL CARE SUPPORT EQUIPMENT (MEDCASE) AND 

SUPER CAPITAL EXPENSE EQUIPMENT PROGRAM (SuperCEEP) 

GENERAL INFORMATION 

1-1. PURPOSE AND APPLICABILITY 

The purpose of this publication is to establish procedures and to implement or clarify 

policies for the execution of the MEDCASE/SuperCEEP program. It is applicable to all 

MEDCASE/SuperCEEP program participants worldwide. In cases where the 

instructions in this publication and a published Army regulation are in conflict, the 

Army regulation has precedence. 

1-2. INTRODUCTION 

The MEDCASE/SuperCEEP Program is a centrally managed, Department of the Army 

(DA)-level program which utilizes DHP, OPD and OMD funds, respectively, for the 

acquisition of capital investment and high dollar value capital expense equipment for 

fixed AMEDD Activities worldwide. The program also manages the approval and 

acquisition of investment equipment requirements that are funded by medical Military 

Construction (MILCON) Army funds for major medical construction projects. 

1-3. RESPONSIBILITIES 

a. The U. S. Army Medical Command (USAMEDCOM). The USAMEDCOM is the 

MEDCASE/SuperCEEP program manager and the proponent of MEDCASE/SuperCEEP 

program policy. The USAMEDCOM: 

(1) Publishes MEDCASE/SuperCEEP program policy. 

(2) Develops and defends the MEDCASE/SuperCEEP program budget. 

(3) Determines program funding ceilings for RMCs and MSCs. 

b. Functional Consultants. The OTSG Clinical Consultants or the TARA team 

review and provide propriety approval or disapproval for all MEDCASE/SuperCEEP 

program requirements. 

c. The Strategic Technology/Clinical Policies Council (STCPC). The STCPC 

provides guidance and prioritizes all unfunded MEDCASE/SuperCEEP requirements 

annually to determine what requirements will be funded in the current year of 

execution. 

d. The Diagnostic Imaging and Radiotherapy Subcommittee (DIRS). The 

DIRS is a subcommittee of the STCPC. This subcommittee provides recommendations 

to the STCPC on MEDCASE/SuperCEEP program requirements for diagnostic imaging 

and radiation therapy equipment. 

e. The USAMMA. The USAMMA administers and executes the 

MEDCASE/SuperCEEP program for the USAMEDCOM, as well as: 
SB 8-75-MEDCASE 

1-2 

(1) Determines the adequacy of MEDCASE Program Requirements 

(MPRs) and rejects those which are inadequate or which are not eligible for funding 

through the MEDCASE/SuperCEEP program. 

(2) Serves as the proponent for the WebMRE System and provides 

technical assistance for online access to the WebMRE system for management 

purposes. 

(3) Controls and accounts for MEDCASE/SuperCEEP funds, managed in 

the WebMRE system, for participating organizations as directed by the USAMEDCOM 

and maintains funds files within the WebMRE System through the posting of 

distributions, commitments, and obligations. 

(4) As the Service Item Control Center (SICC) for medical materiel, 

determines the appropriate acquisition source for all MEDCASE/SuperCEEP 

requirements. 

(5) Receives and processes requisitions for MEDCASE/SuperCEEP 

executions from program participants, and forwards them to the appropriate source 

of supply for procurement. 

(6) Serves as the liaison between program participants and wholesale 

sources of supply. 

(7) Publishes SB 8-75-MEDCASE. 

(8) Coordinates with activities of the Defense Logistics Agency (DLA), 

Army commands, command surgeons and Army Health Care activities in matters 

relating to MEDCASE/SuperCEEP program management. 

(9) Administers the TARA program. 

(10) Serves as the functional consultant, appointed by USAMEDCOM, for 

reviewing and providing propriety approval or disapproval for diagnostic imaging and 

radiation therapy equipment MPRs. 

e. The RMCs and MSCs. The RMCs and MSCs manage the development and 

execution of MEDCASE/SuperCEEP requirements within their command in accordance 

with USAMEDCOM policy, and: 

(1) Review and approve or disapprove MPRs before they are forwarded 

to USAMMA. 

(2) Develop and publish command guidance for MEDCASE/SuperCEEP 

program implementation within their command. 

(3) Direct the distribution of excess equipment within their command to 

meet equipment requirements, as appropriate. 

(4) Monitor and ensure program execution is in accordance with 

USAMEDCOM guidance and command goals. 
SB 8-75-MEDCASE 

1-3 (1-4 blank) 

f. MEDCASE/SuperCEEP Program Participants: 

(1) Develop equipment requirements consistent with mission needs. 

Develop equipment requirements for construction/renovation projects in accordance 

with project milestones and published guidance. 

(2) The activity commander shall review and approve or disapprove 

requirements in accordance with established MEDCASE/SuperCEEP policy and 

procedures. 

(3) Ensure information provided on MPRs is complete and accurate. 

(4) Maintain a record of program management decisions regarding 

prioritization and execution of MPRs prior to the beginning of each Fiscal Year. 

(5) Ensure equipment items received are accounted for, installed, 

maintained and used. 

(6) Report and dispose of excess equipment in accordance with AR 40-61 

(Medical Logistics Policies) and SB 8-75-11, (Medical Logistics Procedures). 

(7) Utilize exchange/trade-in of replacement equipment to the maximum 

extent possible. 

g. The U.S. Army Health Facilities Planning Agency (USAHFPA): 

(1) Provides, through the Health Facilities Project Officer assigned to 

construction projects, assistance to the local Chief of Logistics in the development of 

equipment requirements to support the project. 

(2) Provides propriety review of all Budget Line Item Code (BLIC) "MB" 

MEDCASE/SuperCEEP requirements. 

1-4. DEVIATIONS 

Requests for deviation from the procedures stated in this publication should be 

directed with complete justification through command channels to the 

U.S. Army Medical Materiel Agency 

ATTN: MCMR-MMO-AT 

1423 Sultan Drive, Suite 100 

Fort Detrick MD 21702-5001 
SB 8-75-MEDCASE 

2-1 

CHAPTER 2. MEDCASE/SUPERCEEP PROGRAM POLICIES

2-1. INTRODUCTION 

This chapter summarizes, interprets, and clarifies the MEDCASE/SuperCEEP program 

policies. Any recommended changes or requests for exception to these policies should 

be forwarded through Command channels with complete justification to the 

U.S. Army Medical Materiel Agency 

ATTN: MCMR-MMO-AT 

1423 Sultan Drive, Suite 100 

Fort Detrick MD 21702-5001 

2-2. MEDCASE/SUPERCEEP PROGRAM ELIGIBILITY

a. Eligibility Criteria. Equipment may be considered eligible for the 

MEDCASE/SuperCEEP program subject to the following criteria: 

(1) It is classified as MEDCASE, capital investment-type equipment with 

a unit price equal to or greater than the DHP, OPD threshold of $250,000. 

(2) It is classified as SuperCEEP, with a unit price equal to/or 

greater than the DHP, OMD threshold of $100,000 and less than $249,999. 

(3) It is required to accomplish or support a health care mission at a 

fixed (i.e., Table of Distribution and Allowances [TDA]), Army Medical Department, 

Reserve Component, or Tri-Service medical activity. 

(4) It is a nonexpendable end item, or a nonexpendable component or 

accessory to an end item, which will be accounted for on the activity’s property book. 

(5) It is not centrally managed and funded through another Department 

of Defense (DOD) or DA-level program. 

(6) It is not required to accomplish a Base Operations (BASOPS) 

function. 

(7) It is not required to provide back-up to existing equipment. 

b. Approval for Non-Medical Equipment. The criteria stated above determine 

whether a requirement is eligible for acquisition through the MEDCASE/SuperCEEP 

program; however, certain types of equipment require separate approval and 

authorization before they can be acquired, regardless of program eligibility. 

Generally, nonmedical items of equipment require separate approval. This separate 

approval does not constitute MEDCASE/SuperCEEP program approval, but must be 

obtained prior to functional consultant review. 

c. MEDCASE/SuperCEEP Funding of Equipment Managed by Another DA 

Program. Nonmedical equipment, which is normally managed and funded by another 

DA level program, such as security, may be considered for funding through the 

MEDCASE/SuperCEEP program. However, this is only after the activity commander 

determines that the primary program will not be able to support an immediate 
SB 8-75-MEDCASE 

2-2 

mission requirement of the health care activity. A MEDCASE/SuperCEEP submission 

for such a requirement must include the following items: 

(1) Documentation of the appropriate program approval, 

(2) A statement from the appropriate manager indicating when funding 

through that program would be available, 

(3) A statement from the activity commander describing the mission 

impact if acquisition of the equipment is delayed until funding through the normal 

program is available. 

d. TDA Authorization and Type Classification. AR 40-61 serves as the 

authorization for medical equipment, except for Army-adopted (i.e., standard, type 

classified) medical equipment. Nonmedical equipment with a unit or system cost 

which meets or exceeds the DHP threshold requires TDA authorization and type 

classification exemption in accordance with AR 71-32 (Force Development and 

Documentation-Consolidated Policies). This is accomplished at the supporting 

command level following submission of the MPR. The MPR will accompany 

documentation for separate approval by the activity. Property Book authorization for 

nonmedical equipment is in AR 71-32. When assignment of a Line Item Number (LIN) 

is obtained by the USAMEDCOM, the equipment becomes authorized on the activity’s 

TDA.

2-3. SPECIAL ELIGIBILITY CRITERIA 

a. In cases where questions arise concerning the application of 

MEDCASE/SuperCEEP program eligibility criteria, clarification should be requested 

through command channels to the USAMMA, ATTN: MCMR-MMO-AT. A completed DA 

Form 5027-R (MEDCASE Program Requirement) must be included with requests for 

program eligibility. Questions that cannot be resolved at the USAMMA will be passed 

to the USAMEDCOM for resolution. 

b. BASOPS

(1) BASOPS is not a term that describes a particular type of equipment; 

rather, it describes a functional responsibility. BASOPS functions are those that are 

the responsibility of the installation commander in support of the garrison and its 

tenants. Examples of BASOPs functions are:

 Base communication equipment, 

 Fire protection, 

 Grounds maintenance, 

 Waste disposal, 

 Common-use automated data processing equipment (ADPE) in support 

of: 

 Standard installation/division personnel system (SIDPERS), 

 Standard Army Finance System (STANFINS), and 

 Other installation level ADPE.

(2) Equipment for BASOPS functions is the funding responsibility of the 

host installation and is therefore, not eligible for the MEDCASE/SuperCEEP program, 

except Walter Reed Army Medical Center (WRAMC) and Fort Detrick. A related factor 
SB 8-75-MEDCASE 

2-3 

in determining funding responsibility is whether or not the TDA appropriately 

authorizes the item and where property book accountability is maintained. If it is 

authorized on the installation’s TDA, accounted for on the installation commander’s 

property book, and it is for a BASOPS function, then it is not eligible for the 

MEDCASE/SuperCEEP program. 

e. Nurse Call Systems. 

(1) Nurse call systems are personal property (fixed) in accordance with 

(IAW) Army Regulation 735-5 (Policies and Procedures for Property Accountability). 

Nurse call systems are not considered as installed building equipment (DA PAM 

420-11, Project Definition and Work Classification). This means nurse call systems 

must be purchased with DHP Procurement - MEDCASE funds when the dollar 

threshold meets or exceeds $250,000 and SuperCEEP funds when the dollar 

threshold is equal to or greater than $100,000 and less than $249,999. Minor 

construction or repair funding cannot be used to purchase new, replace, or upgrade 

nurse call systems. 

(2) The MEDCASE/SuperCEEP program funds approved equipment and 

installation costs. The USAMEDCOM, Deputy Chief of Staff for Installations, 

Environment, and Facility Management (DCSIE&FM), site preparation program, funds 

site preparation and utility rough-in requirements. 

(3) Facility managers and Chiefs of Equipment Management Branch 

should determine if their system needs to be replaced or updated. Factors such as 

reliability, maintainability, and technical obsolescence must be considered. The 

appropriate Item Description Code (IDC) is “4072”. 

f. Sets. 

(1) A set is defined as an aggregate of components, expendable, durable 

and/or nonexpendable, which maintains its integrity and identity as a set throughout 

its useful life, is accounted for as a nonexpendable end item, and is used by a health 

care provider for a specific clinical procedure. This includes the requirement to control 

the components and replace them as necessary to maintain the integrity of the set. A 

set should be acquired as a single end item, using a single catalog number that refers 

to an established list of components. Requirements for sets, which are not acquired 

under a single catalog number, will be considered on a case-by-case basis. A “set” 

will not be considered MEDCASE/SuperCEEP-eligible if it appears that its sole purpose 

is to aggregate the unit costs of individual expense-type items in order to reach the 

program thresholds. 

(2) Sets may be considered eligible for the MEDCASE/SuperCEEP 

program regardless of the unit price of their components. NOTE: This policy does not 

apply to standard, type classified, medical equipment sets that are listed as serviceregulated items in chapters 2, 4, and 6 of SB 700-20. 

(3) The replacement of components through the MEDCASE/SuperCEEP 

program may be considered only if the component, by itself, meets 

MEDCASE/SuperCEEP eligibility criteria. 
SB 8-75-MEDCASE 

2-4 

g. Medical Equipment Systems. 

(1) A system is defined as a collection or assemblage of component 

items, which must function together to accomplish a given objective. A system’s 

components are usually physically connected and usually cannot function in the 

absence of its other components. 

(2) Systems may be considered eligible for the MEDCASE/SuperCEEP 

program, regardless of the unit price of their component end items, provided that the 

system itself meets the eligibility criteria. A “system” will not be considered 

MEDCASE/SuperCEEP-eligible if a component by itself meets MEDCASE/SuperCEEP 

eligibility criteria. 

(3) It appears that its sole purpose is to aggregate the unit costs of its 

component end items in order to reach the program thresholds. Requirements for 

systems will be considered on a case-by-case basis. 

h. Components. 

(1) Components are defined as sub-elements or sub-assemblies of a set 

or system that are integral to the basic function of that set or system. Components of 

sets are those items which are integral to the set and which are identified and 

accounted for on its component listing. Components of systems are those component 

end items which must function together to accomplish the basic purpose of the 

system and which are identified on the approved MPR. 

(2) Nonexpendable components must be accounted for on the activity 

property book as prescribed by the Defense Medical Logistics Standard Support 

(DMLSS) system. 

(3) Components that are necessary to make the set or system complete 

(regardless of unit price) may be acquired using MEDCASE/SuperCEEP funds when 

acquired with a MEDCASE/SuperCEEP eligible set or system. The acquisition of 

components subsequent to or separate from the set or system may be eligible for the 

MEDCASE/SuperCEEP program provided that the eligibility criteria (funding 

thresholds) are met. A system shall be considered to exist if one or more components 

are part of and function within the context of a whole to satisfy a documented 

requirement. 

i. Accessories.

(1) Accessories are items that enhance or provide additional capabilities 

to an end item. An accessory may be expendable, durable, or nonexpendable; 

whereas a component is a functional element of a set or system, an accessory is 

considered to be a supplementary item. A transducer for an ultrasound scanner is a 

component of that end item. Additional transducers, which provide additional 

capabilities, are considered to be accessories to the end item.

(2)Accessories that are required to provide the full range of functions 

intended for an end item or a system and are identified on the approved requisition 

may be acquired using MEDCASE/SuperCEEP funds at the time the MEDCASE/ 

SuperCEEP-eligible end item or system is acquired. The acquisition of accessories 
SB 8-75-MEDCASE 

2-5 

through the MEDCASE/SuperCEEP program subsequent to or separate from the end 

item or system may be considered, provided that eligibility criteria (funding 

threshold) are met for the specific accessory. 

j. Upgrades. 

(1) Upgrades to existing medical diagnostic/therapeutic equipment 

acquired through the MEDCASE/SuperCEEP program may be considered on a caseby-case basis for MEDCASE/SuperCEEP eligibility. Upgrades can be accomplished 

through the acquisition of a system modification or software that meets the eligibility 

criteria. 

(2) Upgrades/modifications to equipment or systems, which are not 

approved through the MEDCASE/SuperCEEP program, are considered service or 

maintenance in nature and shall not be MEDCASE/SuperCEEP-funded, regardless of 

cost. 

(3) Repair parts are not eligible for the MEDCASE/SuperCEEP program. 

k. Eligibility for Medical MILCON Projects. 

(1) Equipment that is required to complete a medical construction 

project is subject to the same review and eligibility criteria as all other 

MEDCASE/SuperCEEP program submissions. 

(2) Requirements for Government Furnished-Contractor Installed 

Equipment (LOGCAT B and C) with a unit cost less than $250,000 must be acquired 

using DHP OMD funds. 

l. Refurbishment. 

The use of DHP OPD MEDCASE funds or centralized SuperCEEP DHP (OMD) funds to 

refurbish an existing piece of equipment is prohibited. Local DHP (OMD) funds should 

be used for refurbishment of existing equipment. 

2-4. EQUIPMENT REPLACEMENT 

a. General. Equipment will be replaced only when justified and supported by 

valid clinical need, demonstrated deficiency, or sound economic rationale. The age of 

an otherwise functional item of equipment shall not by itself be accepted as sufficient 

justification for replacement. MEDCASE/SuperCEEP program submissions must clearly 

demonstrate, with supporting documentation where appropriate, why an item of 

equipment is no longer acceptable for use. Factors that commonly support equipment 

replacement are: 

(1) Maintenance experience, including excessive one-time or cumulative 

maintenance expenses or an unacceptably high frequency of repair. 

(2) Technological obsolescence which unacceptably inhibits or degrades 

the quality of health care provided or the introduction of new technology which 

improves treatment/diagnostic accuracy or reduces pain/morbidity. 
SB 8-75-MEDCASE 

2-6 

(3) Economic return through demonstrated cost reduction, increased 

efficiency and productivity, or conservation of manpower, supplies and utilities. 

b. Retention for Backup. Equipment that is replaced through the 

MEDCASE/SuperCEEP programs will not routinely be retained for back up. Hospital 

commanders must sign a separate memorandum authorizing equipment retention. 

This memorandum must be submitted with the MPR/MEDCASE Support and 

Transmittal Form (MSTF). 

c. New Facility Construction. The replacement of equipment associated with 

new facility construction is subject to the same requirements for justification, which 

apply to routine replacement and modernization. 

2-5. UTILIZATION OF EXCESS EQUIPMENT 

The utilization of excess equipment shall be the first consideration and the preferred 

means for meeting an equipment requirement. SB-75-11, dated 20 November 2005, 

specifies the procedures for identifying, reporting, and redistributing excess 

equipment. 

2-6. PROPERTY ACCOUNTABILITY 

a. Property Book Accounting. In order to be eligible for MEDCASE/SuperCEEP 

funding, a requirement must be a nonexpendable end item or a nonexpendable 

component or accessory to an end item; therefore, equipment acquired through the 

MEDCASE/SuperCEEP program must be accounted for on the activity property book 

in accordance with: 

•AR 710-2 (Inventory Management Supply Policy Below the Wholesale 

Level), 

• AR 735-5, AR 40-61, and the 

• DMLSS guidance. 

Under the Chief Finance Officer (CFO) Compliance Act all documentation affecting 

capital value of the equipment will be kept in physical files throughout the life of 

the asset (e.g., contracts, invoices, site prep, installation, production engineering, 

etc.) to include documentation related to disposals transfers in from other federal 

activities, exchanges, and trade-ins. This file must be maintained for the entire 

life of the equipment. For more information see SB-8-75-11, 

para 5-6, dated 20 November 2005. This policy applies to all equipment acquired 

with MEDCASE/SuperCEEP funds. 

 b. Uninstalled Equipment. Accountability for equipment acquired through 

the MEDCASE/SuperCEEP program will be established at the time the equipment is 

received by the activity. This policy specifically includes “uninstalled” equipment 

awaiting installation or the completion of site preparation. 
SB 8-75-MEDCASE 

2-7 (2-8 blank) 

2-7. FINANCIAL MANAGEMENT

a. Funds Control. 

(1) The USAMEDCOM programs and receives DHP-MEDCASE/SuperCEEP 

funds. They release MEDCASE/SuperCEEP funds to USAMMA for management, 

control, and execution, and notify the RMCs and MSCs of the amount released. 

USAMMA establishes, controls, and maintains funds accounts for 

MEDCASE/SuperCEEP participants in the AMEDD central database, the WebMRE 

System in conjunction with USAMEDCOM guidance. 

(2) The WebMRE System is the AMEDD central database for funds 

control of DHP-MEDCASE/SuperCEEP funds. The USAMMA is the proponent of this 

system and is the central accounting office for these funds. 

b. Funds Allocation.

(1) The USAMEDCOM, through the STCPC, recommends to TSG which 

requirements will be funded annually. Commands may request adjustments to which 

items are funded in writing to the USAMEDCOM. 

(2) Participating activities will maintain an internal record of the status of 

their MEDCASE/SuperCEEP funds release. 

(3) The USAMEDCOM may withdraw any uncommitted, unobligated funds 

from RMCs and MSCs based upon failure to meet commitment and/or obligation 

targets. The USAMEDCOM can and will “roll-up” uncommitted/unobligated funds for 

centralized execution in the third quarter of the execution year and possibly earlier if 

financial circumstances dictate.

c. Program Execution.

(1) The USAMEDCOM will establish overall program execution targets. 

RMCs and MSCs will develop an execution plan that establishes targets and 

milestones for the commitment and obligation of their command allocation.

(2) Participating activities are responsible for the judicious management 

and use of MEDCASE/SuperCEEP funds. 

(3) The USAMMA will fund the execution of approved program 

requirements through the funding of requisitions or for non-diagnostic imaging items 

using Letters of Authority (LOAs) or issuance of a Military Interdepartmental Purchase 

Requests (MIPRs). 

2-8. NONCOMPETITIVE ACQUISITION

The DOD policy requires that acquisitions be made on a competitive basis to the 

maximum practical extent. Equipment requirements shall be evaluated based upon a 

specific, but generic, need and described in terms of minimum essential 

characteristics. In cases where such needs and characteristics can only be met by 

noncompetitive acquisition, the provisions of the Federal Acquisitions Regulations 

(FAR) and the Defense Acquisition Regulation Supplement (DFARS) must be satisfied. 
SB 8-75 MEDCASE 

3-1 

CHAPTER 3. DEVELOPMENT OF MEDCASE/SUPERCEEP REQUIREMENTS 

3-1. INTRODUCTION 

a. MEDCASE/SuperCEEP Requirements. A MEDCASE/SuperCEEP requirement is 

a need for an item of equipment which is eligible for funding through the MEDCASE/ 

SuperCEEP program. A requirement equates to a single end item or system. 

(1) MEDCASE/SuperCEEP requirements are forecasted and initiated by 

each MEDCASE/SuperCEEP program participant and are submitted through command 

channels for review and approval or disapproval. The unit price and functional area of 

the equipment requirement determine the level of approval authority. 

(2) Approved and disapproved MEDCASE/SuperCEEP requirements are 

retained in the program database of the WebMRE System. Approved requirements may 

be executed when it is determined that funds are available. 

b. Requirements Development by the MTF. The process of requirement 

development includes three broad functions. Unless otherwise specified in this manual, 

local or command directives may establish specific procedures and responsibilities for 

the accomplishment of these functions. The following paragraphs describe the functions 

that must be accomplished at the activity level during the three phases of requirements 

development: 

(1) Identification of requirements. The identification of requirements 

includes forecasting requirements for equipment replacement and modernization and 

the identification of equipment requirements to meet additional missions, 

advancements in technology or standards of medical practice. 

(2) Initiation of MEDCASE/SuperCEEP requirements. The initiation of 

requirements includes the preparation of the DA Form 5027-R (MEDCASE Program 

Requirement) and DA Form 5028-R (MEDCASE Support and Transmittal Form), the 

obtaining of separate approvals (when required), and the assigning of a MEDCASE/ 

SuperCEEP Asset Control Number (ACN) with BLIC for MEDCASE items. Appendix B 

provides instructions for the preparation of DA Form 5027-R and DA Form 5028-R. 

(3) Submission of MEDCASE/SuperCEEP requirements. The submission of 

requirements includes the assembly of a completed DA Form 5027-R/5028-R with all 

attachments and supporting documentation through applicable channels. 

c. Requirements Development by the TARA. The process of requirement 

development includes two broad functions. The following paragraphs describe the 

functions that must be accomplished during the two phases of requirements 

development: 

(1) The identification of requirements. During a TARA site visit (see 

chapter 17), the team develops a 5-year equipment upgrade and replacement plan for 

all diagnostic imaging items that meet the MEDCASE/SuperCEEP threshold. 

 

(2) The initiation of MEDCASE/SuperCEEP requirements. Per the 5-year 

plan, the USAMMA develops an ACN in the WebMRE and requests MTF and RMC 

concurrence. 
SB 8-75 MEDCASE 

3-2 

3-2. IDENTIFICATION OF REQUIREMENTS 

With the exception of TARA reviewed items, identification of requirements is normally 

the responsibility of the user. Although some requirements may be identified by other 

sources, such as a Hospital Risk Management Committee, generally, MEDCASE/ 

SuperCEEP requirements are identified based upon one of the following reasons: 

a. Routine Replacement. 

(1) The user, based upon maintenance, technology, and/or economic 

considerations, forecasts the routine replacement of existing equipment. 

 

(2) To assist the user, DMLSS and the Joint Medical Asset Repository 

provide an Equipment Replacement Report. This report is available by property book 

and hand receipt and identifies equipment that may be eligible for replacement based 

upon date-in-service and life expectancy. While life expectancy alone is not an 

acceptable justification for replacement, this report provides a "starting point" for 

evaluating equipment for possible replacement. MEDCASE/SuperCEEP managers must 

provide users with this report on an annual basis or upon request. 

b. New Technology. The user or the DIRS identifies new products arising from 

advancements in technology. Sources of information commonly include professional 

publications, professional development conferences, consultant visits, and equipment 

vendors. 

c. New Mission. New missions assigned to an activity must be evaluated as 

soon as possible to determine if they can be supported by existing equipment. The 

activity or agency assigning the new mission as well as the activity receiving the new 

mission must conduct this evaluation. The directive assigning the new mission must be 

identified on the DA Form 5027-R. 

d. Military Construction. New requirements for equipment may arise as a result 

of facility construction or a renovation project, which provides an increase in either the 

size or the capability of the activity. 

3-3. MTF OR RMC INITIATION OF REQUIREMENTS

a. A MEDCASE/SuperCEEP requirement is initiated by the preparation and 

processing of a DA Form 5027-R and a DA Form 5028-R. This is the responsibility of 

the user or the requester. The DA Forms 5027-R and DA Form 5028-R must be 

initiated once it has been determined that a need cannot be met through the use of 

existing or reported excess assets. 

b. The DA Forms 5027-R/5028-R are the basic documents of the 

MEDCASE/SuperCEEP program. Appendix B provides instructions for the preparation of 

DA Form 5027-R and DA Form 5028-R. Together they provide an auditable record that 

documents the need, coordination, and approval of a MEDCASE/SuperCEEP 

requirement. MEDCASE/SuperCEEP program participants, MSC/RMCs, and USAMMA are 

responsible for ensuring that DA Forms 5027-R/5028-R are complete, adequate, 
SB 8-75 MEDCASE 

3-3 

accurate, and equipment requested is eligible for funding with MEDCASE/SuperCEEP 

funds. The requesting activity must maintain copies of all DA Forms 5027-R/5028-R for 

audit purposes. 

(1) DA Forms 5027-R/5028-R must be prepared for each eligible 

MEDCASE/SuperCEEP requirement. As an exception, multiple quantities of a single line 

item may be requested on a single DA Form 5027-R/5028-R provided that the items 

are identical, the maintenance information for each item being replaced is provided and 

the justification on the DA Form 5027-R MPR is adequate for the total quantity. An ACN 

will be assigned to each item identified on the DA Form 5027-R, consequently, funding 

approval will occur independently. 

(2) MEDCASE/SuperCEEP requirements shall be described in generic terms 

using the Standard Item Descriptions provided in Appendix A. Requirements will not be 

described by brand name. Where necessary for clarity, a brand name reference may be 

included following the generic item description; however this will not be accepted as an 

endorsement of that particular brand. 

(3) Each individual block on the DA Form 5027-R must be completed. 

Continuation sheets may be used where necessary provided there is a clear reference 

to the block being continued. It is acceptable to leave a block on the DA Form 5027-R 

blank with a reference to "see attached sheet." 

(4) The DA Form 5027-R must include a justification that clearly 

establishes the need for the item requested. 

(5) If required for clarity, a copy of manufacturer's literature will be 

attached to the DA Forms 5027-R/5028-R as an enclosure. The enclosure of 

manufacturer's literature does not constitute endorsement of that brand. 

(6) The initiator or requester certifies that the requirement described on 

the DA Form 5027-R is valid and that the justification provided is accurate to the best 

of his/her knowledge. The initiator's release also certifies that consideration has been 

given to the availability of existing or excess assets and that none are available that 

will meet the requirement. 

(7) If the requirement is not a TARA-generated approved requirement, 

regardless of cost, you are required to provide a total case analysis (TCA) as noted in 

appendix F. 

(8) If your facility had a TARA visit within the last four years, no TCA or 

detailed justification is necessary. 

3-4. ASSIGNMENT OF A MEDCASE/SUPERCEEP ACN 

Each MEDCASE/SuperCEEP requirement is identified by an ACN. ACNs are used to track 

requirements throughout the review and approval process and are the means by which 

requirements are identified and funded in the WebMRE system. (See figure 3-1.) 
SB 8-75 MEDCASE 

3-4 

FIGURE 3-1. ASSET CONTROL NUMBER 

IDC FISCAL YEAR (FY) SEQUENCE NUMBER (SEQ) 

Is determined by the AMEDD 

Standard Item Description in 

appendix A 

The target FY for 

execution 

A unique, locally assigned, 

3-position number used to identify 

a specific requirement. 

3265 04 001 

Scanner, Computed 

Tomography, Computed FY 2004 Identifies the specific requirement for a CT X-ray system 

a. Construction of an ACN. MEDCASE/SuperCEEP ACNs consist of three 

elements as stated below: 

(1) IDC. The IDC is a four-position numeric code that relates to a 

standard item description for each type of equipment. Accurate IDCs are necessary for 

tracking and identifying equipment in automated property accounting and asset 

visibility systems. Appendix A provides a list of standard IDCs by functional area and in 

nomenclature sequence. 

(2) FY Code: The FY Code refers to the fiscal year in which acquisition of 

the requirement is recommended or requested. For routine submissions, this will be the 

FY of the budget year, i.e., the next fiscal year. For urgent or emergency requirements, 

this will be the FY of the current or execution year. 

(3) SEQ Code: SEQ is a three-digit code assigned from an ACN control 

register in accordance with local or command procedures. Normally, the activity 

MEDCASE/SuperCEEP manager maintains the ACN control register. 

b. Assignment of an ACN. An individual ACN will be assigned to each 

requirement. In cases where multiple items are requested on a single DA Form 5027-

R/5028-R, an ACN will be assigned for each item. 

c. Recording ACNs in DMLSS. For MEDCASE/SuperCEEP program participants 

utilizing DMLSS for property accountability, the ACN must be entered when establishing 

a Planning Record. 

d. The USAMMA/USAMEDCOM Unique ACNs. Sequence numbers 700 through 

999 are reserved for the USAMMA use only. Sequence numbers 700 through 799 will be 

used for Picture Archiving Communications Systems (PACS). Sequence numbers 800 

through 899 identify MEDCOM generated items. Sequence numbers 900 through 999 

identify TARA recommended items. This technique is intended to allow uninterrupted 

processing of requirements. When a 700, 800, or 900 series ACN is used, the USAMMA 

will notify the activity. 

3-5. ASSIGNMENT OF A BLIC 

a. General. MEDCASE funds and requirements are divided into six categories 

that are identified by a BLIC. These categories describe the purpose for which the 

equipment and funds are required. The DMLSS and the WebMRE system incorporate a 

two-position BLIC. Input and output transactions in both the DMLSS and WebMRE 

utilize the two-position BLIC. 
SB 8-75 MEDCASE 

3-5 

(1) BLIC UR (Replacement and Modernization). Identifies funds and 

equipment required to replace, upgrade, or modernize existing equipment or to provide 

new or expanded capabilities. 

(2) BLIC CF (Clinical Investigation). Identifies funds and equipment 

required to support the AMEDD's Clinical Investigation Program. 

(3) BLIC PC (Pollution Control). Identifies funds and equipment required 

to support the AMEDD's Pollution Control Program. 

(4) BLIC DA (Drug Abuse and Control). Identifies funds and equipment 

required to support the AMEDD's Drug Abuse Prevention and Control Program. 

(5) BLIC NF (New Facilities Equipment [DHP-funded]). Identifies funds and 

equipment required to equip medical MCA-funded construction/renovation projects. 

(6) BLIC MB (New Facilities Equipment for Medical Military Construction 

Projects). Identifies funds and equipment required to equip medical MILCON new 

construction/renewal projects. 

b. Responsibility. All MEDCASE requirements must accurately reflect the 

appropriate BLIC on the DA Forms 5027-R/5028-R. The BLIC is entered on the forms 

by the activity MEDCASE manager. 

3-6. JUSTIFICATION OF REQUIREMENTS 

a. General. Adequate clinical, logistical, or economic justification for 

MEDCASE/SuperCEEP requirements is absolutely essential to the integrity of the 

MEDCASE/SuperCEEP program. All requirements must be justified. The justification is 

the responsibility of the user or the initiator of the requirement, although it is the 

responsibility of every individual who releases a requirement to evaluate and, if 

appropriate, to question the justification provided. 

b. Justifications. Justifications must be concise and entered in the appropriate 

space on the DA Form 5027-R. Continuation sheets may be used where necessary, 

provided there is a clear reference to the block being continued. It is acceptable for the 

justification block on the DA Form 5027-R to reflect, "see attached sheet." 

(1) Minimum Essential Characteristics. A justification should state the 

minimum essential characteristics of the item requested and provide a clinical or 

functional reason for each. 

(2) Justifications Supported by Facts. General statements such as, 

"...required to meet an increase in workload" will not be accepted unless the actual 

increase in workload is quantified and explained. Justifications that cite maintenance 

problems experienced with existing equipment must be supported by documentation of 

those maintenance problems. Such documentation is provided by the Equipment 

Maintenance Activity and must accompany the DA Forms 5027-R/5028-R through the 

review and approval process. 

(3) Capabilities Versus Requirements. Justifications must relate the 

capabilities requested to the actual requirements of the activity. A requirement 
SB 8-75 MEDCASE 

3-6 

justification that explains in great detail the technological advantages of a type of 

equipment will not be accepted unless the activity’s need for those advantages is 

explained. The phrase "state-of-the-art" is not an acceptable justification unless the 

specific "state-of-the-art" capabilities and the need for those capabilities are described. 

Justifications must not repeat or paraphrase manufacturer's literature. 

c. DA Form 5027-R Justification Block. The justification block on the DA Form 

5027-R prompts the initiator to answer specific questions regarding the requirement. 

These questions must be answered clearly and concisely 

(1) What is the requested item to be used for? Why is the item needed? 

(2) How will the item be used with other equipment? 

(3) What are the advantages of the requested item over equipment 

currently in use or available on the market? Why are these advantages needed? 

(4) Have specific details been presented regarding cost-benefit, personnel 

savings or productivity, the enhancement or curtailment of services, frequency or 

duration of breakdown, or other specific factors that may be relevant? 

(5) What will be the impact upon mission accomplishment if the requested 

item is not acquired? 

(6) Is the anticipated workload provided? 

(7) Has consideration been given to the use of available excess assets to 

satisfy this requirement? 

3-7. THE DMLSS SYSTEM 

a. General. The DMLSS is a standard DOD system utilized by DOD medical 

activities worldwide. DMLSS provides the capability to plan, acquire, account, manage, 

and maintain property. 

b. Requirements. The DMLSS equipment request enables activities to plan 

equipment acquisitions. This function and associated transactions allow for a systematic 

plan for the equipment needs of an activity's ongoing operations, technological 

innovations or change of mission. It provides a variety of tools for the management of 

an activity's MEDCASE/SuperCEEP program. Properly used, this module will provide 

management information applicable to each phase of the development of 

MEDCASE/SuperCEEP requirements. 

c. Equipment Replacement Report. To support the identification of candidates 

for equipment replacement, DMLSS and Joint Medical Asset Repository (JMAR) provide 

Equipment Replacement Reports, which can be produced by property book or by hand 

receipt. This report identifies equipment that may be eligible for replacement based 

upon date-in-service and life expectancy. Although the age of equipment is not in itself 

justification for replacement, this report must be used by the activity to identify items 

of equipment that may warrant further evaluation. 

d. Planning Record. Once the activity/RMC/MSC commander has approved a 

MEDCASE/SuperCEEP requirement, it is ready to be submitted through command 
SB 8-75 MEDCASE 

3-7 

channels for review and approval as deemed appropriate. The DMLSS Equipment 

Request process generates an email that is sent to the USAMMA when the item is 

approved locally. The USAMMA enters the requirement in the WebMRE, but it is the 

responsibility of the activity to ensure the requirement is in the WebMRE system. 

3-8. OBJECTIVES FOR MEDCASE/SUPERCEEP PROGRAM SUBMISSIONS 

a. General. MEDCASE/SuperCEEP requirements must be submitted as they are 

approved by the activity commander. They should not be held at the activity and 

submitted in batches at routine intervals. Routine MEDCASE/SuperCEEP Program 

requirements are submitted during the budget year (i.e., during the FY preceding the 

FY in which the equipment is to be acquired). Requirements that are deemed by the 

local activity commander to be urgent or emergency are submitted for approval during 

the current execution year. 

b. Processing Objectives. RMCs may establish processing objectives for their 

subordinate activities. Unless otherwise specified by command policies or procedures, 

activities should consider an average of 30 working days as the goal for the completion 

of internal review and approval. 

3-9. SUBMISSION OF REQUIREMENTS

a. Documents Required for Submission. Requirements must be submitted as 

complete packages, i.e., the DA Forms 5027-R/5028-R with all appropriate supporting 

documentation and enclosures. The following list of documents typically comprises a 

MEDCASE/SuperCEEP program submission: 

 

(1) DA Form 5027-R

(2) DA Form 5028-R

(3) Maintenance records on equipment that is to be replaced 

(4) Documentation of separate approval for non-medical items

(5) Manufacturer’s or vendor's price quote and literature

(6) Total Case Analysis (Appendix F) 

b. Coordination of the DA Forms 5027-R/5028-R. Coordination is necessary to 

ensure that the item requested is appropriate and can be installed and/or supported by 

the activity. The activities most commonly involved in the review process have spaces 

provided on the DA Form 5028-R for comment and concurrence. Documentation of 

additional review may be attached as separate enclosures. Coordination with the 

following areas within the activity must be considered for all MEDCASE/SuperCEEP 

requirements and is generally the responsibility of the local MEDCASE/SuperCEEP 

Manager: 

(1) Equipment Maintenance Activity. All MEDCASE/SuperCEEP 

requirements must be reviewed and commented upon by the equipment maintenance 

activity, which is responsible for the maintenance and repair (or maintaining a service 

contract) of equipment requested. Under no circumstances will the maintenance block 

on the DA Form 5028-R be considered "Not Applicable." The maintenance activity is 
SB 8-75 MEDCASE 

3-8 

responsible for determining if the item requested can be supported, either through 

in-house maintenance or by service contract. For replacement of existing 

MEDCASE/SuperCEEP requirements the maintenance activity is responsible for 

determining if replacement is justified from a maintenance perspective and enters 

specific information obtained from maintenance records onto the DA Form 5028-R. The 

maintenance activity also provides a current copy of the maintenance record to be 

forwarded with the DA Forms 5027-R/5028-R. 

(2) Engineer (Facility Manager). All MEDCASE/SuperCEEP requirements 

that require installation or site preparation must be reviewed and commented upon by 

the facility managing activity that provides facility support. The facility managing 

activity is responsible for determining if the equipment requested can be installed and 

operated in the facility and estimating requirements for site preparation, if necessary. 

Of particular importance are the availability of power, drainage, ventilation, and other 

utilities that may be required for the operation of the equipment. The health facilities 

officer or Project Point of Contact (POC) must sign in the Engineer Block if the project is 

a medical MILCON project. 

(3) Information Management Officer. All MEDCASE/SuperCEEP 

requirements which have Information Mission Area Equipment (IMAE) associated with it 

must be reviewed by the activity's Information Management Officer (IMO). The IMO is 

responsible for determining if the equipment requested requires separate IMA approval 

as prescribed by AR 25-1. 

(4) Health Physics Officer (HPO). The HPO review and clearance is 

required for all MEDCASE/SuperCEEP requirements which emit radiation, microwaves, 

laser, radio waves, or has radioactive materials as a component. HPO clearance may be 

granted if all regulatory requirements are, or shall be, met. 

(5) Local Chief of Radiology. All MEDCASE/SuperCEEP requirements for 

diagnostic imaging or radiation therapy equipment must be reviewed by the local Chief 

of Radiology whether or not it will be operated within the Department of Radiology. The 

concurrence and signature of the Chief of Radiology must appear on the DA Form 

5027-R, if more space is needed use a separate enclosure. 

(6) Resources Manager. All MEDCASE/SuperCEEP requirements that: 

(a) require maintenance by service contract; 

(b) allow termination of a service contract; or 

(c) are justified based upon economic return or savings must be 

reviewed by the activity resources manager. The resource manager determines the 

impact of the requirement upon the activity operating budget to ensure that it can be 

supported and verifies economic analysis used in the justification. Resources manager 

comments and signature must appear on the DA Form 5027-R. 

(7) Logistics. The Logistics Division is the proponent for the activity's 

MEDCASE/SuperCEEP program. The Chief of Logistics is responsible for ensuring that a 

MEDCASE/SuperCEEP requirement is: 

(a) eligible for the MEDCASE/SuperCEEP program; 
SB 8-75 MEDCASE 

3-9 

(b) properly coordinated (to include the screening of excess assets) 

with all of the necessary signatures; and 

(c) ready for submission to the activity commander for review and 

approval. The Chief of Logistics must recommend approval or disapproval of all 

MEDCASE/SuperCEEP program requirements. 

c. Local Approval. Once the DA Forms 5027-R/5028-R are initiated and 

coordinated within the activity, the activity commander reviews and approves or 

disapproves the requirement. This authority will not be delegated. The release of the 

DA Forms 5027-R/5028-R by the activity commander designates approval of the 

requirement and certifies that the requirement represents a valid, justified need for the 

accomplishment of the activity's mission. The Commander also determines whether or 

not an item to be replaced should be turned in or retained. 

d. Role of Local Program Budget Advisory Committee (PBAC). The PBAC is an 

advisory committee that recommends funding and other resource utilization priority 

ranking to the commander. The PBAC neither approves nor disapproves 

MEDCASE/SuperCEEP requirements. The PBAC does not review DA Forms 5027-R or 

5028-R before they are forwarded for final review and approval. The prioritizing of the 

MEDCASE/SuperCEEP requirements must be accomplished prior to the end of 

September in the year of execution or earlier if requested by USAMEDCOM. 

e. Regional Medical Command/Major Subordinate Command Approval. The 

requirement is forwarded to the RMC Commander for approval or disapproval after the 

activity commander reviews and approves the requirement. The RMC Commander 

authority will not be delegated. Upon RMC/MSC approval, all DA form 5027-R/5028-R 

must be sent to USAMMA for OTSG consultant review. 

3-10. MILCON PROJECT REQUIREMENTS MANAGEMENT (BLIC "NF" AND "MB") 

a. Planning for the Equipment. Requirements must be started before 

construction begins. This ensures that sufficient funds are allocated for the equipment 

in advance of construction. Chapter 11 provides an overview of the events and the 

responsibilities associated with a project. The following paragraphs discuss the 

development of MEDCASE requirements for a new or renovated facility. 

b. Management of Medical MILCON Projects. MEDCASE requirements for 

medical MILCON projects are intensively managed at the activity and the command 

level. Each project is identified within the MEDCASE system by a Project Code. 

Activities must add the project code to the Project Code File in the DMLSS 

requirements module to ensure correct interface with the WebMRE system. A project 

code is obtained from USAMMA for each facility project. 

c. Assignment of a BLIC. Equipment requirements developed as part of a 

medical MILCON project are assigned one of two BLICs: NF or MB. These BLICs 

identify the type of funds that will be used to execute the requirement. To determine 

the appropriate BLIC, the activity must determine the Logistical Category (LOGCAT) 

code assigned to that type of equipment. LOGCATs are explained in chapter 11, 

paragraph 11-3. 
SB 8-75 MEDCASE 

3-10 

(1) BLIC "NF" requirements are funded with DHP MEDCASE/SuperCEEP 

funds. BLIC "NF" requirements equate to LOGCAT C equipment. 

(2) BLIC "MB" requirements are funded with medical MILCON funds which 

are set aside by the Corps of Engineers for the acquisition of equipment through the 

MEDCASE program. BLIC "MB" requirements equate to LOGCAT "E" and "F" equipment. 

d. Justifications for BLIC "NF" and "MB" Requirements. Justifications for 

equipment required as parts of a project are subject to the same scrutiny as 

requirements within other BLICs. In order to ensure that justifications provided are 

adequate, the activity should address the following: 

(1) If the DA Forms 5027-R/5028-R are for a replacement item of 

equipment, include supporting documentation such as maintenance records for the 

item being replaced. This requirement is no different from that which is required for a 

BLIC "UR" submission. 

(2) If the DA Form 5027-R/5028-R are for equipment that is needed to 

meet the requirements of a larger facility or expanded capabilities, describe the 

difference between the old and new facilities and explain what existing assets can and 

cannot be used. 

(3) Do not assume that the approving authority can consider the fact that 

a requirement is listed on the Project Room Report (PRR) or has been identified by the 

transition committee as justification by itself. Every requirement must stand on its own 

merits and clearly explain why the equipment requested is required. 

e. Submission of Requirements. 

(1) BLIC “NF” and “MB” requirements may be submitted up to 5 years 

before the anticipated year of execution. Requirements, which require installation must 

be submitted in time to allow for sufficient acquisition lead-time to prevent construction 

delays. The ACNs shall reflect the FY of the year in which execution is expected. These 

requirements must be developed and submitted in time to routinely flow through the 

MEDCASE/SuperCEEP review process and to allow adequate procurement lead-time 

following approval and funding. Activities must plan to have "1A" approval on individual 

requirements no later than 12 months prior to the execution year. 

(2) Requirements that are not funded will be purged from the MEDCASE 

database at time of Beneficial Occupancy. Requests for exceptions to the policy for DA 

Forms 5027-R/5028-R submission and/or funding must be submitted through 

command channels to USAMMA, ATTN: MCMR-MMO-AT, for evaluation on an individual 

case-by-case basis. 

f. Review Criteria for On-hand Equipment. It is AMEDD policy that existing 

assets be used to meet the equipment requirements of construction/renovation 

projects to the maximum extent feasible. The review and evaluation of equipment 

requirements and existing assets must take into account the potential obsolescence of 

equipment at the time the new facility will be occupied. Also, consideration must be 

given to the cost of removing, transferring and reinstating existing equipment, as well 

as the useful life of on-hand assets if there is slippage in the occupancy dates due to 

construction delays. A project shall not be viewed as an opportunity to acquire all new 

equipment for a facility. Replacement of existing equipment must be fully supported 
SB 8-75 MEDCASE 

3-11 

and justified through the MEDCASE/SuperCEEP approval process. The following criteria 

may be used as a guide in evaluating existing equipment: 

(1) Equipment having at least 24 months of useful life remaining at the 

time of planned occupancy of the new facility should be used in the new facility unless 

the equipment would be technologically obsolete or cannot be made to conform to 

safety standards or project design. Equipment that is essential to operations in both 

the old and new facility may be considered for replacement if the equipment cannot be 

removed, transferred, and reinstalled in time to prevent curtailment of essential 

services. 

(2) Equipment in place is normally not eligible for MEDCASE/SuperCEEP 

funding. Equipment in place that has at least 12 months of useful life remaining at the 

time of planned occupancy of the new facility should be used in the new facility unless 

the equipment would be technologically obsolete. 

g. Early Replacement of Equipment. If, during the review process, it is 

determined that an item of equipment must be replaced due to maintenance or 

technological reasons before it would otherwise be moved to the new facility, it should 

be replaced as a BLIC "UR" MEDCASE/SuperCEEP requirement. Consideration will be 

made on a case-by-case basis. 

3-11. INITIATION OF BLIC "NF" AND BLIC "MB" REQUIREMENTS 

a. Equipment Planning. For planning purposes, there are two categories of 

equipment that must be programmed for a medical MILCON project. 

b. LOGCAT Codes - Government Furnished Equipment (GFE). (Note: Few 

items, if any, are MEDCASE/SuperCEEP eligible.) GFE items are those LOGCAT "E" 

items that are listed in the final design drawings and contract specifications for the new 

facility. The government must provide this equipment to the construction contractor, 

who is responsible for their installation. It is essential that these items are made 

available to the contractor by various deadlines established in the construction 

contract; otherwise, the government may be liable for costs associated with a project 

delay. The Health Facility Project Office (HFPO) assigned to the project will advise the 

activity of the required delivery dates for GFE. 

c. X-ray equipment. X-ray equipment is typically MILCON funded and are 

categorized as LOGCAT "F" items. X-ray equipment is installed by the equipment 

vendor as part of the purchase contract. The technical complexity of these systems 

requires considerable effort to adequately prepare the necessary documentation for 

their approval and purchase. Due to their high dollar value, long acquisition lead times 

are often experienced, especially for overseas customers. 

3-12. CENTRAL REQUIREMENTS 

a. General. There may be cases where it is determined that it would be 

advantageous to generate consolidated MEDCASE/SuperCEEP equipment requirements 

for approval and/or acquisition. Advantages of such action could include: the 

standardization of an item, the ability to apply funds for a large requirement without 
SB 8-75 MEDCASE 

3-12 

decrementing activities' accounts, ensuring the timely or coordinated receipt of 

equipment by several activities, or cost savings which may be obtained through the 

competitive acquisition of large quantities of equipment. 

(1) A consolidated acquisition pertains to the consolidation of approved 

MEDCASE/SuperCEEP requirements for central acquisition by a designated procurement 

activity. 

(2) A central requirement pertains to the identification, initiation, 

coordination and approval of a MEDCASE/SuperCEEP requirement. Central 

requirements may be executed by either a consolidated acquisition or by decentralized 

local procurement by the designated activities. 

b. Development of Central Requirements. Central requirements may be 

developed and submitted for approval using a single DA Form 5027-R/5028-R with a 

listing of the activities designated to receive the equipment included as an enclosure. A 

central requirement provides sufficient justification to support the acquisition of the 

equipment for all of the designated activities and, when applicable, to include 

maintenance summaries. The activity preparing the central requirement is responsible 

for the preparation of the acquisition purchase description of the equipment. 

(1) The USAMEDCOM and USAMMA may generate central requirements for 

medical activities. In such cases, there is no requirement for the receiving activity to 

generate a DA Form 5027-R or a DA Form 5028-R. Activities must establish the 

requirement in the Requirements module of DMLSS. 

(2) The USAMMA will assign an ACN for each activity and notify the activity 

of the ACN and request they assign and provide a document number in order to 

process the requirement for procurement. The USAMMA will notify the activity when to 

establish a due in and the activity will update DMLSS with the due in. 

c. Coordination. Central requirements and/or consolidated acquisitions require 

careful coordination to ensure that activities are provided with the information 

necessary to post MEDCASE/SuperCEEP records and establish property accountability. 
SB 8-75-MEDCASE 

4-1 

CHAPTER 4. APPROVAL OF MEDCASE/SUPERCEEP REQUIREMENTS 

4-1. INTRODUCTION 

a. General. All MEDCASE/SuperCEEP program requirements must be 

approved for propriety. The level of approval is determined by the unit price of the 

requirement. The USAMEDCOM, the RMCs, MSCs, or the USAMMA retains the 

prerogative to review and override approvals on an exception basis. 

(1) MEDCASE/SuperCEEP requirements will be evaluated based upon 

MEDCASE/SuperCEEP program eligibility, adequacy of justification and 

documentation, and the capabilities and mission requirements of the requesting 

activity. MEDCASE/SuperCEEP requirements that are determined to be ineligible for 

the MEDCASE/SuperCEEP program, insufficiently justified or documented, or are 

determined to be beyond the capability and mission of the requesting activity shall be 

disapproved. 

(2) The review of MEDCASE/SuperCEEP requirements shall include an 

evaluation of administrative accuracy to include the proper completion of the DA 

Forms 5027-R/5028-R, the use of a proper nomenclature, and the assignment of an 

appropriate IDC. Requirements that are not administratively correct will not be 

approved. 

(3) If your facility had a TARA visit within the last 4 years, no TCA, 

detailed justification, or MEDCASE/SuperCEEP package is required. 

b. Approval Versus Funding. The determination of MEDCASE/SuperCEEP 

program approval is made based upon propriety of need and not related to the 

present or the anticipated availability of funding. Approved MEDCASE/SuperCEEP 

requirements constitute a database against which funding may be applied based upon 

AMEDD, command and activity priorities. 

c. Resubmission of Disapproved Requirements. Requirements that have been 

disapproved by the USAMEDCOM, RMC, MSC or USAMMA may be resubmitted. They 

will be resubmitted using the same ACN within 120 days after the disapproval action 

code is entered into the WebMRE system. (After 120 days, the ACN becomes inactive 

in WebMRE and will not be reinstated. Requirements may be resubmitted with a 

newly assigned ACN.) Resubmissions must address the reasons for which the 

requirement was disapproved. Correspondence regarding the disapproval and the 

actions or additional information provided by the activity become part of the 

requirement documentation and should be forwarded with the resubmission. 

d. MEDCASE/SuperCEEP Nonmedical Requirements. MEDCASE-eligible 

commercial-type non-medical equipment ($250,000 and greater) and SuperCEEPeligible commercial-type non-medical equipment (equal to or greater than $100,000 

and less than $249,999) must be submitted for USAMEDCOM "type classification 

exemption" and approval for inclusion in the TDA. 
SB 8-75-MEDCASE 

4-2 

4-2. ACTIVITY/RMC/MSC COMMANDER REVIEW AND APPROVAL 

a. General. Activity/RMC/MSC Commanders review, approve or disapprove 

all MEDCASE/SuperCEEP requirements that originate within their activity. This 

authority will not be delegated. 

b. Evaluation and Approval. The Activity/RMC/MSC Commander will: 

(1) Evaluate and conduct a functional review of each requirement and 

approve or disapprove based on propriety need. 

(2) Forward all requirements to USAMMA (as applicable) for coordination 

and final approval/disapproval. 

c. Redistribution of RMC Assets. All RMCs may direct the redistribution of 

excess assets within their RMC to meet validated MEDCASE/SuperCEEP requirements, 

as appropriate. 

d. Non-medical Requirements. Commands will process requirements for nonmedical items of equipment for type classification exemption and TDA approval in 

accordance with AR 71-32. 

e. Command-Processing Objectives. All RMCs should use an average of 21 

working days as an objective for processing MEDCASE/SuperCEEP requirements from 

the date received to the date forwarded to the USAMMA. 

4-3. USAMEDCOM/OTSG CONSULTANT REVIEW AND APPROVAL 

a. The USAMEDCOM/OTSG Consultants review and approve or disapprove all 

non-diagnostic imaging RMC/MSC-approved DA Forms 5027-R/5028-R which have a 

unit cost of $100,000 or more. The TARA team reviews and approves or disapproves 

all diagnostic imaging RMC/MSC-approved DA Forms 5027-R/5028-R with a unit cost 

of $100,000 or more. 

b. The USAMMA receives and reviews all requirements submitted for the 

consultant approval. The USAMMA is responsible for the requirements database. 

(1) The USAMMA ensures that MEDCASE/SuperCEEP requirements are 

ready for functional review and final approval/disapproval with respect to program 

eligibility and adequacy. Requirements that are not MEDCASE/SuperCEEP-eligible will 

be disapproved. Requirements which are not correct or do not have sufficient 

information or documentation for the functional consultant's review will either be 

disapproved or have the deficiency resolved. When necessary, the USAMMA will 

provide administrative comments on the requirement transmittal to enhance packet 

for consultant review. 

(2) The USAMMA posts the action codes (see table 4-1) assigned by the 

consultant to the WebMRE system. The USAMMA will notify activities and commands 

of disapproval action. Activities must query the WebMRE system for requirement 

status. 

(3) The USAMMA will maintain a record copy of approved or disapproved 

DA Forms 5027-R/5028-R by the functional consultant representative. 
SB 8-75-MEDCASE 

4-3 

4-4. MEDCASE/SUPERCEEP ACTION CODES 

a. Action Codes. The MEDCASE/SuperCEEP action code reflects approval or 

disapproval action taken by the TARA or the OTSG clinical consultant. Only 

requirements that are assigned a "1A" approval action code are approved 

requirements and may await future funding through the MEDCASE/SuperCEEP 

program (see table 4-1). 

(1) MEDCASE/SuperCEEP participants must closely monitor the approval 

status of requirements that have been submitted for MEDCOM/OTSG clinical 

consultant review. 

(2) MEDCASE/SuperCEEP action codes reflect approval/disapproval 

status only, and do not relate to the funding status of a requirement or to the 

availability of funds for a requirement. 

b. Explanation. The MEDCASE/SuperCEEP action code is a two-character 

data element. With the exception of the action codes 5A, 5M, and 4M, which are 

deferral codes to indicate special administrative processing; MEDCASE/SuperCEEP 

action codes reflect either approval or disapproval. The alpha character indicates 

either the reason for disapproval or qualifies an approval. 

4-5. EXPIRATION OF UNFUNDED MEDCASE/SUPERCEEP REQUIREMENTS 

a. Approved Requirements. Approved (1A) unfunded MEDCASE (BLIC CF, 

DA, PC and UR) requirements remain active for 3 FYs. MEDCASE MILCON (BLIC MB) 

requirements remain active for 5 FYs. 

Example: MEDCASE requirement with a fiscal year of “06” 

in the ACN will remain active until 30 September 2008. 

Example: MILCON requirements with a fiscal year of “06” 

in the ACN will remain active until 30 September 2010. 

At the end of 3 or 5 FYs, whichever is applicable, remaining unfunded requirements 

will be automatically purged from the AMEDD central database (WebMRE) at the 

USAMMA. These requirements will no longer be available for execution. In the case 

where a site generated requirement expires and there is still a valid need, action 

should be initiated by the activity to resubmit the documentation with a new ACN. 

The TARA will revalidate and assign a new ACN, if applicable, for all unfunded TARA 

generated requirements. Approved SuperCEEP funding is only active for 1 year. 

Example: SuperCEEP requirement with a fiscal year of “06” in 

the ACN will remain active until 30 September 2006. 

b. Disapproved Requirements. The USAMMA will purge all disapproved or 

rejected MEDCASE/SuperCEEP requirements from the central database 120 days 

from date of disapproval action, unless action is taken by the activity to re-justify the 

requirement or comply with consultant instructions. Resubmission after 120 days 

requires a new ACN and TARA and/or OTSG consultant approval. 
SB 8-75-MEDCASE 

4-4 

c. Certification of Active Requirements. Approved MEDCASE/SuperCEEP 

requirements remain active for obligation purposes until they are executed or expire. 

Activities must periodically review their approved unfunded MEDCASE/SuperCEEP 

requirements, validate prices, and delete requirements that are no longer needed. 

TABLE 4-1. MEDCASE/SUPERCEEP ACTION CODES 

ACTION CODE DEFINITION

RMC/ 

MSC 

Clinical 

Consultant 

 5A Receipt confirmation, by the USAMMA, of DMLSS interface from 

submitting activity. 

 5M The WebMRE system was pre-loaded with a requirement 

resulting from a TARA visit. 1A action code will be assigned 

after approval from the activity and RMC commanders. This 

code is only assigned by USAMMA. 

 1A Non-TARA generated: approved by the MEDCOM/OTSG clinical 

consultant. 

TARA generated: Concurrence w/ TARA recommendations from

activity and RMC commanders. 

 4M Requirement is receiving special administrative reviews prior to 

assignment of a final 4P command approval. No further action 

required by originator. 

 4P Awaiting MEDCOM/OTSG consultant approval/disapproval. 

 4T TARA transmittal sent to site and region for concurrence. 

 3B Disapproved. Item is beyond your mission requirements. 

 3C Disapproved. Justification for requested equipment is 

inadequate. Submit additional justification. 

 3D Disapproved. Documentation required was not submitted with 

DA Forms 5027-R/5028-R. Resubmit with complete 

documentation. 

 3E Disapproved. Professional personnel are not currently 

authorized/ assigned to your activity with qualifications to 

operate this equipment. 

 3F Disapproved. Communication 

(meeting/conversation/note/letter) has or will indicate reason 

for disapproval. 

 3G Disapproved. Incorrect IDC was assigned. 

 3H Disapproved. Equipment requested is not eligible for the 

MEDCASE/SuperCEEP program. 

 3R Disapproved. Rejected for administrative reasons. 

Communication (meeting/conversation/note/letter) has or will 

indicate reason. 
SB 8-75-MEDCASE 

5-1 

CHAPTER 5. EXECUTION OF MEDCASE/SUPERCEEP REQUIREMENTS 

5-1. INTRODUCTION 

Execution refers to the expending of MEDCASE/SuperCEEP funds for the acquisition of 

approved MEDCASE/SuperCEEP requirements. MEDCASE/SuperCEEP requirements 

are funded in the order determined by the STCPC, using the MEDCASE/SuperCEEP 

funds released to the activity's station account by the command. Any deviation from 

that plan must be approved by the STCPC via the USAMEDCOM. There are three 

methods for executing MEDCASE/SuperCEEP requirements: local purchase, 

requisitioning, or an alternate acquisition activity. 

a. Local Purchase. To execute requirements by local purchase, the USAMMA 

issues a LOA directly to the participating activity. The LOA provides a fund citation 

(drawn from the activity's station account), which the activity applies to a DA Form 

3953 (Purchase Request and Commitment) for local purchase. The issuance of an 

LOA constitutes a commitment of MEDCASE/SuperCEEP funds. Procedures for 

requesting and managing LOAs are contained in Chapter 7. 

b. Wholesale Supply System. To execute MEDCASE/SuperCEEP requirements 

through the wholesale supply system, an activity submits a DD Form 1348-6 (DOD 

Single Line Item Requisition System Document) to the USAMMA. The USAMMA 

applies a MEDCASE/SuperCEEP fund cite to the 1348-6 and passes the requisition to 

the appropriate source of supply. The submission of a funded requisition to a 

wholesale supply source constitutes an obligation of MEDCASE/SuperCEEP funds. 

Procedures for requisitioning MEDCASE/SuperCEEP requirements are contained in 

Chapter 6. Appendix D contains an example of DD Form 1348-6 for use in preparing 

requisitions for MEDCASE/SuperCEEP requirements. Requisitioning via a 1348-6 is 

required for all diagnostic imaging systems. 

c. Alternate Acquisition Activity. To execute MEDCASE/SuperCEEP 

requirements through an alternate acquisition agency, i.e., the U.S. Army 

Engineering and Support Center (USACE-HNC), Huntsville, AL, an activity submits a 

DD Form 1348-6 to the USAMMA. The USAMMA applies a MEDCASE/SuperCEEP fund 

cite to a MIPR drawn from the activity's station account. The requisition or MIPR is 

passed to the alternate acquisition activity. The acceptance of a reimbursable MIPR 

by the performing acquisition agency constitutes an obligation of MEDCASE/ 

SuperCEEP funds. The acceptance of a direct cite MIPR constitutes a commitment of 

MEDCASE/SuperCEEP funds. Chapter 8 provides procedures for requisitioning 

alternate acquisition activity MEDCASE/SuperCEEP requirements. 

5-2. FUNDING MEDCASE/SUPERCEEP REQUIREMENTS 

a. Requirements will be funded based upon STCPC recommendations and final 

approval by the Army Surgeon General. 

b. Requirements Listing. The WebMRE central database at the USAMMA 

provides status of all requirements in an online, real time mode. Chapter 10 provides 

information pertaining to online access to the MRE system. 
SB 8-75-MEDCASE 

5-2 

5-3. FUNDS MANAGEMENT AT THE STATION 

a. General. MEDCASE/SuperCEEP funds are released by the USAMEDCOM to 

the USAMMA. MEDCOM advises the USAMMA how to distribute funds among the 

subordinate activities based on the approved STCPC line items. Upon this advice, the 

USAMMA establishes accounts within the MEDCASE/SuperCEEP requirements and 

execution system that indicate the amount of funds for which each activity is 

authorized. These accounts are referred to as "station accounts." 

b. Program Release. The program release is the actual distribution of funds 

by the USAMMA into the station accounts as directed by the commands. It will be 

made available as soon after 1 October of the execution year as possible. The 

program release is divided by BLIC (see chapter 3), and funding status is resident in 

the WebMRE. Status of all station accounts is available in an online, real-time mode. 

Chapter 10 provides information pertaining to online access to the WebMRE system. 

c. Program Status. Activities are responsible for execution of their program 

release, to include current commitments and obligations by BLIC and project, if 

applicable. 

(1) Commitments. A commitment is an administrative reservation of 

funds. It constitutes the "setting aside" of funds for a specific purpose. 

MEDCASE/SuperCEEP program commitments occur when the LOA is issued for the 

local purchase of a MEDCASE/SuperCEEP requirement or upon acceptance of a direct 

cite MIPR. Appendix C provides an example of an LOA. Commitments become 

obligations when a contract or delivery/purchase order from the local purchase action 

is posted to the WebMRE system. 

(2) Obligations. An obligation is a legal reservation of funds. An 

obligation occurs when a contract or delivery/purchase order is posted to the MRE 

system or upon the submission of a funded requisition (DD Form 1348-6) to a 

wholesale level of supply or acceptance of a reimbursable MIPR by the performing 

acquisition agency. Appendix D provides an example of a requisition. 

5-4. EXECUTION OF BLIC "MB" REQUIREMENTS 

BLIC "MB" funds are medical MILCON funds appropriated by Congress for a health 

facility project that are set aside to procure LOGCAT code "E" and "F" equipment for 

the New Facility. 

 

a. The Army Corps of Engineers has all MILCON funds for LOGCAT code "E" 

and "F" equipment at HQ USACE for control. The HQ USACE releases the funds for 

equipment purchases through USACE Regions after coordination with the Health 

Facilities Project Office responsible for the medical MILCON project. 

b. Funding BLIC "MB" requirements. Activities will not receive a BLIC "MB" 

funds release. 

c. Requisitions. All BLIC "MB" requirements will be executed by forwarding a 

requisition to USAMMA as prescribed in Chapter 6. The USAMMA will forward 

requisitions for LOGCAT code "E" items to USACE-HNC for procurement. 
SB 8-75-MEDCASE 

5-3 (5-4 blank) 

5-5. RECEIPT PROCESSING 

a. Receipt Processing. The receipt processing links the MEDCASE/SuperCEEP, 

property accountability, and asset visibility in a database. This consists of accounting 

for the new item on the property book and submitting a Receiving Report. 

b. Property Book Items. All items of equipment procured through the 

MEDCASE/SuperCEEP program must be accounted for on the activity property book. 

The ACN and IDC fields in the DMLSS property record must be correct. The 

nomenclature should be generic and consistent with standard item descriptions in 

appendix A. Attention should be directed toward compliance with procedures for 

DMLSS and command guidance. 

c. MEDCASE/SuperCEEP Receiving Reports. MEDCASE/SuperCEEP receiving 

reports must be forwarded to the USAMMA within 5 business days of receipt IAW the 

Prompt Payment Act: 

U.S. Army Medical Materiel Agency 

ATTN: MCMR-MMO-AT 

1423 Sultan Drive, Suite 100 

Fort Detrick MD 21702-5001 
SB 8-75-MEDCASE 

6-1

CHAPTER 6. WHOLESALE SUPPLY SYSTEM (REQUISITIONS) 

6-1. INTRODUCTION 

a. General. Requisitions for approved MEDCASE/SuperCEEP requirements are 

submitted by activities through the USAMMA to an alternate acquisition source or to a 

wholesale supply source. The primary wholesale supply source is the the Defense 

Supply Center Philadelphia (DSCP) (S9M). 

b. Mandatory Use. Requisitions are used for the following types of 

equipment: 

(1) Standard stocked or centrally procured items (Acquisition Advice 

Code [AAC] "D" or "H") for all MEDCASE/SuperCEEP participants. 

(2) Nonstandard and standard nonstocked items (AAC other than "D" 

and "H") for OCONUS MEDCASE/SuperCEEP participants. (Note: Not mandatory, see 

Chapter 7.) 

(3) Diagnostic imaging and radiation therapy systems for all 

MEDCASE/SuperCEEP participants. 

c. Use of Requisitions by Continental United States (CONUS) and Outside 

Continental United States (OCONUS) Activities. 

(1) The wholesale supply system can provide procurement support to 

CONUS activities for nonstandard equipment. Activities should contact DSCP to 

coordinate transmittal of requisitions and product description data for all nonstandard 

equipment. 

(2) OCONUS activities obtain most of their approved 

MEDCASE/SuperCEEP requirements by requisition. 

(3) Requests for exception to policy to acquire by local procurement 

must be justified and forwarded in writing to the: 

U.S. Army Medical Materiel Agency 

ATTN: MCMR-MMO-AT 

1423 Sultan Drive, Suite 100 

Fort Detrick MD 21702-5001 

6-2. BASIC REQUISITIONING PROCEDURES 

a. General. Requisitions will be submitted only for approved (1A) 

requirements that have been approved by the STCPC and notified by the 

USAMEDCOM. Participants must submit requisitions to the USAMMA in accordance 

with Command policy. The USAMMA must receive three (3) copies of requisitions and 

all supporting documentation. 
SB 8-75-MEDCASE 

6-2 

(1) Diagnostic Imaging. Participants must submit the DD Form 1348-6 

with a manufacturer price quote and site preparation estimate. Refer to chapter 12 

for further guidance regarding requisitions for diagnostic equipment. 

(2) All requisitions for nonstandard items requesting acquisition through 

restricted competition (i.e., "sole-source") must include a justification for less-thanfull-and-open competition. Chapter 14 contains guidance regarding the Competition 

in Contracting Act (CICA). 

b. DD Form 1348-6. The DD Form 1348-6 is the basic document used for 

most requisitions. It must be completed in correct MILSTRIP format with additional 

exception data provided as shown in Appendix D samples. The DD Form 1348-6 must 

be submitted to USAMMA in three (3) copies. Useful references which can be used 

when preparing DD Form 1348 series MILSTRIP requisitions are: 

(1) Chapter 3 of this SB and, AR 725-50, The Requisitioning, Receipt, 

and Issue System. 

(2) The DLA Customer Supply Assistance Program Handbook. This 

publication may be obtained by contacting the DLA customer assistance 

representative in your geographic area. 

6-3. OVERVIEW OF REQUISITION PROCESSING 

The following brief description shows some of the major steps involved in processing 

a MEDCASE/SuperCEEP requisition through the USAMMA to a wholesale supply source 

a. Unavailable Excess Assets. After a final, unsuccessful check for available 

excess assets that could meet the requirement, a requisition (DD form 1348 or 

1348-6) is prepared in MILSTRIP format and the necessary supporting documents are 

attached. At least three (3) complete copies are prepared. 

b. Requisition Submission. The requisition, with supporting documentation, is 

forwarded to USAMMA in accordance with command policy. A Due-In is entered into 

the DMLSS, which updates the Funds Control Journal. Appendix D provides an 

example of a requisition (DD Form 1348-6). 

c. Requisition Processing at the USAMMA. The USAMMA reviews the 

requisition, verifies that it is for an approved (1A) requirement, ensures that funds 

are available in the station account, posts the execution to the WebMRE system, and 

forwards the requisition to the appropriate wholesale supply source. This transaction 

obligates funds. 

d. Requisition Processing at Wholesale Activity. The wholesale supply activity 

receives the requisition and processes it for acquisition and/or delivery. The USAMMA 

receives supply and shipment status in MILSTRIP format, where it is posted to the 

WebMRE. Shipment status will cause the previously recorded obligation to move from 

the UDO stage to the "accounts payable" (AP) stage in the WebMRE system. 

e. Receipt Processing. The activity receives the item and forwards a receipt 

confirmation DD Form 250 (Materiel Inspection and Receiving Report) or DD Form 

1155 (Order For Supplies or Services) to the USAMMA within 5 business days of 
SB 8-75-MEDCASE 

6-3 

receipt. For BLIC "MB" requisitions, a receiving report (DD Form 250 or DD Form 

1155) must also be submitted to: 

U.S. Army Engineering Support Center 

P.O. Box 1600 

Huntsville AL 35807-4301 

The activity also posts the receipt to its property accounting records. 

f. Shipment/Billing. Based upon shipment information, the supply center has 

used funds from its stock fund to pay the supplier (nonstandard and nonstocked 

items only) for direct delivery to the activity. The wholesale supply source in turn 

forwards a bill (called an Interfund Transfer [IFT]) to the USAMMA for 

reimbursement. 

g. Funds Disbursement. The USAMMA receives the IFT and makes a 

disbursement of MEDCASE/SuperCEEP funds to the wholesale stock fund. This 

obligation moves from the accounts payable stage to the disbursement stage and this 

"liquidates" the obligation. 

6-4. WHOLESALE SUPPLY SOURCE ACTIONS 

a. Status. The wholesale supply system transmits status in MILSTRIP format 

to the USAMMA. MILSTRIP status will normally occur in the following sequence: 

Non-standard/non-stocked items: 

1st status 

(AE1 card) BD Requisition has been received by the wholesale 

supply source and is under review. 

2nd status 

(AE1 card) BZ 

Requisition is delayed in contracting. Upon 

contract award, additional status will be 

provided. 

3rd status 

(AE1 card) BV 

Item has been contracted for shipment to the 

requisitioner. An AB card will also be provided 

which indicates the contract number. 

4th status 

(AS1 card) Shipment Status. 

b. Request for Additional Information. 

(1) Occasionally, a wholesale supply source will require additional 

information (such as clarification of specifications, accessories, or color) from a 

customer before it can complete procurement action. When this happens, the 

wholesale supply source will notify the customer requesting the information. An 

information copy of the request is to be provided to the USAMMA by the supply 

center. 

(2) The customer must reply to the wholesale supply source within the 

suspense date established. Normally there is a 21-day suspense. If the activity does 

not meet the suspense, the supply center will reject (C status) the requisition and it 
SB 8-75-MEDCASE 

6-4 

will have to be resubmitted. Supply center rejections and cancellations deobligate 

funds. 

(3) Activities must provide an information copy of all correspondence 

sent to a wholesale supply source to the: 

U.S. Army Medical Materiel Agency 

ATTN: MCMR-MMO-AT 

1423 Sultan Drive, Suite 100 

Fort Detrick MD 21702-5001 

c. Only the USAMMA may certify additional funds. If a customer receives a 

request for additional funds, the request must be referred to the USAMMA. 

d. Procurement lead times for nonstandard, nonstocked items are generally 

established by the dollar value, as well as the technical complexity of the 

requirement. As a guide, the following timeframes provide a rough estimate of 

procurement lead times for DSCP. 

(1) $100,000 to $500,000: 120 days. 

(2) Award over $500,000: 150-180 days. 

(3) Requisitions that require synopsis: add 30 days to the above 

estimates. 

e. When a requisition is rejected or canceled in error by a wholesale supply 

source, the USAMMA will attempt to resubmit the requisition. Because supply centers 

will not accept the same document number, the USAMMA will either assign a new 

document serial number using an alpha character in the serial number field (i.e., 

W74MYG-6185-0013 would be resubmitted as W74MYG-6185-A013) or assign a new 

document number using document serial numbers which are reserved for the 

USAMMA (8550-8999). When this occurs, the USAMMA will notify the customer so 

that the document register and due-in records may be adjusted accordingly. 

6-5. SHIPMENT OF MEDCASE/SUPERCEEP ITEMS 

a. CONUS Activities. CONUS activities will receive shipment from vendors by 

commercial carriers and freight forwarders. 

b. OCONUS Activities. When USAMMA processes a customer's requisition, the 

"ship to" address of the Consolidated Containerization Point (CCP) at either Defense 

Depot Tracy (for the Pacific) or Defense Depot Mechanicsburg (for Europe) is entered 

on the requisition. 

(1) Military air transport may be used for OCONUS shipment. Special 

requests for military air transport require the activity to provide a local transportation 

fund citation. 

(2) Surface shipment will be used for items with high volume or weight. 

(3) In some cases, suppliers may ship smaller, low-dollar value items 

directly to the requisitioner via parcel post. 
SB 8-75-MEDCASE 

6-5 

c. Commercial Air. Commercial air shipment is used only in emergency 

situations. MEDCASE/SuperCEEP funds cannot be used to pay for commercial air 

shipment; therefore, in cases where commercial air is requested, the activity will be 

required to provide a local transportation fund citation. 

6-6. MANAGEMENT OF REQUISITIONS 

a. Submission of Requisitions. Activities must ensure that their requisitions 

are received by the USAMMA. All requisitions must be posted to the Property Book 

Officer's (PBO) nonexpendable document register and a due-in established in DMLSS 

property records. Requisitions that have been submitted by the activity, but do not 

appear in the WebMRE system should be followed-up telephonically to the USAMMA. 

b. Priority Modifications. Requests for priority upgrade should be submitted 

by AM card to the supply center by Defense Messaging Service (DMS). 

c. Overdue Shipment. Tracer action should be initiated for overdue 

shipments through the local transportation office in accordance with MILSTAMP 

procedures. A shipment should be considered overdue if it has not been received 

within 90 days of the ship date as reflected on the AS card. 

6-7. RECEIPT PROCESSING 

a. Equipment Receipt. The MEDCASE/SuperCEEP manager, the PBO, and the 

biomedical equipment maintenance activity must establish a coordinated procedure 

for the receipt of equipment acquired through the MEDCASE/SuperCEEP program. 

b. Property Accountability. Accountability for equipment acquired through the 

MEDCASE/SuperCEEP program will be established at the time the equipment is 

received by the activity. This specifically includes "uninstalled" equipment that is 

awaiting installation or the completion of site preparation. If necessary, uninstalled 

equipment may be accounted for on a separate hand receipt. Maintenance 

information can be loaded into DMLSS after the completion of installation. The 

"date-in-service" should be adjusted, as necessary, to reflect the date when 

installation is completed. 

c. Acceptance Inspection. Equipment should be inventoried and inspected for 

visible damage as soon after receipt as possible. Damage and/or missing items or 

components should be reported by submission of a Report of Discrepancy (ROD) in 

accordance with AR 735-11 Uniform Settlement of Military Freight Loss and Damage 

Claims) and AR 735-11-2 (Reporting of Item and Packaging Discrepancies). 

Acceptance should not be delayed until operational testing is possible as long as the 

equipment is complete and apparently undamaged. Operational deficiencies should 

be corrected through enforcement of the warranty. 

d. Receiving Report. Receipt of equipment must be reported to the USAMMA 

by immediate submission of a DD Form 250 or DD Form 1155 within 5 business days 

of receipt. 

e. Acceptance Test. Upon completion of installation, the vendor is required 

to notify DSCP contracting office, in writing that the system is ready for acceptance 
SB 8-75-MEDCASE 

6-6 

inspection. The inspection must occur within 30 working days following the DSCP 

receipt of the notification. Initial or first-time inspection costs are at government 

expense, any and all re-inspections are paid for by the vendor. See Appendix E for 

more detailed information. 
SB 8-75-MEDCASE 

7-1 

CHAPTER 7. LOCAL PURCHASE AND LETTERS OF AUTHORITY (LOA) 

7-1. INTRODUCTION 

a. General. The local purchase of approved MEDCASE/SuperCEEP 

requirements is accomplished through the application of MEDCASE/SuperCEEP funds 

to a local purchase request. The purchase request is forwarded by the activity to its 

supporting Purchasing and Contracting activity. An electronic LOA provides the 

MEDCASE/SuperCEEP funds from the USAMMA to the activity. 

b. Local Purchase. Both CONUS and OCONUS activities may use local 

purchase, provided that purchasing and contracting support is available. 

c. Local Purchase of Equipment. Local purchase is used for the following 

types of equipment: 

(1) Nonstandard equipment. 

(2) Standard, nonstocked items (AAC other than “D,” or “H”). 

d. Local Purchase of Equipment Not Authorized. Local purchase may not be 

used for the following types of equipment: 

(1) Standard, stocked (AAC “D,” or “H”), or centrally procured items. 

(2) Diagnostic imaging systems. 

(3) Radiation therapy systems. 

Note: Exceptions must be requested through the U.S. Army Medical Materiel 

Agency, ATTN: MCMR-MMO-AT, 1423 Sultan Drive, Suite 100, Fort Detrick MD 

21702-5001. 

7-2. OVERVIEW OF THE LOCAL PROCUREMENT PROCESS 

The following is a brief description of the steps involved in a local purchase process: 

a. Excess Assets. Before requesting an LOA, check for available excess 

assets that could meet the requirement. 

b. Local Purchase Documents. Activities must prepare the necessary local 

purchase documents (e.g., DA Form 3953) prior to requesting the LOA to ensure 

there is no delay in processing the requirement when the LOA is received. 

c. LOA. Once the LOA is requested from the activity, the USAMMA will 

provide the electronic LOA. The LOA commits funds for a specified period of time, 

usually 120 days, for the purchase of the ACN specified on the LOA. Appendix C 

shows examples and explains the LOA and an amended LOA. 

d. LOA Processing. The activity receives the LOA and certifies funds 

availability on the DA Form 3953, then forwards it to the supporting procurement 
SB 8-75-MEDCASE 

7-2 

office for action. It is not necessary to provide the contracting office a copy of the 

LOA. 

e. Purchasing and Contracting. Purchasing and Contracting places an order 

and awards a contract. A copy of this contract is provided to the MEDCASE/ 

SuperCEEP manager at the Activity. 

f. Activity MEDCASE/SUPERCEEP Manager. The activity 

MEDCASE/SuperCEEP manager annotates the LOA with a document number and 

returns the LOA with a copy of the contract to the USAMMA. 

g. The USAMMA. The USAMMA receives the LOA and contract from the 

activity and posts the obligation in the WebMRE system and the accounting system. 

h. Receiving Reports. The activity receives the item from the supplier and 

forwards a receiving report to the paying office indicated on the contract. Local 

DMLSS records are updated with the receipt. 

i. Receipt Processing. Upon receipt of the receiving report, the paying office 

will verify receipt against their copy of the contract and pay the supplier when the bill 

(invoice) is received. Receiving reports must be submitted in a timely manner so the 

paying office can take advantage of prompt payment discounts. Failure to submit a 

receiving report in a timely manner usually results in the payment of interest and 

penalties and will be charged to the operating funds of the receiving activity. 

7-3. LOA MANAGEMENT 

a. Funding Authority. The LOA grants authority to cite MEDCASE/SuperCEEP 

program funds and incur obligations for equipment by local purchase. 

(1) The electronic LOA certifies the availability of MEDCASE/SuperCEEP 

funds for the local procurement of the specific requirement(s) listed by ACN on the 

LOA. The issue of an LOA constitutes a commitment of MEDCASE/SuperCEEP funds. 

(2) Obligations (contract awards) shall not exceed the amount specified 

on the LOA without the prior written approval of the USAMMA. The funding authority 

is valid until the expiration date indicated on the LOA. 

(3) Funds cited on an LOA will be used only for items that are eligible for 

funding through the MEDCASE/SuperCEEP program. This is limited to 

MEDCASE/SuperCEEP-eligible equipment, components and/or accessories, and the 

installation thereof. MEDCASE/SuperCEEP funds are specifically excluded from the 

funding of site preparation or first destination transportation charges. Note: First 

destination transportation charges that are included in the contract line for the 

equipment, i.e., Freight On Board [FOB] destination, may be eligible (see chapter 

15). 

(4) Individual LOAs are issued for single requirements; however, 

USAMMA may list multiple ACNs on a single LOA provided that the requirements are 

identical (i.e., the IDCs and standard item descriptions are the same). 
SB 8-75-MEDCASE 

7-3 

(5) Brand name references that may be included in the nomenclature of 

the requirement do not constitute endorsement or authority for acquisition under 

less-than-full-and-open competition. 

b. LOA Requests. LOAs for approved (1A) requirements may be requested at 

any time provided that the STCPC has approved the requirement for funding. LOAs 

are requested by activities via letter or message addressed to the USAMMA, ATTN: 

MCMR-MMO-AT. Multiple LOAs may be requested on a single message or letter. LOA 

requests must contain, as a minimum, the following information: 

o ACN 

o Dollar amount 

o BLIC (MEDCASE) 

c. LOA Suspense. LOAs are issued for specific periods of time. Each activity 

is responsible for maintaining a suspense file of ‘working” LOAs to ensure that local 

purchase action is completed before the LOA expiration date. Contracts cannot be 

awarded using funds cited on an expired LOA. LOAs are issued for an initial period of 

120 days. 

d. Extension of LOA. When an activity determines that a contract award 

cannot be made prior to the expiration of an LOA, an extension from the USAMMA 

may be requested. In such cases, the activity should try to determine as closely as 

possible how much additional time is required. 

(1) Requests for LOA extensions may be made by letter or email. 

Extensions should be requested at least two weeks prior to the expiration of the LOA. 

(2) Extensions will be provided electronically by the USAMMA in the form 

of an LOA amendment. 

(3) LOA extensions will normally be granted in 30-day increments. 

Normally only two 30-day extensions will be granted. Activities may request an 

extension exception for more than 30 days if it is known that a longer period will be 

required to award a contract. Request for extensions in excess of 30 days must 

provide the current status of the procurement action, the estimated award date, and 

an explanation of why 150 days is not sufficient to make an award. 

e. LOA Price Increases. In cases where the contract award price will exceed 

the funds cited on the LOA, the station must request an LOA increase from the 

USAMMA. 

(1) The USAMMA will evaluate each request for an LOA increase based 

on the original value of the requirement, age of the price estimate, amount of the 

increase, and any other factors provided by the requesting activity. Price increases 

that do not appear excessive will normally be issued without further justification. For 

price increases that appear excessive, the USAMMA may require further justification 

to ensure that the item being procured is, indeed, the item that was originally 

approved. Cases that cannot be resolved by the funds certification officer will be 

passed to the appropriate consultant for resolution. 

(2) LOA increases may be requested by mail or email. An LOA increase 

may be requested at the same time of an extension, if applicable. LOA increases 
SB 8-75-MEDCASE 

7-4 

should be requested only when the actual contract price is known. This will eliminate 

the need for multiple LOA amendments. 

(3) LOA increases will be released by the USAMMA only if there are 

sufficient funds. If there are not sufficient funds available, the activity must 

reevaluate their requirement. 

(4) LOA increases will be issued in the form of an LOA amendment. 

f. LOA Amendments. LOA amendments are issued electronically. A single 

LOA amendment may contain both an extension and a price adjustment. The 

USAMMA may issue a maximum of four LOA amendments. If an additional extension 

or price adjustment is needed after the fourth amendment, the activity must return 

the LOA (with amendments) to the USAMMA and a new LOA will be issued. The 

USAMMA will not reissue an LOA until it has received the initial LOA. 

7-4. BASIC PROCEDURES FOR LOCAL PURCHASE 

a. Actions Upon Receipt of an LOA. Upon receipt of the LOA by the activity, 

the MEDCASE/SuperCEEP manager should: 

(1) Ensure the LOA is administratively correct, e.g., it has the correct 

ACN(s), funds cite, dollar amount, expiration date, activity name, etc. 

(2) Enter the fund citation provided on the LOA onto the DA Form 3953. 

Ensure the DA Form 3953 is complete and accurate and include attachments, such as 

essential characteristics or procurement specifications. The requirement should be 

clearly defined as to accessories, shipping instructions, installation requirements, and 

warranty requirements. 

(3) Ensure that only the requirements identified by the ACN(s) listed on 

the LOA are purchased. The purchase of any other equipment with an LOA is not 

authorized. 

b. Certification of MEDCASE/SUPERCEEP Funds. LOAs issued by the USAMMA 

provide the using activity with the authority to certify the availability of 

MEDCASE/SuperCEEP funds to the supporting purchasing and contracting activity. 

(1) The activity certifies the availability of MEDCASE/SuperCEEP funds to 

the purchasing and contracting activity by the signature of an individual designated 

by the activity commander on the DA Form 3953. The individual(s) designated by the 

commander are normally the Chief of Logistics, the Chief of Property Management, 

and/or the MEDCASE/SuperCEEP Manager. 

(2) DD Form 577 (Signature Cards) for the persons appointed by the 

commander to certify the availability of MEDCASE/SuperCEEP funds should be kept 

on file at the procurement activity and the supporting finance and accounting office. 

(3) There is no requirement to provide a copy of the LOA to the 

purchasing and contracting office.
SB 8-75-MEDCASE 

7-5 (7-6 blank) 

c. Contract Information Posting. Upon contract award, the activity must post 

the obligation to DMLSS and to the appropriate lines on the LOA.

(1) Copies of all LOAs and contracts awarded against a LOA must be 

forwarded to the 

U.S. Army Medical Materiel Agency 

ATTN: MCMR-MMO-AT 

1423 Sultan Drive, Suite 100 

Fort Detrick MD 21702-5001 

as early as possible after the award to ensure timely posting of the obligation to the 

WebMRE and accounting systems. This will usually be well before the equipment is 

actually received. This includes partial awards. Upon completion of all procurement 

actions authorized by an LOA, the LOA and copies of all obligation documents not 

already provided to the USAMMA must be forwarded to the USAMMA by the activity. 

(2) Activities will establish a suspense file for LOAs and contracts that 

have been returned to the USAMMA to ensure that the obligations have been 

properly posted. Obligations not posted within a reasonable period (taking into 

account mail time), as well as obligations that have been posted erroneously should 

be reported to the USAMMA. 

(3) Local purchase contracts, purchase orders, or delivery orders, except 

those administered by the Defense Contract Management Command, must identify 

the appropriate Defense Finance and Account Service (DFAS) payment office. Prior to 

August 2006, annotate DFAS, San Antonio at: 

DFAS-SA/FPA 

500 McCullough Ave 

San Antonio TX 78215-2100

After August 2006, annotate DFAS, Rome at: 

DFAS-ROME 

325 Brooks Rd 

Rome NY 13441-4527 

Note: If there is a time or location change to the information stated above, the 

USAMMA will immediately notify your MEDCASE/SuperCEEP Manager.

d. Receipt Processing. A receiving report shall be prepared within 5 business 

days of equipment receipt IAW the Prompt Payment Act and forwarded to the 

appropriate paying office. Receiving reports for locally procured items are 

documented on a DD Form 250, DD Form 1155, or via Wide Area Work Flow. 

(1) Receiving reports must reflect the line number of the contract, 

purchase order, or delivery order of the item(s) received, as well as the complete 

accounting classification and LOA number as shown on the obligation document.

(2) After receipt of the item(s), copies of the receiving report will be 

forwarded to the USAMMA within 10 working days. This includes receiving reports for 

partial receipts. 
SB 8-75-MEDCASE 

8-1 

CHAPTER 8. ALTERNATE ACQUISITION ACTIVITY 

8-1. INTRODUCTION 

An alternate DOD acquisition may be used when appropriate. Non-DOD acquisition 

sources, such as the Department of Veteran’s Affairs are no longer viable sources. 

The authority to use an alternate acquisition activity resides with the USAMMA. The 

proper instrument to use in this case is a DD Form 448 (Military Interdepartmental 

Purchase Request [MIPR]). 

8-2. OVERVIEW OF THE MIPR PROCESS

The MIPR is used to procure items that cannot be purchased through the local 

Purchasing and Contracting agency or the DLA supply system. In most cases, the 

suggested source has a contract in place and delivery orders will be awarded against 

the main contract. The MIPR will be posted to the WebMRE system as a LOA. 

8-3. MIPR REQUESTS 

A request for a MIPR for a TSG approved (1A) requirement may be submitted to the 

USAMMA. MIPR requests must contain, as a minimum, the following information: 

a. DD Form 1348-6 to include source of Supply with complete mailing 

address, FAX number, POC, and phone number. 

b. All procurement information required for the purchase. 

8-4. TYPES OF MIPRS 

The MIPR type will be determined by how the Source of Supply accepts the 

MEDCASE/SuperCEEP funds. All MEDCASE/SuperCEEP MIPRs must be accepted in 

block 6 of the DD Form 448-2 (Acceptance of MIPR) as either a, b, or c. 
SB 8-75-MEDCASE

8-2 

a. Block a, (Category I). All items will be provided through reimbursement. 

All reimbursable MIPRs are considered as an obligation of MEDCASE/SuperCEEP 

funds when the acceptance form is received at the USAMMA (see DD Form 448-2). 

b. Block b, (Category II). All items will be procured by the direct citation of 

funds. All MIPRs accepted by the Source of Supply as a direct cite MIPR will be 

considered as a commitment of MEDCASE/SuperCEEP funds. When the delivery order 

is awarded and received at the USAMMA, the information will be posted to the 

WebMRE system as an obligation (see DD Form 448-2). 

c. Block c. Items will be provided by both Category I and Category II. 

MEDCASE/SuperCEEP funds can be accepted as both direct cite and reimbursable. 

When this happens, each of the dollar amounts is posted accordingly in the WebMRE 

(see DD Form 448-2). 
SB 8-75-MEDCASE 

9-1 

CHAPTER 9. PROCESSING OF 

URGENT AND EMERGENCY MEDCASE/SUPERCEEP REQUIREMENTS 

9-1. INTRODUCTION 

a. Program Management. A properly managed MEDCASE/SuperCEEP 

program at the activity includes a clear and well-distributed Standard Operating 

Procedure (SOP). This SOP shall explain how to use the MEDCASE/SuperCEEP 

program to acquire equipment. Nonetheless, instances will arise where routine 

requirement approval procedures will not be able to respond in a timely manner. 

b. Urgent Requirements. Urgent requirements are those that must be both 

approved and executed during the current execution year. Urgent requirements must 

be mission essential and required to meet the mission in the current fiscal year. 

Urgent submissions are not a method to cover a lack of prior equipment planning or 

an attempt to secure funding for an unfunded item. 

c. Emergency Requirements. A true emergency situation is rare and involves 

requirements that are required to save a life, prevent suffering, distress, or loss of 

faculty or limb. 

9-2. URGENT MEDCASE/SUPERCEEP REQUIREMENTS 

a. General. Unless otherwise indicated, urgent requirements are processed 

for approval in the same manner as routine MEDCASE/SuperCEEP program 

requirements. MEDCASE/SuperCEEP requirements, which are considered to be 

urgent, should be clearly labeled as such on the top margin of the DA Form 5027-R 

and should contain the FY of the current execution year in the ACN. 

b. Urgent or Emergency Documentation. When an activity has an urgent or 

emergency MEDCASE/SuperCEEP requirement, they are required to submit a 

memorandum that addresses the questions below. In addition, if the requirement is 

for a non-TARA item, a Total Case Analysis must be prepared and submitted. The 

format is provided in Appendix F. Previously established requirements must address 

questions 2-4. 

(1) Why was the requirement not identified in the MEDCASE/ 

SuperCEEP program earlier? 

(2) Why is the requirement urgent or an emergency? 

(3) Why can’t the requirement wait for midyear review or funding next 

fiscal year? 

(4) What is the impact on the mission if this requirement is not funded? 

c. Routing. The activity is required to send the memorandum with 

endorsement from the activity Commander to the RMC Commander. Subsequently, 

the RMC will forward the memorandum with endorsement from their Commander to 

the USAMEDCOM. When packet is forwarded to the RMC, a duplicate packet should 

also be sent to the USAMMA to begin the OTSG Consultant or TARA review process. 
SB 8-75-MEDCASE 

9-2 

Requests for funding are not to be sent through or to the USAMMA. Funding requests 

go to the USAMEDCOM. 

d. Execution. Urgent requirements must be approved and funding allocated 

by the STCPC before they can be executed. Once approved and funded, the 

requirement will either be processed using an LOA or a requisition as requested by 

the activity. 
SB 8-75 MEDCASE 

10-1 

CHAPTER 10. THE WEB MEDCASE REQUIREMENTS AND 

EXECUTION (WEBMRE) SYSTEM 

10-1. INTRODUCTION 

The previous chapters dealt with the development, approval and execution of 

MEDCASE/SuperCEEP requirements. This chapter deals with the centralized 

automated system, which controls all parts of the MEDCASE/SuperCEEP program. 

The WebMRE system is the automated system that provides information and data for 

the management and control of the program. The WebMRE is accessible via the web 

(https://usamma-extranet.detrick.army.mil/MRE/). Only the following people have 

access to the WebMRE: Activity MEDCASE Managers, Regional MEDCASE Managers, 

USAMMA MEDCASE manager, USAMMA TARA team, and USAMEDCOM MEDCASE 

Manager. 

10-2. THE WEBMRE/THEATER ENTERPRISE WIDE LOGISTICS SYSTEM 

(TEWLS) 

The WebMRE System along with USAMMA’s TEWLS controls all parts of the 

MEDCASE/SuperCEEP program above the station level. It is designed to assist in the 

management of the program and provide detailed information on requirements, 

execution and financial functions. 

a. Capabilities. The WebMRE system provides: 

Tracking of approval and execution actions for requirements. 

Automated issue and management of LOAs. 

An interface with DMLSS to improve property accountability. 

The USAMMA TEWLS and STANFINS systems provide: 

Automated accounting for DHP. 

Automated funds control on all supply and billing actions to preclude 

over-obligations. 

An interface with MILSTRIP systems to improve supply management. 

b. System Operation. 

(1) The WebMRE interfaces with the USAMMA TEWLS system by sending 

data from the WebMRE to the TEWLS system when requirements are executed. 

(2) The WebMRE system operates according to policies specified by the 

USAMEDCOM and the USAMMA. 

10-3. WEBMRE ACCESS FORM 

Information for obtaining access to the WebMRE is provided in Appendix G. 
SB 8-75 MEDCASE 

10-2 

10-4. RECOMMENDING CHANGES TO THE WEBMRE SYSTEM 

Suggested improvements to the WebMRE system should be made in writing. Letters 

or emails should be forwarded through command channels to the:

U.S. Army Medical Materiel Agency 

ATTN: MCMR-MMO-AA 

1423 Sultan Drive, Suite 100 

Fort Detrick MD 21702-5001 

or 

medcasemgr@amedd.army.mil

The recommended change should be described in detail providing flow charts or 

example formats where necessary. The USAMMA will provide a written response to all 

recommended changes indicating either the rationale for disapproval or an intended 

implementation date. 
SB 8-75-MEDCASE 

11-1 

CHAPTER 11. MEDICAL MILCON PROJECTS 

(BLIC "NF" AND "MB" REQUIREMENTS) 

11-1. INTRODUCTION 

This chapter provides an overview of the events and responsibilities associated with a 

medical MILCON project. MEDCASE requirements must meet the eligibility threshold 

of $250,000 (unit price) under DHP Procurement funding. Items qualifying for 

MEDCASE BLIC “NF” are, in most cases, those major equipment items that are not 

funded with MILCON funds. Specific responsibilities and procedures related to the 

identification and initiation of MEDCASE requirements associated with medical 

MILCON projects are provided in chapter 3. 

11-2. OVERVIEW OF A MEDICAL MILCON PROJECT 

a. Authority. The U.S. Congress approves medical MILCON projects. 

Congressional approval is based upon the description of the project submitted to 

Congress on a DD Form 1391 (Military Construction Project Data). This form is 

prepared by the installation Directorate of Public Works, with major input from the 

USAHFPA. The approved construction project is statutorily limited to the work 

described on the DD Form 1391. 

b. Project Design. There are six submittal and design reviews associated with 

the development of a project, beginning with concept design drawings and leading to 

final drawings at the Sixth Submittal (S6) design stage. Design reviews are held 

during the First Submittal (S1) through (S6). Each design review results in an 

updated set of drawings. Beginning with the Third Submittal (S3) design stage, 

drawings will reflect room layouts and recommended equipment placement. As the 

project continues, HFPA’s Equipment Planners develop the Project Rooms Report that 

provides a room-by-room listing of all equipment requirements. 

c. Funding. 

(1) There are three types of funding associated with medical MILCON 

projects: BLIC “MB” and BLIC “NF” And Operations and Maintenance (O&M) Initial 

Outfitting Funds. 

(a) Medical MILCON funds are appropriated by Congress to build or 

renovate a facility, and acquire certain items of installed equipment. 

(b) MEDCASE funds are programmed by the USAMEDCOM to 

acquire the equipment. MEDCASE requirements must meet the eligibility threshold of 

$250,000 (unit price). Items qualifying for MEDCASE BLIC “NF” are, in most cases, 

those major equipment items not funded by MILCON funds, but necessary to make 

the new facility "complete and usable." 

(c) O&M funds are programmed by the USAMEDCOM to acquire 

SuperCEEP and CEEP equipment (unit price less than $250,000) necessary to make 

the new facility "complete and usable" or constructing and equipping a facility to 

enable the facility to achieve the purpose for which it was constructed. For 
SB 8-75-MEDCASE 

11-2 

information on requesting O&M funds for initial outfitting of new construction 

projects, contact the: 

CDR, USAMEDCOM 

ATTN: MCLO 

2050 Worth Rd, Suite 8 

Fort Sam Houston TX 78234-6008 

Commercial telephone 210-221-7119 

(2) Funds management: 

(a) BLIC "MB": Corresponds to the medical MILCON funds set aside 

for the acquisition of certain items of installed equipment called for in the project 

plans. MILCON funds are managed by the Army Corps of Engineers Engineering District 

having oversight of the project. 

(b) BLIC "NF": Corresponds to the MEDCASE funds that are 

programmed by the USAMEDCOM for the acquisition of investment equipment 

required for a new facility. 

(c) DHP "O&M": Corresponds to the local operating funds 

programmed by the USAMEDCOM for the acquisition of SuperCEEP and CEEP 

equipment required for a new facility. 

d. Equipment Planning. Equipment planning for a project begins when the 

USAHFPA uses a computer-generated planning document that lists the total 

equipment requirements, by room, anticipated for each project. This planning 

document is known as the Project Rooms Report (PRR). As the project continues, the 

architects develop an Equipment and Casework Schedule that supersedes the PRR. 

The equipment and casework schedule provides a "refined" room-by-room listing of 

equipment requirements. 

(1) As discussed in chapter 3, the PRR is based on the final design (S6) 

drawings for the project. It lists the equipment requirements and equipment 

placement within the new facility. The activity along with the HFPO are responsible 

for making the necessary adjustments of the equipment listing to accurately reflect 

the specific needs of the facility. The equipment list is a planning document that 

provides a "starting point" for the identification of equipment requirements, and the 

initiation of MPRs. The identification and initiation of MEDCASE requirements for a 

project is the responsibility of the activity. 

(2) The PRR is usually available to the activity prior to commencement of 

construction. The activity should establish a time-line for planning the critical actions 

that must be accomplished, to include the initiation of MEDCASE requirements. 

11-3. LOGCAT CODES 

a. General. LOGCAT codes are single letter designators that delineate 

responsibility for the acquisition and installation of the equipment required for a 

project. LOGCAT codes are used in the PRR and later in the project’s final design 

drawings. LOGCAT codes are explained in Table 11-1. 
SB 8-75-MEDCASE 

11-3 

TABLE 11-1. LOGISTICAL CATEGORY CODES 

LOGCAT CODES 

 

LOGCAT "A" Contractor Furnished and Contractor Installed (2)

 

LOGCAT "B" Government Furnished and Contractor Installed (1)

 

LOGCAT "C" Government Furnished and Government Installed (1)

 

LOGCAT "E" Government Furnished and Contractor Installed (3)

 

LOGCAT "F" Government Furnished and Government (by 2nd Source Vendor) 

Installed (3)

NOTES: 

(1) Typically paid for by activity's DHP O&M funds or MEDCASE BLIC "NF" (if 

eligible). 

(2) Paid for by major medical MILCON funds - Not MEDCASE. 

(3) Funded through the major medical MILCON-MEDCASE (BLIC "MB") Program.

b. Funding Responsibilities. 

(1) LOGCAT "A" items are provided by the construction contractor as 

part of the project and paid for by MILCON funds. 

(2) LOGCAT "E" and "F" items are acquired through the MEDCASE 

program as BLIC "MB" requirements paid for by MILCON funds. LOGCAT "F" items are 

generally installed diagnostic imaging systems. 

(3) The LOGCAT codes are identified in the PRR. 

11-4. REFERENCES AND RESOURCES 

The following documents are available to assist the activity in managing the 

equipment requirements for a facility construction/renovation project. 

a. DD Form 1391. The DD Form 1391 describes the scope and provides the 

approval for the project. It also contains the justification for the project that was 

submitted to Congress. The DD Form 1391 is a useful document for activity 

commanders, logisticians, and MEDCASE managers. 

b. Program For Design (PFD). The PFD is produced early in the planning 

process. The Defense Medical Facilities Office (DMFO)/Office of the Assistant 

Secretary of Defense for Health Affairs (OASD-HA), is responsible for programming 

and space planning of medical construction projects. DMFO organizes the study 

around the mission of the facility and the projected workload. It can also provide 

information (i.e., regarding mission and work load) that can be useful in preparing 

the justification for MPRs. 
SB 8-75-MEDCASE 

11-4 

c. Final Drawings. The final drawings for a new or renovated facility will 

reflect room layouts and equipment placement, and will contain PRR. (Note: This 

schedule may be included within the contract specifications which accompany the 

final drawings.) The information in these documents is based upon the PRR. 

d. PRR. The PRR is the initial Equipment Planning document. It is produced at 

the S-4/S-5 design stage. 

e. Military Standard (MIL-STD) 1691. MIL-STD 1691 (Construction and 

Materiel Schedule for Military Medical and Dental Facilities), is a Tri-Services 

document listing equipment which is commonly reflected in the drawings for military 

medical construction projects. Each equipment item is referenced by a Joint Service 

Number (JSN), which is used to identify that item on plans and drawings. The MILSTD also provides a short functional description of the item, indicates its utility 

requirements, and reflects the LOGCAT Code. 

f. The HFPO Guide. This guide is published by the USAHFPA as a resource for 

their project officers in the field. It contains valuable information concerning the 

responsibilities involved in a project. 

11-5. RESPONSIBILITIES DURING THE PROJECT 

a. Activity Commander. The activity commander must ensure that the overall 

planning effort necessary to support the project and accomplish the transition to the 

new facility is accomplished. The commander's responsibilities include: 

(1) Providing comments during the project design reviews 

(2) Planning to acquire equipment and furnishings that are compatible 

with the scope and design of the project 

(3) Appointing a project officer to serve as point of contact with 

USAHFPA and other agencies/activities regarding the project 

(4) Creating a transition committee to manage transition issues. This 

minimizes the disruptions to the delivery of patient care. 

b. Transition Committee. A transition committee will be established at all 

activities undergoing a medical MILCON project. The committee will have 

representation from each affected department/service, the Chief of Logistics, and 

other impacted/applicable areas in order to: 

(1) Coordinate project review and utilization planning 

(2) Coordinate equipment planning, to include decisions regarding the 

use or replacement of existing assets (see chapter 3) 

(3) Coordinate transition and movement of equipment and services
SB 8-75-MEDCASE 

11-5 (11-6 blank) 

c. Chief of Logistics. The importance of the Chief of Logistics in the planning 

process cannot be overstated. In many, if not most, cases the equipment planning for 

a new facility must begin before an HFPO is assigned. The Chief of Logistics must 

ensure programs for the project are established, and that requirements are identified 

in a timely manner. Logistics responsibilities include: 

(1) Advising the transition committee and the commander of the actions 

that must be accomplished to support the project 

(2) Assisting in the identification of requirements by coordinating the 

Equipment and Casework Schedule with the using services 

(3) Coordinating the review and amendment, as appropriate, of the 

equipment and casework schedule when it is received 

d. HFPO. The HFPO is the individual assigned to a construction project for the 

expressed purpose of fulfilling USAHFPA’s project responsibilities and to represent the 

AMEDD during a medical MILCON project. The HFPO is assigned to the USAHFPA, with 

duty at the construction site. The HFPO is: 

(1) The primary POC between the activity, the USAHFPA, the Engineer 

District responsible for the project, and the construction contractor. 

(2) Responsible for notifying the Chief of Logistics of the equipment 

delivery dates required to meet construction contract schedules, and for coordinating 

the turnover of government-furnished/contractor-installed equipment (LOGCATs "B" 

and "E") to the contractor. 

(3) Responsible for contacting the USAMMA at the start of any renewal 

or new construction project in order to properly understand the activities MEDCASE 

requirements and to request TARA support. This will assist in the generation of all 

diagnostic imaging and radiation therapy equipment MEDCASE requirements. By 

doing this up front and early, time and money will be saved and the MILCON 

MEDCASE requirements will be front-loaded into the WebMRE. Thus, no MEDCASE 

packages will be required. 
SB 8-75-MEDCASE 

12-1 

CHAPTER 12. DIAGNOSTIC IMAGING AND 

RADIATION THERAPY REQUIREMENTS 

12-1. INTRODUCTION 

This chapter describes the additional steps and considerations that must be made in 

order to successfully plan for the acquisition, installation and acceptance of diagnostic 

imaging and radiation therapy requirements. 

12-2. SCOPE

a. Diagnostic Imaging Equipment. This includes any item or equipment which 

uses electromagnetic waves (either ionizing or non-ionizing radiation) or ultrasonic 

waves to produce a diagnostic image of a patient, or any item that incorporates such 

an imaging modality within its function. Examples include: 

(1) Diagnostic x-ray (radiographic and fluoroscopic systems), fixed and 

mobile 

(2) Diagnostic ultrasound scanners 

(3) Gamma cameras and associated image processing computers 

[including Single Photon Emission Computed Tomography (SPECT) and Molecular 

Coincidence Detection] 

(4) Magnetic Resonance Imaging (MRI) systems 

(5) Computed Tomography (CT) scanners 

(6) Positron Emission Tomography (PET) systems 

b. Radiation Therapy Equipment. Radiation therapy equipment includes 

equipment that uses ionizing or non-ionizing radiation, or electro-magnetic wave 

emission as part of a direct therapeutic treatment to a patient. Examples include: 

(1) Cobalt therapy systems 

(2) Linear accelerators 

(3) Stereotactic Radiosurgery or “Gamma Knife” systems 

(4) Radiation therapy simulators 

(5) Therapy planning computers 

12-3. DIAGNOSTIC IMAGING AND RADIATION THERAPY REQUIREMENTS 

a. All MEDCASE/SuperCEEP Program requirements for diagnostic imaging and 

radiation therapy equipment $100,000 and greater, regardless of BLIC, are centrally 

managed by the USAMEDCOM. This ensures consistency of application and 

compliance with Army Medical Department strategic plans. 
SB 8-75-MEDCASE 

12-2 

b. TARA Review. The USAMMA Materiel Acquisition Directorate is responsible 

for technical review and approval of all diagnostic imaging and radiation therapy 

equipment requirements $100,000 and greater, regardless of BLIC. The USAMMA will 

return disapproved requirements to the requesting facility for further justification or 

clarification. 

c. TARA Visits. If your facility has not had a TARA visit within the last four 

years, contact the TARA team before submitting any diagnostic imaging or radiation 

therapy requirements. This simplifies the approval process and avoids any 

unnecessary delays in processing the requirements. 

12-4. SPECIAL REQUIREMENTS FOR SUBMISSION AND APPROVAL 

(ROUTINE) 

a. MEDCASE/SuperCEEP requirements for diagnostic imaging and radiation 

therapy equipment are identified, initiated, and submitted for approval in the same 

manner as other MEDCASE/SuperCEEP Program requirements. Certain additional 

documentation, coordination, and review, as described below, may be required. A 

chart that summarizes review criteria for diagnostic imaging, radiation therapy, and 

associated equipment is provided at Appendix E. 

b. Neither the USAMMA nor the USAMEDCOM require you to submit a PreAcquisition Site Survey (PASS) or Facilities Survey Report (FSR) document along with 

the DA Forms 5027-R/5028-R for the approval process. However, your RMC/MSC 

may require the PASS/FSR for internal decision making matters such as lead shielding 

and site preparation costs. 

c. Review by Local Chief of Radiology. 

(1) All MEDCASE/SuperCEEP requirements for diagnostic imaging 

equipment must contain documentation of review and concurrence or comment by 

the activity chief of radiology. This specifically includes all types of imaging systems 

described in this chapter. 

(2) The signature and typed name of the Chief, Department of Radiology 

is required on the DA Form 5027-R. 

12-5. EXECUTION AND ACQUISITION SOURCE 

a. Funding. Once a diagnostic imaging or radiation therapy requirement has 

received "1A" approval, it is eligible for execution. Funding will be accomplished in 

accordance with command policy and this SB. 

b. Acquisition Sources. The DSCP is the primary source for all diagnostic x-ray 

equipment. 

c. Exception to Policy. In accordance with AR 40-61, activities may request 

an exception to policy in order to locally procure or have an alternate acquisition 

source procure a diagnostic imaging or radiation therapy system. 
SB 8-75-MEDCASE 

12-3 

(1) The USAMMA, ATTN: MMO-AT, Fort Detrick, MD, is the approving 

authority. Request for exception to policy must be forwarded by memorandum 

through command channels to the: 

U.S. Army Medical Materiel Agency 

ATTN: MCMR-MMO-AT 

1423 Sultan Drive, Suite 100 

Fort Detrick MD 21702-5001 

(2) Requests should cite the availability of local or alternate acquisition 

source purchasing and contracting support to accomplish the acquisition and a brief 

justification for the exception. 

12-6. EXTENDED INSTALLATION 

Extended installation is an acquisition strategy whereby a single vendor is awarded a 

contract to supply and install a safe functional system. It requires the manufacturer 

to interface their equipment to the existing room and utilities. This strategy includes 

as a minimum, connecting with existing utilities and furnishing and installing support 

structures for the equipment. Cosmetic work will not be included in the scope of work 

or contract and will be the responsibility of the customer. 

a. Extended installation is currently being offered by DSCP. Activities that 

desire extended installation must budget and ensure availability of MEDCASE/ 

SuperCEEP DHP funds to accommodate the limited site preparation portion of the 

project. The request must be annotated on the DD form 1348-6. Eligibility for 

extended installation will be evaluated on a case-by-case basis by the USAMMA upon 

receipt of a requisition. General guidelines and typical systems that may be satisfied 

with extended installation are: 

(1) All DOD universal x-ray rooms 

(2) Cardiac catheterization systems 

(3) Special procedures systems 

(4) Radiographic/fluoroscopic systems (limited) 

(5) CT scanners 

(6) Radiographic systems (case-by-case basis only) 

(7) Replacement system must be similar to existing system 

b. The requesting activity shall provide the following information with their 

requisition: 

(1) Point of contact with commercial and DSN phone numbers 

(2) Five sets of single-line room drawings showing existing utilities and 

equipment layout and proposed layout 

(3) Preliminary work statement of what is required 
SB 8-75-MEDCASE 

12-4 

12-7. AWARD AND ACCEPTANCE 

a. Contract Award by DSCP. Once a contract for a diagnostic imaging 

system has been awarded by DSCP, both the customer and the contractor are 

advised of specific responsibilities. The principal responsibilities and actions required 

following award is: 

(1) Site Visit. Within 30 days of contract award for a diagnostic imaging 

system, the contractor is required to visit the receiving activity to survey electrical 

power and other identified site preparation requirements. The contractor is required 

to provide complete equipment layout plans for the system, as well as room 

preparation drawings and instructions. 

(2) Activity Action. The activity is responsible for using the plans and 

drawings provided by the contractor to initiate action for accomplishing site 

preparation. 

(3) Required Delivery Date (RDD). The contract will identify the RDD for 

the system. Sixty days prior to that date, the activity is required to review site 

readiness to determine if delivery and installation can continue on schedule. If 

delivery must be delayed due to problems with site preparation, or other 

unanticipated problems, the activity must immediately contact DSCP by telephone 

DSN 444-2896, or commercial 215-737-2896, to advise them of the problem. 

Note: Storage costs charged by the vendor due to customer-initiated delays must 

be borne by the activity and cannot be financed with MEDCASE/SuperCEEP funds. 

(4) Contract Problems. The activity should immediately notify the 

USAMMA if it is suspected or known that the vendor is not fulfilling his/her 

responsibilities under the provisions of the contract. 

b. X-ray Acceptance. Upon completion of installation, the vendor must notify 

DSCP in writing, that the system is ready for acceptance inspection. X-ray acceptance 

inspection is performed at government expense by technicians from one of the 

Medical Equipment Repair Activities assigned to the USAMMA, or by medical 

maintainers assigned to the local organization. If the system fails acceptance 

inspection, a portion of the total payment is withheld until the contractor effects 

appropriate corrective actions. A detailed explanation of x-ray acceptance procedures 

is provided in Appendix E. 

c. Warranty. Diagnostic imaging systems acquired by the DSCP include a 

one-year warranty against defective material, workmanship and performance. Any 

extension of the warranty period must be funded by the activity their DHP operating 

funds. 

d. Local Procurement. If the exception to policy was granted for local 

procurement, then the acceptance of diagnostic x-ray systems acquired through local 

procurement is the responsibility of the activity and must be accomplished in 

accordance with the protocol established by the contracting officer. Commands may 

require submission of acceptance reports and the creation and maintenance of 

acceptance documentation. Activities that do not have the qualified personnel or 

necessary equipment to perform an acceptance inspection may request support 

through command channels to the: 
SB 8-75-MEDCASE 

12-5 (12-6 blank) 

U.S. Army Medical Materiel Agency 

ATTN: MCMR-MMO-AT 

1423 Sultan Drive, Suite 100 

Fort Detrick MD 21702-5001 

12-8. SPECIAL PROCEDURES 

a. Factory Refurbishment. Requests for removal, factory refurbishment, and 

reinstallation of LOGCAT "F" equipment must also be submitted for approval on DA 

Forms 5027-R/5028-R. Maintenance records of the actual equipment to be 

refurbished must be provided. 

b. Universal Room. LOGCAT "F" requirements that are to be installed into the 

USAHFPA approved “Universal Room” do not require individual site surveys. 
SB 8-75 MEDCASE 

13-1 

CHAPTER 13. ADMINISTRATIVE AND INFORMATION MANAGEMENT 

13-1. INTRODUCTION 

a. General. Operating a medical treatment facility requires much more than 

just medical supplies and equipment. Many administrative items of equipment are 

essential. Since a great number of administrative items are common requirements 

throughout all organizations in the Army, central controls have been established for 

certain categories of equipment to optimize expenditures and encourage 

standardization. The number of controls has made the MEDCASE/SuperCEEP 

manager's job more complex. 

b. Funding. Non-medical equipment that is normally managed and funded by 

another DA-level program, such as security equipment, may be considered for 

funding through the MEDCASE/SuperCEEP program. However, it must be determined 

that the proper program will not be able to meet an immediate mission requirement 

of the health care activity. The AMEDD policy regarding the funding of such 

equipment is provided in chapter 2. To qualify for MEDCASE funding, requirements 

must meet the threshold of $250,000 or greater (unit or system price). To qualify for 

SuperCEEP funding, requirements must be equal to or greater that $100,000 and less 

than $249,999 (unit or system price). 

c. Evaluation. Administrative items must be carefully evaluated against the 

eligibility criteria. Careful evaluation is necessary for several reasons. First, it is 

necessary to ensure that no time is wasted due to disapprovals. Second, it is 

necessary to conserve MEDCASE/SuperCEEP program funds for use with 

MEDCASE/SuperCEEP eligible items. Finally, it is necessary to ensure application of 

the appropriate management controls specified in various regulations. When 

questions about the eligibility of specific items arise, they should be forwarded either 

to the USAMMA or USAMEDCOM. Responses will be provided in writing, when 

necessary. 

d. Submission. When other-than-MEDCASE/SuperCEEP-approval channels 

are required, these approvals must be obtained before action code 1A (approval) can 

be assigned to a MEDCASE/SuperCEEP requirement. Type Classification and IMA 

approval are typical of the types of approvals that are required outside of 

MEDCASE/SuperCEEP approval channels. The originating activity is responsible for 

originating all documentation required to secure approval of the requirement. In 

general, a copy of appropriate approvals outside of the MEDCASE/SuperCEEP 

program must be submitted with DA Forms 5027-R/5028-R. These approvals 

enhance the consultant review process. When non-MEDCASE/SuperCEEP approval 

channels parallel the MEDCASE/SuperCEEP approval channels, both types of 

documentation may be submitted together, but the non-MEDCASE/SuperCEEP 

approval must be completed first at each level of review. 

13-2. TDA APPROVAL AND TYPE CLASSIFICATION EXEMPTION 

a. General. Nonmedical standard-type-classified equipment (see SB 700-20, 

chapter 2, [Cataloging of Supplies and Equipment, Army Adopted Items of Materiel, 

and List of Reportable Items]) will not be approved for acquisition until the item is 
SB 8-75-MEDCASE 

13-2 

approved for the TDA. Request for standard-type-classified equipment will be 

submitted in accordance with AR 71-32. 

b. Documentation. Memorandum requesting type-classification exemption 

and TDA approval will be submitted along with the DA Forms 5027-R/5028-R and 

other documents to the USAMMA for submission to the USAMEDCOM. The letter will 

contain the following information: 

(1) Manufacturer's nomenclature 

(2) Model number 

(3) Quantity required 

(4) Unit price 

(5) Manufacturer's name and mailing address 

(6) Manufacturer's brochure if available 

(7) A statement that there is not an acceptable standard item in the 

supply system. (Line Item Numbers [LINs] of items considered but found 

unacceptable will be listed.) Refer to SB 700-20 for LINs. 

(8) Applicable TDA paragraph and name of the using activity 

(9) MEDCASE/SuperCEEP ACN 

(10) The name and telephone number of an individual able to discuss the 

requirement 

c. Approval. TDA authorization does not constitute eligibility for the 

MEDCASE/SuperCEEP program. TDA authorization merely permits acquisition of the 

item. The funding level requirement for the DA-level program must be determined 

based upon the nature of the equipment and applicable Army regulations. 

13-3. INFORMATION MISSION AREA (IMA) SOFTWARE AND HARDWARE 

a. General. Congressional direction, DOD, and Army guidance state the 

acquisition, modification, and support costs for purchase of IMA software and 

hardware must be funded with O&M funds if the cost is less than the 

expense/investment threshold of $250,000. MEDCASE and centrally managed 

SuperCEEP funds are used if the cost is equal to or greater than the threshold of 

$100,000. The only exception to this rule is the acquisition of all ADPE at Research, 

Development, Test and Evaluation (RDTE)-funded facilities will be financed with RDTE 

funds, regardless of cost. 

b. Systems. The “system” concept must be considered in evaluating the 

acquisition of IMA end items. A system exists if a number of components are 

designed primarily to function within the context of a whole and will be 

interconnected to satisfy an approved Army requirement. Fragmented or piecemeal 

acquisition of the documented requirement will not be used as a basis to circumvent 

the “system” concept. 
SB 8-75 MEDCASE 

13-3 

c. Installation. Normal installation costs will be included as part of the total 

IMA system cost. 

d. Training. IMA training will normally be funded separately with O&M funds 

or RDTE, and not included within the cost of the total system. However, when the 

cost of training is included as part of the original contract and is not separately 

priced, it then becomes part of the total system cost and is funded with the same 

type of funds as the system. 

e. Maintenance. Annual fees for maintenance will normally be funded 

separately with O&M or RDTE funds and not included within the cost of the total 

system. However, when the cost of maintenance/warranty service is not separately 

priced, it then becomes part of the total system cost and is funded with the same 

type of funds as the system. 

13-4. COMMUNICATION/AUTOMATION DATA PROCESSING EQUIPMENT 

ACQUISITION 

a. New Equipment/System Acquisition. The aggregate cost of an end 

item/system procured to address a valid requirement (including peripherals, 

installation and system unique software) will be used to determine whether it should 

be treated as an expense (O&M) or investment (OP) cost. Determination of what 

comprises an end item/system will be based on the primary function of the hardware 

and software to be acquired as stated in the approved requirements document. 

b. An Example. The appropriate type of funds for the purchase of five standalone computers is determined by deciding whether the primary function of the 

computers is to operate as independent workstations (i.e., five systems) or as a part 

of a larger system. If the computers are designed to operate independently, they 

should be considered as separate end items and applied against the expense/ 

investment criteria individually. If they function as a component of a larger system, 

i.e., interconnected and primarily designed to operate as one, then they should be 

considered a system and the total cost applied against the expense/investment 

criteria. 

c. Additional or Replacement Equipment/System. When requirements 

necessitate adding/replacing or modifying equipment/software that is a component or 

support the functioning of an existing system, only the additional equipment/ 

software costs (including installation) will be used to determine whether the 

acquisition is an expense (O&M) or an investment (OP) cost. 

13-5. LOCAL AREA NETWORK (LAN) AND WIDE AREA NETWORK (WAN)

LANs and WANs are considered to be systems. As such, the total cost of all 

component parts must be applied against the dollar threshold to determine the 

appropriate color of money when the LAN or WAN is acquired as an add-on or 

upgrade to an existing system. If the WAN or LAN is part of the initial hardware/ 

software acquisition, the cost will be included as part of the total system cost. 
SB 8-75-MEDCASE 

13-4 

13-6. CENTRALLY MANAGED SYSTEMS 

The acquisition of any system that is centrally managed is considered an investment 

regardless of the amount. Systems managed by an Army-Acquisition-ExecutiveChartered Program Executive Officer or Program Manager are considered centrally 

managed systems. 

13-7. TURNKEY ACQUISITION 

Acquisitions where a single or prime contractor provides a complete system (i.e., 

hardware, software, installation, etc.), the system may be entirely financed with 

procurement funds. A turnkey system is typically large and at the point of 

contracting, the appropriate type of funds cannot be readily determined due to the 

nature of the system. Therefore, it is appropriate to budget and execute the entire 

acquisition within MEDCASE/SuperCEEP. 

13-8. TELECOMMUNICATIONS EQUIPMENT 

a. Base Communications Equipment. Base communications, which includes 

the following, must be developed and approved through an Information Management 

Plan (IMP)/Project Document, DA Form 5695-R-E (Information Management 

Equipment/Project Document): 

(1) Base radio stations (including hospital systems) 

(2) Radio paging systems 

(3) Outside plant television transmission facilities 

(4) Telecommunications support for automation systems 

b. Hospital Unique Communications Equipment. Hospital unique 

communications equipment is used to support the operations or mission of a medical 

activity and does not have a frequency assigned or have a transmission interface with 

a commercial telephone system. Hospital unique communications equipment that 

otherwise meets the eligibility criteria stated in chapter 2 of this SB, may be funded 

through the MEDCASE/SuperCEEP program, provided that TDA approval and typeclassification exemption are first obtained. Examples of hospital-unique 

communications equipment include: 

(1) Nurse call systems 

(2) Intra-hospital intercom systems 

(3) Emergency room telephone recording equipment 

(4) Dictation equipment 

(5) Telephone answering equipment 

(6) Hospital Radio Communication (Emergency Room) 
SB 8-75 MEDCASE 

13-5 (13-6 blank) 

13-9. BASE LEVEL COMMERCIAL EQUIPMENT (BCE) 

BCE is a budget line of the same appropriation that funds MEDCASE/SuperCEEP. The 

BCE program funds other activities in the Army with TDA investment equipment in a 

similar fashion to the way the MEDCASE/SuperCEEP Program funds medical care 

support equipment. AMEDD activities do not participate directly in the BCE program. 
SB 8-75-MEDCASE 

14-1 

CHAPTER 14. COMPETITION IN CONTRACTING REQUIREMENTS 

14-1. INTRODUCTION 

a. Policy. It is Federal law and DOD, DA, and AMEDD policy that the needs of 

the government will be acquired through full-and-open-competition, using 

commercial sources to the maximum extent possible. The noncompetitive acquisition 

of equipment is a matter of concern and intense scrutiny. It is essential that all the 

following individuals involved in the acquisition of equipment be cognizant of the 

requirement for competitive acquisition. 

(1) Requesters 

(2) Logisticians 

(3) MEDCASE/SuperCEEP managers 

(4) Review and approval authorities at the activity 

(5) Review and approval authorities at the RMCs 

(6) The USAMEDCOM level 

b. MEDCASE/SuperCEEP Requirements. MEDCASE/SuperCEEP requirements 

must be stated in terms of minimum needs using generic descriptions whenever 

possible. The use of brand-name descriptions to identify MEDCASE/SuperCEEP 

requirements shall not constitute endorsement, approval, or acquisition under lessthan-full-and-open competition. 

c. MEDCASE/SuperCEEP Program Executions. The acquisition of equipment 

through the MEDCASE/SuperCEEP program shall use competitive procedures to the 

maximum extent practical regardless of the acquisition source. 

(1) For local procurement, activities must comply with the policies and 

procedures established by the supporting purchasing and contracting office to 

implement the CICA, see paragraph 14-2. It is essential that MEDCASE/SuperCEEP 

participants coordinate and work closely with the contracting officer to ensure that 

acquisition is not unnecessarily delayed due to a failure to comply with CICA 

requirements. 

(2) For acquisitions through the wholesale supply system, it is especially 

important for the activity to provide detailed descriptive information in the most 

competitive form possible. The time/distance relationship between the customer, the 

USAMMA, and the supply source, as well as the tremendous volume of transactions 

handled by wholesale supply activities, complicates the resolution of problems arising 

from noncompetitive item descriptions. This can easily result in the cancellation or 

delay of the acquisition of a needed requirement. 
SB 8-75-MEDCASE 

14-2 

14-2. CICA 

The CICA of 1984 substantially changed the policies and the regulations concerning 

the acquisition of equipment by government activities. While it is not the purpose of 

this manual to supplement acquisition regulations, an outline of areas that have a 

significant impact upon the acquisition of MEDCASE/SuperCEEP items is provided as 

follows: 

a. FAR. The FAR established acquisition policy for all branches of the Federal 

government. The DFARS provides more detailed guidance and implementation 

procedures for the DOD. The FAR and DFARS implement the CICA. 

b. Exceptions to Competitive Procedures. The CICA specifies the 

circumstances that may permit the use of “other-than full-and-open competition” 

procedures for acquisition. These exceptions must be justified and approved in 

accordance with CICA procedures. The two most common exceptions that may apply 

to MEDCASE/SuperCEEP acquisitions are: 

(1) When only one responsible source can provide the required 

equipment and no other equipment can provide the capabilities that meet the 

minimum essential needs. This exception requires written justification and approval 

prior to the award of a contract under less-than-full-and-open competition. 

(2) When the equipment is required due to unusual and compelling 

urgency. If necessary, the written justification for this exception may be provided 

after the fact; however, offers must be requested from as many potential sources as 

possible under the circumstances. 

c. Competition Advocates. The CICA established the requirement for 

competition advocates to review acquisitions subject to CICA and challenge those, 

which unnecessarily and/or unjustifiably restrict competition. A competition advocate 

review will add 30 to 90 days to the acquisition process. 

14-3. METHODS OF DESCRIBING MEDCASE/SUPERCEEP REQUIREMENTS 

a. General. The acquisition activity must provide a description of the required 

item. The law prescribes that requirements will be stated in terms of minimum 

essential needs. The degree of detail used by the activity in providing a purchase 

description correlates with the cost of the item. The higher the cost or importance of 

the features, the greater the detail which must be provided. 

b. Performance Specifications. Specifications are the most detailed form of 

purchase description. Specifications describe in detail the minimum essential features 

and performance characteristics required for an item of equipment. Technical 

personnel who are familiar with the equipment or the requirement usually provide 

specifications. The specifications are further prepared by the contract specialist at the 

procurement activity to ensure the data is complete and thorough enough for the 

procurement process. Procurement specifications are drawn from the information 

provided by the requesting activity (for example., from the EDL are ECs), and from 

the specification writer's knowledge of the market. 

c. Brand Name or Equal. "Brand name or equal" is a shorthand method of 

describing essential characteristics. When a "brand name" is used to provide 
SB 8-75-MEDCASE 

14-3 (14-4 blank) 

description of the basic function that must be performed, it is generally difficult for 

the purchasing office to determine what is "equal." Therefore, the activity must also 

describe the minimum essential characteristics. Brand name references on approved 

MEDCASE/SuperCEEP requirements do not constitute endorsement or authority for 

limited competition. 

d. Limited Competition. Limited competition arises when an activity specifies 

the need for features or capabilities that restrict competition. Restrictive 

characteristics require written justification and must be approved by the appropriate 

authority. The "appropriate authority" is dependent on the cost of the item. 

14-4. JUSTIFICATION FOR OTHER-THAN-FULL-AND-OPEN COMPETITION 

a. Requisitions. Requisitions for MEDCASE/SuperCEEP requirements must be 

accompanied by written justification for acquisition under other-than-full-and-open 

competition, if limited competition is requested or restrictive essential characteristics 

or specifications are provided. This is often referred to as a CICA Justification or a 

Justification and Approval (J&A). The J&A must clearly address the following areas: 

(1) Identify the features or specifications which limit competition and 

efforts made to eliminate restrictions for this and future requirements. 

(2) Provide a clinical rationale for the essentialness for each feature or 

specification that limits competition. A clinical rationale must explain the clinical 

application of the restrictive essential characteristics. 

(3) Identify the impact if those features or essential characteristics are 

not met. 

b. Justification Statement. The CICA justification/J&A must include the 

following statement signed by the clinical/health care professional initiating the 

requirement: 

"I certify that the information contained in this justification 

supports the government's minimum essential requirements 

and that the statements contained herein for other-than-fulland-open competition are accurate and complete." 
SB 8-75-MEDCASE 

15-1 

CHAPTER 15. SPECIAL MEDCASE/SUPERCEEP PROGRAM CONSIDERATIONS 

15-1. INTRODUCTION

This chapter addresses specific areas that have presented problems for MEDCASE/ 

SuperCEEP managers and logisticians. Activities may direct questions regarding 

these, or any other MEDCASE/SuperCEEP problems, to their MEDCASE/SuperCEEP 

station manager at the USAMMA. 

15-2. PRICE ESTIMATES 

a. Unit and System Prices. Perhaps no other attribute of a requirement 

influences routine processing more than price. Unit and system prices are used to 

determine MEDCASE/SuperCEEP program eligibility. Items with high unit prices 

require extra documentation as described in chapter 3 of this Bulletin. Because of 

these processing considerations, unit prices must be accurate. Personnel at various 

review levels are particularly aware of the effect prices have on subsequent reviews 

and approvals. It is apparent when unit prices are inflated or deflated to avoid 

various edits and reviews. This practice is prohibited and will result in processing 

delays or cancellation of the activity’s requirement. 

b. Accurate Prices. Vendor quotes are the most reliable source. Normally, 

price estimates will vary with the source and age of the price information. Most 

quotes are valid for a period of 90 to 120 days; the quote submitted with the MPR 

package is for reference and supporting documentation only. It is important that all 

quotes are reviewed, validated and updated when they are submitted with the 

procurement requisition package. Any significant price changes need to be updated in 

DMLSS to interface with WebMRE. When estimating prices, judgment and care should 

be exercised for two reasons: 

(1) Workload Savings. Inaccurate prices will generate requests for 

verification, cause increased commitments of funds, and require reconciliation of 

financial records. 

(2) Price estimates establish the nature of the requirement such as 

investment, or expense. These categories of equipment are budgeted in different 

channels and, therefore, accurate price will ensure application of the proper type of 

funds. Initial price estimates establish the type of funds to use. 

15-3. RELOCATABLE BUILDINGS

The purchase of relocatable buildings considered personal property must follow the 

MEDCASE program rules when the cost is equal to or greater than the expenseinvestment threshold funding limitation of $250,000 per building. Requests for 

authority to obtain relocatable buildings are governed by AR 420-18, Facilities 

Engineering Materials, Equipment, and Relocatable Building Management. Approval 

authority to purchase is the Deputy Assistant Secretary of the Army for Installations 

and Housing (DASA-I&H). This approval must be completed before MEDCASE funds 

are released. Detailed information on approval procedures for relocatable buildings 

can be found in SB-8-75-11, chapter 8 or Facility Information Bulletin (FIB) 

#2005-001 on Army Knowledge Online (AKO). 
SB 8-75-MEDCASE 

15-2 

15-4. MEDCASE/SUPERCEEP ELIGIBILITY OF COSTS OTHER THAN UNIT 

PRICE 

The MEDCASE/SuperCEEP program requirements frequently involve costs other than 

the unit price of the item to be acquired. Examples of these costs include 

transportation costs, costs of training equipment operators and maintenance 

personnel, installation costs, site preparation costs, and consumable supplies costs. 

While all of these costs must be considered when developing a MPR, some are eligible 

for MEDCASE/SuperCEEP Program funding while others are not. The following 

represents a general set of rules to use when considering use of MEDCASE/ 

SuperCEEP Program funds. 

a. Transportation Costs. Transportation costs are divided into first and 

second-destination transportation costs. 

(1) First-Destination Transportation Costs. This is the cost of moving an 

equipment item from the commercial source to the point at which the government 

first takes delivery (i.e., a depot or treatment facility receiving dock). 

(a) MEDCASE/SuperCEEP funds may be used to pay first-destination 

transportation charges. Normally first-destination charges are incorporated in the 

price of the equipment purchased, e.g., FOB Destination. If questions or doubts arise 

on this point, the local contracting office can clarify contract terms or USAMMA may 

be contacted for assistance. 

(b) MEDCASE/SuperCEEP funds cannot be used to pay first 

destination transportation costs when it is not associated with the acquisition of a 

MEDCASE/SuperCEEP requirement, rather O&M operating funds will be used to pay 

for transportation. Assistance should be sought from the local comptroller in these 

cases. Participants who do not have O&M funds should contact their parent command 

or USAMMA, Resources Management Division, ATTN: MCMR-MMA-R, Fort Detrick, MD 

21702-5002; DSN 343-4445/commercial 301-619-4445, for assistance. 

(c) MILCON funds used for BLIC "MB" requirements may be used to 

pay for first-destination transportation costs regardless of the terms of the equipment 

contract. 

(2) Second-Destination Transportation Costs. 

(a) Costs arise when equipment is shipped between two locations 

within the government. 

(b) Neither MEDCASE/SuperCEEP nor medical MILCON funds may 

be used to pay for second-destination transportation costs. 

(c) O&M are used when excess equipment is redistributed within the 

AMEDD. 

b. Training Costs. Training costs include user and maintenance personnel 

training and is normally associated with the operation of equipment after receipt and 

acceptance. The MEDCASE/SuperCEEP program will pay for some training weather it 

is intrinsic to the contract or priced separately. Per Diem and transportation costs 

associated with such training must be funded by local user mission funds. 
SB 8-75-MEDCASE 

15-3 

c. Installation. 

(1) The vendor normally accomplishes the installation of diagnostic 

imaging and radiation therapy systems. 

(2) Installation includes the electrical, plumbing and mechanical 

interconnection between the components of the system and the mounting of system 

components to existing support structures. Unless otherwise specified in the delivery 

order, contractor installation DOES NOT INCLUDE carpentry work, plumbing, 

electrical infrastructure, or demolition work. To ensure that installation fulfills the 

requirement, coordination between the customer, the USAMMA, and the acquisition 

activity is strongly encouraged. 

(3) Contractor installation must be specified on the local purchase 

document. Installation must appear as a separate contract line item (CLIN) on the 

contract or delivery order. The cost of installation is funded by MEDCASE/SuperCEEP. 

d. Site Preparation. 

(1) Site preparation is the responsibility of the activity and may become 

a major problem when it is not planned for and budgeted by the activity. The 

activity’s supporting facility engineer normally accomplishes site preparation either 

in-house or by a service contract. 

(2) Site preparation includes any and all of facility modifications that 

must be accomplished to allow the contractor to install the system. Site preparation 

may consist of rough-in carpentry work, plumbing, the mounting of conduit or the 

running of wires through conduit, and/or the mounting of junction boxes, lines 

switched, and fuses. 

(3) Site preparation is not funded with MEDCASE or centralized 

SuperCEEP funds. The activity must program for and obtain DHP O&M funds for site 

preparation in accordance with command procedures. See FM 8-75-11 chapter 8 

(Facility Life Cycle Management), for more details on the site preparation program. 

e. Turnkey Acquisition. A turnkey acquisition is a strategy whereby a single 

vendor is awarded a contract to perform site preparation functions, as well as supply 

and install the equipment. 

(1) Generally, a local contracting activity does not accomplish turnkey 

acquisition; therefore, activities that desire turnkey acquisition must request an 

exception to policy in order to locally procure the requirement. The request must cite 

the availability of DHP O&M funds for the site preparation portion of the project. 

(2) Turnkey acquisition consists of a contract or delivery order for the 

equipment and installation and a service contract for site preparation. The activity 

must prepare a "Statement of Work," which is the specification for the site 

preparation portion of a turnkey acquisition. The activity must provide a separate, 

DHP O&M fund citation to the local purchasing and contracting activity for that 

function. 

f. Consumable and Operating Supplies. Many manufacturers include a small 

amount of supplies, not to exceed a 30-day supply level, with the equipment when it 

is sold. These supplies, provided they are part of the basic equipment contract, may 
SB 8-75-MEDCASE 

15-4 

be financed with MEDCASE/SuperCEEP funds. Beyond these "start up" supplies, any 

supplies needed must be funded with O&M. 

15-5. WARRANTIES

Most medical equipment suppliers warrant their products. Terms of the warranty can 

vary between suppliers and facilities depending upon their location and between the 

sources of contracting support. The following guidelines apply: 

a. Diagnostic Imaging Equipment. Warranties for diagnostic imaging 

equipment purchased through DSCP are quite specific and comprehensive. Refer to 

chapter 12. 

b. Other Equipment Purchased by DSCP. Unless otherwise specified by the 

customer, DSCP will specify the standard commercial warranty for the item being 

acquired. A customer may request additional (extended) warranty coverage; 

however, costs associated with the coverage must be funded by the activity using 

O&M funds. 

c. Local Procurement. Activities should specify necessary warranty coverage 

of their purchase request to the local purchase and contracting officer. Standard 

commercial warranty that is included as part of the contract price for the equipment 

is MEDCASE/SuperCEEP eligible. Additional charges for extended warranty coverage 

must be funded by the activity using O&M funds. 

15-6. LEASED EQUIPMENT 

a. General. The MEDCASE and SuperCEEP programs were established to 

purchase new or replacement technology in the USAMEDCOM facilities. Leasing 

equipment, regardless of the cost of the lease or the value of the equipment lease, is 

generally not included within the MEDCASE/SuperCEEP programs. Most equipment 

leases are considered operating leases and are executed with local O&M funds. 

b. Buy-outs of Equipment on Lease. The buy-out of an equipment lease, 

provided that the cost of the buy-out exceeds the threshold of $100,000 for 

SuperCEEP and $250,000 for MEDCASE and the equipment otherwise meets the 

eligibility criteria stated in chapter 2 of this Supply Bulletin may be funded through 

the MEDCASE/SuperCEEP program. 

(1) Proposed lease buy-outs must be established as MEDCASE/ 

SuperCEEP program requirements in accordance with normal program procedures. 

(2) The buy-out of an equipment lease requires careful monitoring and 

coordination in order to prevent lapse of the lease prior to consultant approval and 

subsequent procurement/requisition. 
SB 8-75-MEDCASE 

15-5 

15-7. REPORTING DISCREPANCIES 

a. General. Equipment that is lost in shipment or received in the wrong 

quantity or condition must be expeditiously reported to the supply source and to the 

USAMMA. Shipment discrepancies that arise when the equipment is acquired through 

local procurement must be coordinated directly with the supporting purchasing and 

contracting activity. 

b. Lost or Damaged Shipments. Equipment acquired through the MEDCASE/ 

SuperCEEP program that is either lost or damaged in shipment must be reported 

using SF Form 364, (Report of Discrepancy [ROD]), in accordance with AR 735-11-2. 

The ROD must be submitted by the activity directly to the supply source by the 

methods specified in the regulation and an information copy provided to the: 

USAMMA 

ATTN: MCMR-MMO-AT 

1423 Sultan Drive, Suite 100 

Fort Detrick MD 21702-5001

The resolution of the ROD may provide the activity with a credit or may direct the 

return of the equipment to the vendor. 

c. Wrong Specifications Provided. In cases where the vendor has provided 

the wrong specifications, the receiving activity must submit a ROD as described 

above. A copy of the contract or delivery order should be attached to the ROD. 

(1) In cases where the return of equipment is directed by the supply 

source, the activity must expeditiously follow the instructions provided. The return 

shipment must always be made by traceable means. MEDCASE/SuperCEEP funds 

cannot be used for the transportation costs. 

(2) In cases where the vendor grants a credit to the activity, a written or 

.pdf copy of the document which grants the credit must be provided to the: 

U.S. Army Medical Materiel Agency 

ATTN: MRMC-MMO-AT 

1423 Sultan Drive, Suite 100 

Fort Detrick MD 21702-5001 

d. Over shipments. Activities receiving an over shipment of items acquired 

through the MEDCASE/SuperCEEP program should immediately contact the USAMMA 

for assistance. The customer may be required to submit a ROD. 

(1) If the activity has a need for the quantity over shipped and there are 

sufficient funds available, the USAMMA may certify the additional funds to the supply 

source so that the over shipment may be retained. 

(2) Over shipments shall not be treated as a "free issue." Over 

shipments cannot be accepted by an activity unless approval has been obtained and 

funds have been certified by the USAMMA. 
SB 8-75-MEDCASE 

15-6 

(3) If the activity does not have a need for the over shipment, the 

USAMMA will coordinate with the supporting command to determine if there are any 

other requirements that could be satisfied. If a requirement is identified and funding 

is available, the USAMMA and the command will coordinate transportation and funds 

adjustments. 

(4) If return of the over shipment is directed, the information provided in 

this chapter applies. 
SB 8-75 MEDCASE 

16-1 

CHAPTER 16. EQUIPMENT REPLACEMENT REPORTS 

16-1. INTRODUCTION

This chapter discusses equipment replacement reports for MEDCASE/SuperCEEP 

requirements. 

16-2. GENERAL

The user can access an equipment replacement report by utilizing an ad hoc Business 

Objects query through DMLSS or by downloading the report via JMAR. The report lists 

equipment eligible for replacement based on year-in-service and projected life 

expectancy. This information can be used for numerous purposes, including defense 

of the MEDCASE/SuperCEEP program budget. 

16-3. EQUIPMENT REPLACEMENT REPORT 

a. The Equipment Replacement report is intended as a long-range, 5-year 

equipment requirements forecast. The report is centrally generated for all MEDCASE/ 

SuperCEEP requirements to develop and defend the program budget as part of the 

Program Objective Memorandum (POM) process. Activities may also generate this 

report whenever required. Reports should be used as a management tool for strategic 

planning and should not be the sole justification for replacement. 

b. DMLSS. Reports generated in DMLSS are accessed by entering the 

Equipment Management module and clicking on the Reports tab. The Equipment 

Replacement report is located under the Standard Inquiry tab. 
SB 8-75-MEDCASE 

16-2 

Replacement Year 1 – Indicates items deferred from previous years, which are past 

their life expectancy. In the example above, the report was generated in 2002, thus 

equipment listed in Replacement Year 1 should have been replaced in 2001 or earlier. 

Replacement Year 2 – Indicates items that will reach their life expectancy in the 

current calendar year. For the above example, equipment in Replacement Year 2 

should be replaced in 2002. 

Replacement Year 3 – Indicates items that will reach their life expectancy in the 

following calendar year. For the above example, equipment in Replacement Year 3 

should be replaced in 2003. 

Replacement Year 4 – Indicates items that will reach their life expectancy in two 

calendar years. For the above example, equipment in Replacement Year 4 should be 

replaced in 2004. 

Replacement Year 5 – Indicates items that will reach their life expectancy in three 

calendar years. For the above example, equipment in Replacement Year 5 should be 

replaced in 2005. 

LE – Indicates the life expectancy of the item. 

YRS DEF – Indicates years past life expectancy of the item. 

MAINT COST – Indicates maintenance costs. 

ACQ COST – Indicates acquisition costs. 

c. JMAR. Reports generated in JMAR are accessed by logging on to the 

website https://jmar.detrick.army.mil. Click Asset Visibility, Equipment, and then 

Equipment Replacement Value Roll-up or Equipment Replacement Value Detail based 

upon preference. 
SB 8-75 MEDCASE 

16-3 
SB 8-75-MEDCASE 

16-4 

Previous Years - Indicates items deferred from previous years, which are past their 

life expectancy. In the example above, equipment listed in Previous Years should 

have been replaced in 2005 or earlier. 

Base Year – Indicates items that will reach their life expectancy in the current 

calendar year. In the above example, equipment listed in the Base Year should be 

replaced in 2006. 

2007 – Indicates items that will reach their life expectancy in calendar year 2007. 

2008 - Indicates items that will reach their life expectancy in calendar year 2008. 

2009 – Indicates items that will reach their life expectancy in calendar year 2009. 

ACQ – Acquisition Date 

ACQ Cost – Acquisition Cost 

Life Expectancy QTY – Life expectancy of requirement 
SB 8-75-MEDCASE 

17-1 

CHAPTER 17. TECHNOLOGY ASSESSEMENT AND 

REQUIREMENTS ANALYSIS (TARA) 

17-1. INTRODUCTION 

The TARA program establishes a standardized methodology for assessing, planning, 

and pursuing the acquisition of capital investment technology within the AMEDD. 

17-2. MISSION 

The TARA’s mission is to provide the activity and the USAMEDCOM with management 

information needed to make informed decisions on the technology resources required 

to accomplish business plan missions and optimize clinical outcomes. This is 

accomplished through an unbiased assessment of diagnostic imaging and laboratory 

functional departmental operations under the authority of the STCPC.

17-3. COORDINATION 

The TARA Team Leader is responsible for coordinating the TARA with the facility to 

be assessed as well as the appropriate specialty consultants. There are two types of 

TARAs: 

a. Routine TARA. These TARA assessments are conducted on a regional 4- to 

5-year cyclic basis under the guidance of the STCPC. Each TARA consists of an 

assessment of requirements, current equipment, and operations as they relate to the 

equipment and clinical operations. The Materiel Acquisition Directorate (MCMRMMO), USAMMA, conducts the TARA and the clinical consultant from the OTSG or his 

or her representative performs the clinical assessment. The clinical consultant from 

the OTSG and the MCMR-MMO will lead all TARAs conducted at MTFs. The results of 

this assessment are provided only to the requesting facility and their respective RMC 

to use as they see appropriate. Trends and command-wide management issues 

discovered during these assessments will be presented to the DIRS and the STCPC 

on a semiannual basis to assist in policy development and strategic planning. No 

specific reference will be made to issues at individual facilities except under 

extenuating circumstances such as serious safety or risk management issues or with 

the permission of the facility. 

b. Specialty TARA. The specialty TARA is conducted at the direction of the 

USAMEDCOM/STCPC or at the request of a site to serve a specific function not 

addressed by the routine TARA. The results of this assessment are provided to the 

USAMEDCOM/STCPC and the activity, respectively. If the TARA is at the request of 

the activity, the activity may have to fund the travel of the team. 

17-4. METHODOLOGY 

a. The methodology for conducting an integrated TARA is broken into two 

parts. The technical assessment focuses on equipment issues. Staffing and 

operational considerations are only assessed to the extent that they directly impact 

equipment utilization. The clinical assessment evaluates the correct clinical staffing 
SB 8-75-MEDCASE 

17-2 

based on the annual workload and procedural mix. Data is gathered during a site 

visit by the USAMEDCOM clinical consultant or his/her representative and the 

technical TARA team from the USAMMA. 

b. The site visit provides the assessment team the opportunity to observe 

departmental operations, talk to staff members, review maintenance histories, and 

physically inspect the equipment. Prior to the site visit, the facility will be required to 

provide information on the type and condition of equipment, numbers and types of 

procedures performed annually, clinic layouts, and existing business plans. The 

synthesis of this information provides a snapshot of the facility's technology 

utilization. This information and assessment shows where improvement is possible 

and where capital might be expended for the greatest benefit. The technical TARA 

consists of three primary components: 

(1) Assessment of requirements. Commercial equipment utilization 

factors, tempered by contingency issues unique to military hospitals, are applied to 

the facility's workload to determine how the activity compares with its commercial 

counterparts. This comparison does not imply that Army activities should be held to 

commercial standards. However, these utilization factors provide the TARA team a 

yardstick with which to begin the evaluation process. An evaluation of the 

requirements will indirectly assess the facility's efficiency and help determine where 

resources might best be applied in the capital equipment program. 

(2) Assessment of operations as it relates to equipment. This includes 

an evaluation of procedural mix, staffing, work schedule, patient flow and 

throughput, and quality assurance/risk management to the extent that these factors 

apply to the acceptability and appropriate utilization of existing equipment. This 

information is obtained through a combination of staff interviews and personal 

observation of patient scheduling and throughput patterns. The evaluation models 

will be determined from clinical consultant input and subject to periodic review. The 

Program, Analysis, and Evaluations Division at OTSG is responsible for quantitative 

staffing analysis. 

(3) Assessment of equipment. This evaluation assesses whether the 

facility's existing equipment uses abandoned or obsolete technology and whether the 

equipment meets standards for acceptability. The assessment includes a market 

survey of current technology, a comprehensive evaluation of the state of existing 

equipment, an evaluation of trends and developments that will affect requirements 

and contract information where pertinent. This assessment will also help determine 

where resources might best be expended to preserve or extend the life of 

equipment. 

c. The clinical operations assessment is a clinical functional review by OTSG 

clinical consultants. The functional review generally focuses on staffing, customer 

service, quality and risk management, patient workflow and management, 

appropriate functional task performance, and integration with other care issues and 

areas. This review incorporates clinical input from the assessed facility with respect 

to workforce design, functional success, and mission. In addition, the review 

compares the functional operation to accepted practice models and addresses leader 

development, training, and other military relevant management issues. 

d. Prior to conducting the on-site assessment, the TARA team will in-brief the 

command group and respective specialty chiefs. At the conclusion of the site visit, an 
SB 8-75-MEDCASE 

17-3 (17-4 blank) 

informal out-brief of the major issues and findings will be offered to the assessed 

facility. A final written report will be provided in 8 to 10 weeks outlining the 

following: 

(1) Recommended additions, deletions, and replacement of equipment 

and technology 

(2) Requirements of the facility related to recommended changes 

(3) Considerations for operational and departmental layout 

(4) Recommended procurement methodology for new or replacement 

equipment 

(5) A discussion of the clinical issues as discussed above. 

17-5. INTEGRATION 

The MCMR-MMO-A will ensure that the utilization factors and models used in the 

conduct of a TARA are consistent with AMEDD strategic plans and specialty 

consultant focus. The utilization factors will also be consistent with current DOD 

existing criteria to present a seamless interface to the assessed facility. Periodically, 

the USAMEDCOM/STCPC may direct special emphasis areas that will be integrated 

into the TARA, but reported separately to the command. 

17-6. ACCOUNTABILITY 

As the purpose of the TARA program is to provide management information to the 

USAMEDCOM and activity decision makers; it is expected that TARA results will be 

incorporated into business and strategic plans. Management data from the final 

report will be used as a yardstick for allocation of resources to the facilities in 

question. 

17-7. CONFIDENTIALITY 

At no time will the confidential data obtained during a TARA be discussed during the 

allocation of resources, or will a facility's requirement be approved or disapproved 

based solely on the data obtained during a TARA. If a significant safety or risk 

management problem is discovered during the course of a TARA, this information will 

be provided to the USAMEDCOM at the discretion of the TARA team chief. Specific 

data from activity requested TARAs will remain confidential. Command-wide trends 

may be discovered that affect the approval process for specific types or classes of 

capital equipment. 

17-8. PROGRAM REVIEW 

The TARA program is subject to periodic (annual) review and modification by the 

STCPC. 
SB 8-75-MEDCASE

A-1 

APPENDIX A. IDCS AND STANDARD ITEM DESCRIPTIONS 

A-1. GENERAL 

a. This appendix provides three separate IDC tables: 

(1) Table A-1 provides examples of specific and generic IDCs. 

(2) Table A-2 provides a list in IDC sequence. 

(3) Table A-3 is the nomenclature list provided in alphabetical order. 

b. This IDC list is current as of the time of this publication. Activities are strongly 

recommended to use the IDC list available in DMLSS as it is periodically updated. 

(1) The use of these IDCs and standard item descriptions to identify 

MEDCASE/SuperCEEP requirements is mandatory. They are intended to ensure the generic 

description of MEDCASE-acquired equipment and provide the consistency that is essential for 

centralized asset visibility and reporting systems. MPRs will be edited at the USAMMA for 

accuracy. MPRs with incorrect item descriptions or IDCs may be rejected for correction. 

(2) IDCs and standard item descriptions must be consistent between 

MEDCASE/SuperCEEP requirements and DMLSS property records; that is, the same IDC and 

standard item description used on the MPR and DMLSS planning record should also be used 

to account for the item on the DMLSS property book. 

(3) The abbreviation EMSS (Emergency Medical Services System) is used in 

several medical item descriptions. This is used to denote items that require special 

adaptation to an EMSS or an Ambulatory Care Program (e.g., attention to radio frequency 

shielding), which are operated under varied weather conditions, or coordinated with a 

telemetry system. 

(4) In cases where an activity has difficulty selecting an appropriate standard 

item description and IDC, the assistance of biomedical maintenance or other technically 

qualified personnel should be sought. Questions that cannot be resolved at the local level 

may be addressed to: 

U.S. Army Medical Materiel Agency 

ATTN: MCMR-MMO-AT 

1423 Sultan Drive, Suite 100 

Fort Detrick MD 21702-5001 

DSN 343-6984/commercial 301-619-6984 

A-2. SELECTION OF A STANDARD ITEM DESCRIPTION 

a. Standard item descriptions provide generic, standardized nomenclatures for types 

of equipment acquired through the MEDCASE/SuperCEEP program. Standard item 

descriptions have been created based upon past frequency of use and the importance of the 

item from a central management standpoint. 
SB 8-75-MEDCASE

A-2 

b. An item description should be selected from the Standard Item Description, Table 

A-2 or Table A-3. Where appropriate, other generic descriptive data should be added to the 

standard item description to further identify the item. In cases where an appropriate 

standard item description is not provided, the nomenclature should be constructed using the 

following instructions. 

(1) Most common generic description, e.g., Illuminator. 

(2) Next most common generic descriptive data, e.g., vertical. 

(3) Other descriptive data, e.g., w/revolving nosepiece. 

c. The standard item description must never be the name of a general category 

description (e.g., "Administrative Item"). 

A-3. SELECTION OF AN IDC 

a. IDCs provide a shorthand reference to standard item descriptions. They are used 

in the construction of MEDCASE/SuperCEEP ACNs, and are entered into the IDC field of the 

DMLSS Property record. The functional area that is based upon the functional type of the 

equipment item, e.g., groups IDCs, a pharmaceutical refrigerator (IDC 6170) is a pharmacy 

item whether it is used in a pharmacy or in the installation medical supply activity. 

b. IDCs are selected based upon the standard item description and/or the functional 

area selected. In cases where an appropriate standard item description is not provided, the 

nomenclature should be constructed as described and the IDC of the general functional area 

(e.g., 3500 for a laboratory science item) of the item applies. Table A-1 provides examples 

of specific and generic IDCs. 

TABLE A-1. SELECTION OF 

IDC AND STANDARD ITEM DESCRIPTION 

FROM IDC LIST:

0543 Bronchoscope 

2647 Dental Operating System 

3246 X-Ray Apparatus, Radio 

USING GENERAL CATEGORY IDC: 

0000 Administrative Item 

0001 Base Operations (BASOPS) Item 

3500 Laboratory Science Item 
SB 8-75-MEDCASE

A-3 

A-4. EXPLANATION OF IDC "NOTES" 

Tables A-2 and A-3 include references to "notes" which provide additional information 

regarding the eligibility, coordination or approval of MEDCASE requirements for the 

equipment described. These notes are explained below: 

NOTE EXPLANATION

A 

Supplemental (or "other") ADPE. Requires review by activity IMO and approval 

under the provisions of AR 25-1. 

D 

IMAE other than ADPE. Requires review by activity IMO. Approval under other 

regulations may also be required. 

F Applies to MILCON requirements only. NOT eligible for MEDCASE. 

G 

General category. Use this IDC, with a generic item description for the item, 

when a specific IDC and standard item description are not provided. DO NOT 

use the name of the functional area (e.g., "Medicine Item") as the item 

description. 

H 

Activity must submit a requisition through USAMMA, ATTN: MCMR-MMO-AT. 

See chapter 6. 

P 

Review by the activity Health Physicist or Radiological Protection Officer is 

required. 

Q Hospital-unique communications equipment. Review required by activity IMO. 

R 

Diagnostic Imaging/Radiation Therapy equipment. Review required by activity 

Chief of Radiology. See chapter 12. 

T 

Non-medical equipment. If over $250,000, requires TDA authorization and 

type classification exemption IAW AR 310-40 and command guidance. See 

chapter 13. 

U 

Item contains or may contain embedded ADPE. Review by activity IMO is 

required. See chapter 13. 

X 

Requirements with a system price of $250,000 or more must be reviewed by 

the functional consultant 

Z 

Managed by another DA-Level program. Not MEDCASE/SuperCEEP-eligible 

unless requirement cannot be supported by the appropriate program. See 

chapter 2. 
SB 8-75-MEDCASE 

TABLE A-2. STANDARD ITEM DESCRIPTION TABLE – IDC SEQUENCE 

A-4 

IDC FSC STANDARD ITEM DESCRIPTION NOTES

 

 0000-0249 Health Care Administration

0000 ADMINISTRATIVE ITEM G 

0001 BASE OPERATIONS (BASOPS) ITEM 

0003 7490 EMBOSSER, PLASTIC CARD T 

0004 NEW FACILITY PACKAGE (specify type) F,G 

0005 FURNITURE AND FURNISHING PACKAGE F 

0006 GRAPHIC ARTS PACKAGE F 

0007 INTERIOR DECORATIVE PLANT PACKAGE F 

0008 INTERIOR SIGN PACKAGE F 

0009 WINDOW COVERING PACKAGE F 

0010 LOGISTICS ITEM G,T 

0011 MATERIEL DISTRIBUTION SYSTEM 

0012 MATERIELS HANDLING EQUIPMENT T 

0013 SHELVING SYSTEM, TRACK-MOUNTED (often called "space-saver" 

shelving)

0014 CABINET, FLAMMABLE STORAGE T 

0015 READER, BAR CODE LABEL T 

0016 7490 EMBOSSER, PLASTIC SIGN T 

0017 3540 SEALER, HEAT (for hospital linen packaging) T 

0018 7910 SCRUBBING MACHINE, FLOOR T 

0019 7910 SHAMPOOING MACHINE, CARPET T 

0020 OXYGEN GENERATION SYSTEM M 

0024 EMBOSSER PLASTIC CARD (USE 0003) 

0025 POWER SUPPLY, UNINTERRUPTED (UPS) M,T 

0033 POWER SUPPLY, UNINTERRUPTED (UPS) (USE 0025) 

0050 HOSPITAL COMMUNICATIONS SYSTEM (Nurse call system = 

IDC 4072)

G,Q,T 

0051 HOSPITAL INTERCOM SYSTEM Q,T 

0052 CENTRAL DICTATION SYSTEM Q,T,U 

0053 MONITOR/RECORDER, COMMUNICATIONS SYSTEM Q,T 

0055 6350 INTRUSION DETECTION SYSTEM M,T 

0056 SHELVING SYSTEM TRACK MOUNTED (USE 0013) 

0100 AUTOMATIC DATA PROCESSING EQUIPMENT A,G,T 

0110 TELECOMMUNICATIONS EQUIPMENT D,G,T,Z 

0111 5830 PAGING SYSTEM, RADIO D,T,Z 

0115 5830 RADIOTELEPHONE SYSTEM D,T,Z 

0120 VISUAL INFORMATION EQUIPMENT (formerly Audiovisual 

Equipment)

D,G,T,Z 

0121 5820 CAMERA, TELEVISION D,T,Z 

0130 MICROGRAPHICS EQUIPMENT D,G,T 

0131 6730 READER, MICROFICHE D,T,Z 

0132 6730 READER-PRINTER, MICROFICHE D,T,Z 

0140 RECORDS MANAGEMENT EQUIPMENT D,G,T 

0150 PRINTING AND BINDING EQUIPMENT D,G,T,Z 

0151 POINT OF USE 

0160 3610 COPIER, ELECTROSTATIC D,T 

0200 BASE OPERATIONS (BASOPS) ITEM D,G,T 

 
SB 8-75 MEDCASE 

(continued) TABLE A-2. STANDARD ITEM DESCRIPTION TABLE – IDC SEQUENCE 

A-5 

IDC FSC STANDARD ITEM DESCRIPTION NOTES

 

 0250-0499 TMDE

0250 TEST EQUIPMENT GENERAL (TMDE) G,E 

 

0251 ADAPTER (TMDE) 

0252 AMMETER AMC (TMDE) 

0256 AMPLIFER (TMDE) 

0260 6625 X-RAY CALIBRATION/VERIFICATION SYSTEM (TMDE) E 

0262 AMPLIFIER FOUR TRACE (TMDE) 

0270 6625 OSCILLISCOPE (TMDE) E 

0272 ANALYZER CAP (TMDE) 

0274 ANALYZER DISTORTION (TMDE) 

0276 ANALYZER SURGICAL (TMDE) 

0278 ANALYZER LOGIC (TMDE) 

0280 6625 TEST SET, DIGITAL (TMDE) E 

0288 AUDIOMENTER CALIBRATION (TMDE) 

0305 BRIDGE (TMDE) 

0310 BRIDGE INP (TMDE) 

0314 BRIDGE RES (TMDE) 

0320 CALIBRATOR/VER SYS X-RAY (TMDE) 

0322 CALIBRATOR GAS FLO RATE (TMDE) 

0324 CAMERA OSCILLOSCOPE (TMDE) 

0330 COUNTER (TMDE) 

0332 COUNTER ELECTRICAL (TMDE) 

0334 COUNTER UNIVERSAL (TMDE) 

0340 DENSITOMETER (TMDE) 

0344 DETECTOR (TMDE) 

0346 DETECTOR LEAK (TMDE) 

0354 GAGE SET (TMDE) 

0360 GENERATOR (TMDE) 

0362 GENERATOR FUNCTIONAL (TMDE) 

0366 GENERATOR PULSE (TMDE) 

0370 GENERATOR SIGNAL (TMDE) 

0372 GENERATOR SWEEP (TMDE) 

0380 METER (TMDE) 

0384 METER AC VA (TMDE) 

0390 METER FLO RATE (TMDE) 

0392 METER FREQUENCY (TMDE) 

0396 METER MULT (TMDE) 

0400 METER POWER (TMDE 

0402 METER RADIAC (TMDE) 

0404 METER SOUND (TMDE) 

0410 METER WATT (TMDE) 

0420 MODULE (TMDE) 

0422 MONIOR (TMDE) 

0426 OSCILLATOR AUDIO (TMDE) 

0440 OSCILLOSCOPE (TMDE) 

0442 OSCILLOSCOPE DUAL BEAM (TMDE) 
SB 8-75 MEDCASE

(continued) TABLE A-2. STANDARD ITEM DESCRIPTION TABLE – IDC SEQUENCE 

A-6 

IDC FSC STANDARD ITEM DESCRIPTION NOTES

 

 0250-0499 TMDE (Continued) 

0444 OSCILLOSCOPE PLUG IN (TMDE) 

0446 OSCILLOSCOPE PORTABLE (TMDE 

0448 OSCILLOSCOPE STORAGE (TMDE)

0449 6625 PHANTOM, NUCLEAR E 

0450 6625 PHANTOM, RADIOGRAPHIC (Changed from PHANTOM) E 

0451 6625 PHANTOM, ULTRASONIC E 

0452 PLUG IN (TMDE) 

0454 POWER SUPPLY (TMDE) 

0456 PROBE (TMDE) 

0460 RADIOMETER (TMDE) 

0462 RECORDER (NON-MEDICAL) (TMDE) 

0464 RECORDER X Y (TMDE) 

0466 SCALES (NON-MEDICAL) (TMDE) 

0470 TACHOMETER (TMDE) 

0472 TACHOMETER PHOTO (TMDE) 

0474 TEST CASSETTE (TMDE) 

0476 TEST PATTERN (TMDE) 

0478 TEST SET (TMDE) 

0480 TEST SET BIOMEDICAL (TMDE) 

0482 TEST SET CONDUCTIVITY (TMDE) 

0484 TESTER (TMDE) 

0486 TESTER CURRENT LEAKAGE (TMDE) 

0488 TESTER DEFIBRILLATOR (TMDE) 

0490 TESTER TRANSISTOR (TMDE) 

0492 TESTER TUBE (TMDE) 

0493 THERMOMETER (NON-MEDICAL) (TMDE) 

0494 TIMER (TMDE) 

0496 TRANSFORMER (TMDE) 

0497 VISCOMETER (TMDE) 

 

 0500-0999 MEDICINE

0500 MEDICINE ITEM G 

0504 ADAPTER CLOS OPE-GASTROSCOPE 

0513 ANALYZER CARDIAC OUTPUT 

0530 AUSCULTATION SYS 

0543 6615 BRONCHOSCOPE 

0545 CARDIOSCOPE 

0550 6515 DEFIBRILLATOR (without monitor) 

0555 6515 DEFIBRILLATOR/ECG MONITOR (also see IDC 2060) 

0560 6515 DETECTOR, FETAL MONITOR 

0562 6530 DRIER FOR RESPIRATOR THERAPY EQUIPMENT 

0563 6515 ELECTROCARDIOGRAPH G 

0565 6515 ELECTROCARDIOGRAPH SYSTEM 1 CHAN 

0566 ELECTROCARDIOGRAPH SYSTEM 2 CHAN 

0567 6515 ELECTROCARDIOGRAPH SYSTEM 3 CHAN NON CAPOC 
SB 8-75 MEDCASE 

(continued) TABLE A-2. STANDARD ITEM DESCRIPTION TABLE – IDC SEQUENCE 

A-7 

IDC FSC STANDARD ITEM DESCRIPTION NOTES

 

 0500-0999 MEDICINE (Continued) 

0568 6515 ELECTROCARDIOGRAPH SYSTEM MULTI CHAN (specify no. of 

chan)

0569 6515 ELECTROCARDIOGRAPH SYSTEM, MULTI CHAN. CAPOC 

COMPATIBLE 

0570 6540 ELECTRONYSTAGOMOGRAPH 

0571 6515 ENDOSCOPE 

0572 6515 ENDOSCROPE TRAINING ATTACHMENT 

0575 6515 ESOPHAGEAL MOTILITY SYSTEM 

0580 6515 FIBERSCOPE (Add more description to the nomenclature) G 

0585 6515 FIBERSCOPE, COLON 

0590 6515 FIBERSCOPE, DUODENAL 

0595 6515 FIBERSCOPE, PHOTO UPPER GI 

0597 6515 RECORDER, PHYSIOLOGIC MULTI-CHANNEL 

0603 6530 HYPOBARIC CHAMBER 

0605 6515 HYPODERMIC INJECTION APPARATUS, JET AUTO M 

0610 6515 INJECTOR, ANGIOGRAPHIC 

0611 6515 KIDNEY MACHINE (Hemodialysis Machine) 

0612 6515 INTENSIVE CARE SYSTEM INFANT 

0614 6515 LIGHT, BILIRUBIN 

0615 6515 INTENSIVE CARE SYSTEM MED 

0619 6515 MONITOR, CARBON DIOXIDE 

0620 6515 MONITOR, BLOOD PRES 1 STA 

0621 6515 MONITOR, BLOOD PRES (Specify number of stations) 

0622 MONITOR, BLOOD PRES 4 STA 

0624 MONITOR, BLOOD PRES 8 STA 

0625 6515 MONITOR, CARDIAC 1 STA 

0626 6515 MONITOR, CARDIAC (Specify number of stations) 

0627 MONITOR, CARDIAC 4 STA 

0628 MONITOR, CARDIAC 6 STA 

0629 MONITOR, CARDIAC 8 STA 

0630 6515 MONITOR, SYSTEM EXERCISE-STRESS (Includes treadmill 

and ECG)

0631 MONITOR, EXERCISE STRESS COMPUTERIZED 

0635 6515 MONITOR, HEART RATE 1 STA 

0636 6515 MONITOR, HEART RATE (Specify number of stations) 

0637 MONITOR, HEART RATE 4 STA 

0638 MONITOR, HEART RATE 6 STA 

0639 MONITOR, HEART RATE 8 STA 

0640 MONITOR, HEART SOUND 

0641 6515 MONITOR, COMPUTERIZED 

0645 6515 MONITOR, PHYSIOLOGICAL SYSTEM 1 STA (Vital signs 

monitor) 

0646 6515 MONITOR, PHYSIOLOGICAL SYSTEM (Vital signs monitor, specify 

# stations)

0647 MONITOR, PHYSIOLOGICAL SYS 4 STA 

0648 MONITOR, PHYSIOLOGICAL SYS 6 STA 

0649 MONITOR, PHYSIOLOGICAL SYS 8 STA 
SB 8-75 MEDCASE

(continued) TABLE A-2. STANDARD ITEM DESCRIPTION TABLE – IDC SEQUENCE 

A-8 

IDC FSC STANDARD ITEM DESCRIPTION NOTES

 

 0500-0999 MEDICINE (Continued) 

0650 6515 MONITOR, RESPIRATION INFANT 

0651 6515 MONITOR, RESPIRATION 1 STA 

0653 6515 MONITOR, RESPIRATION (Specify number of stations) 

0654 6515 PATIENT MONITORING SYSTEM 

0655 6515 MONITOR RESPIRATORY 8 STA 

0656 6515 UPGRADE-PATIENT MONITORING SYS 

0661 6515 MONITOR, VENTILATION (Specify number of stations) 

0662 6515 MONITOR, VENTILATION 2 STA 

 

0663 6515 MONITOR, VENTILATION 4 STA 

0665 6515 MONITOR, VENTILATION 8 STA 

0670 6515 NEONATAL CARE SYSTEM 

0672 6515 PULSE OXIMETER 

0673 6515 CO-OXIMETER 

0675 6515 PACEMAKER 

0676 6515 PACEMAKER, EXTERNAL 

0678 6515 PACEMAKER INTERNAL/EXTERNAL 

0680 6515 PNEUMO-PLETHYSMOGRAPH 

0681 6515 PERITONEOSCOPE 

0682 6515 PANENDOSCOPY 

0683 6515 RECORDER, ELECTROCARDIOGRAM PORTABLE 

0686 6515 RECORDER TYMPANOGRAPH 

0690 RECORDER TRACE 

0697 6530 RESPIRATOR, PORTABLE 

0700 6515 RESUSCITATOR, OXYGEN-POWERED, PRESSURE CYCLED 

0705 6515 RESUSCITATOR, HEART-LUNG 

0710 6515 RESUSCITTOR-INHALER, PORTABLE 

0725 6515 SCANNER, DIAGNOSTIC 

0727 6515 SPIROMETER, DIAGNOSTIC 

0728 6515 SPIROMETER, MONITORING 

0730 6530 TABLE, EXAM 

0735 6530 TABLE, PROCTOSCOPE 

0740 6515 TRAINER, ARRHYTHMIA 

0742 6910 MANIKIN, RESUSCITATION TRAINING, RECORDING 

0745 6910 MODEL, ANATOMICAL 

0750 6530 TREADMILL (The monitor or entire system is IDC 0630) 

0760 VECTORCARDIOGRAPH 

 

 1000-1499 SURGERY

1000 SURGICAL ITEM 

1100 AUDIOLOGY, ITEM G 

1105 6515 ANALYZER, HEARING AID G 

1110 6515 ANESTHESIA APPARATUS 

1111 6515 ACOUSTIC METER, COMPLIANCE AND IMPEDANCE 

1113 6515 ARTHROSCOPE 
SB 8-75 MEDCASE 

(continued) TABLE A-2. STANDARD ITEM DESCRIPTION TABLE – IDC SEQUENCE 

A-9 

IDC FSC STANDARD ITEM DESCRIPTION NOTES

 

 1000-1499 SURGERY (Continued)

1114 6515 AUDIOMETER, AUTO OR MANUAL PORTABLE 

1115 6515 AUDIOMETER, DIAGNOSTIC 

1116 6515 AUDIOMETER, SCREENING 1 CHAN 

1118 6515 AUDIOMETER, SCREENING (Specify number of channels) 

1120 AUDIOMETER SCREENING 4 CHAN 

1122 AUDIOMETER SCREENING 6 CHAN 

1124 AUDIOMETER SCREENING 8 CHAN 

1125 AUDIOMETER SCREENING 10 CHAN 

1130 6515 BOOTH, AUDIOMETRIC EXAM 1 COMPARTMENT 

1131 6515 BOOTH, AUDIOMETRIC EXAM (Specify number of 

compartments) 

 

1132 BOOTH, AUDIOMETRIC EXAM 6 CHAN 

1133 BOOTH, AUDIOMETRIC EXAM 8 CHAN 

1134 BOOTH, AUDIOMETRIC EXAM 10 CHAN 

1135 6515 BRONCHOFIBERSCOPE, BIOPSY 

1150 6515 CAMERA, FUNDUS FLASH 

1155 6515 CAMERA, VIDEO, MEDICAL/SURGICAL SCOPE SET 

1160 6530 CHAIR, PODIATRY 

1165 6530 CHAIR, EXAM/TREATMENT SURG 

1170 6515 CHAMBER, ACOUSTIC 

1175 COMPUTER BLOOD VOLUME 

1180 6530 CRYOSURGICAL SYSTEM 

1200 6515 DIALYZER APPARATUS 

1202 6515 DRILL SET, SURGERY 

1207 6515 OPERATING APPARATUS ENT 

1215 6515 ELECTROSURGICAL APPARATUS 

1217 6515 HANDPIECE, BONE SURGICAL 

1218 6515 GASTROSCOPE 

1220 6515 HUMIDIFIER/VOLUME VENTILATOR 

1225 6515 HYPOTHERMIA APPARATUS, INTRAGASTRIC 

1234 6515 INTRACRANIAL PRESSURE MONITOR 

1235 6515 INTENSIVE CARE SYSTEM, SURG 

1236 IRRIGATOR TEM CONTROL 

1237 6515 LAPAROSCOPE, OPERATIVE 

1238 6545 IMPLANT INSTRUMENT SET (Components must be replaced with 

OMA funds)

1239 6515 LASER, THERAPEUTIC, SURGICAL P 

1240 6530 LIGHT, OPERATING/EXAM, FIBEROPTIC 

1245 6530 LIGHT, SURG CEILING M 

1246 6515 LASER, LITHOTRIPSY, URETERAL 

1247 6515 LITHOTRIPTER SYSTEM, EXTRACORPOREAL M,P,X 

1248 6515 LITHOTRIPTER, PERCUTANEOUS ULTRASONIC 

1255 6515 MICROSCOPE, OPERATING ROOM 

1270 6515 PUMP, CARDIAC ASSIST 

1285 RESECTOSCOPE PROSTATIC 
SB 8-75 MEDCASE

(continued) TABLE A-2. STANDARD ITEM DESCRIPTION TABLE – IDC SEQUENCE 

A-10 

IDC FSC STANDARD ITEM DESCRIPTION NOTES

 

 1000-1499 SURGERY (Continued)

1290 RETRACTOR ABDOMINAL SELF RETAINING 

1292 6515 SINK, SURGICAL SCRUB M 

1295 6515 SPHYGMOMANOMETER, ELECTRONIC-ULTRASONIC 

1305 6530 TABLE, ORTHOPEDIC 

1310 6530 TABLE, OPERATING, HOSPITAL (IDC reserved for future 

use) 

1311 6530 TABLE, OPERATING, HOSPITAL 

1312 6530 TABLE, OPERATING, RADIOTRANSLUCENT 

(for use with mobile C-Arm, IDC 3224/3225) 

1315 6530 TABLE, EXAM, UROLOGICAL 

1360 6530 THERMOREGULATOR, PATIENT 

1365 6515 MONITOR, CENTRAL OXYGEN SYSTEM M 

1370 6515 MONITOR, ANESTHESIA (Specify central or stand alone) 

1380 6515 VENTILATOR, AUTOMATIC-MANUAL, ADULT 

1381 6515 VENTILATOR, AUTOMATIC-MANUAL, INFANT 

 

 1500-1999 PSYCHIATRY/NEUROLOGY

 

1500 PSYCHIATRY/NEUROLOGY ITEM G 

1510 6515 BIOFEEDBACK SYSTEM 

1520 6515 ELECTROCONVULSIVE THERAPY APPARATUS 

1525 ELECTROENCEPHALOGRAPH 8 CHAN 

1526 ELECTROENCEPHALOGRAPH 12 CHAN 

1527 ELECTROENCEPHALOGRAPH 1 

1535 6515 ENCEPHALOGRAPH 

1550 6515 SIMULATOR, VISUALLY KEYED 

 

 2000-2499 AMBULATORY CARE PROGRAMS

2000 AMBULATORY CARE ITEM G 

2020 6530 CART, EMERGENCY EMSS 

2025 6530 CART, UTILITY 

2040 6515 DEFIBRILLATOR, EMSS (Without monitor) 

2060 6515 DEFIBRILATOR/ECG MONITOR, PORTABLE, W/CHARGER 

(For ambulance/rescue team use, see also IDC 0555) 

2070 6530 INCUBATOR, INFANT TRANSPORT, EMSS 

2075 6530 LIGHT, SURGICAL, CEILING, EMSS M 

2077 6530 LIGHT, SURGICAL STAND 

2080 6515 MONITOR, PHYSIOLOGICAL SYSTEM (Vital signs monitor) 

2100 5805 RECEIVER - TRANSMITTER, EMSS D,T 

2120 5805 RECEIVER - TRANSMITTER, TELEMETRY D,T 

2140 6515 RESUSCITATOR/ASPIRATOR, EMSS 

2160 RESUSCITATOR HEART LUNG EMSS 

2170 STERILIZER STEAM EMSS 

 
SB 8-75 MEDCASE 

(continued) TABLE A-2. STANDARD ITEM DESCRIPTION TABLE – IDC SEQUENCE 

A-11 

IDC FSC STANDARD ITEM DESCRIPTION NOTES

 

 2500-2999 DENTISTRY

2500 DENTISTRY ITEM G 

2515 6520 ANALGESIA MACH, DENTAL 

2516 6520 CABINET/SINK, DENTAL 

2520 CEPHALOMETER 

2525 ARTICULATOR DENTAL 

2545 6520 CHAIR, DENTAL OPERATING (May be a component of IDC 

2647) 

2546 6520 CHAIR, DENTAL X-RAY 

2550 6520 CLEANER, ULTRASONIC DENTAL 

2565 6520 COMPRESSOR/DEHYDRATOR, DENTAL EQUIP 

2570 DENTAL OPERATING UNIT HYGIENIST 

2575 6520 DEHYDRATOR, COMPRESSOR AIR SYSTEM, DENTAL 

2590 6520 ELECTROSURGICAL APPARATUS, DENTAL 

2605 6520 EVACUATOR, ORAL CAVITY, DENTAL 

2625 6520 FURNACE, VACUUM, DENTAL 

2627 6520 HEATER, DENTAL 

2630 6520 LIGHT, DENTAL OPERATING UNIT (May be a component of IDC 

2647)

M 

2635 6520 LIGHT, DENTAL OPERATING, FIBEROPTIC 

2637 MACHINE CASTING TICONIUM 

2638 6520 MACHINE, CASTING, AUTOMATIC 

2639 MELTER MOLDS AUTOMATIC 

2640 MICROSCOPE PHASE (DENTAL USE) 

2645 6520 DENTAL OPERATING UNIT (May be a component of IDC 

2647) 

M 

2647 6520 DENTAL OPERATING SYSTEM (Must include a chair and a dental 

operating unit)

2650 6525 PROCESSING MACHINE, X-RAY FILM, AUTO DENTAL 

2655 PROCESSING UNIT DENT RESINS 

2660 6520 ULTRASONIC PROPHYLAXIS UNIT, DENTAL RESING 

2665 RESUSCITATOR DENT 

2670 6520 BLAST CLEANING CABINET M 

2685 STERILIZER BENCH MOUNTED-DENTAL 

2686 6530 STERILIZER, ELECTRIC, DENTAL (Specify Bench or Floor 

Mounted) 

M 

2705 6525 TANK, MASTER, X-RAY FILM PROCESS, DENTAL 

2715 6520 VACUUM SYSTEM, DENTAL M 

2725 6525 X-RAY APPARATUS, DENTAL, 7MA FIXED P 

2730 6525 X-RAY APPARATUS, DENTAL, 7MA PORTABLE P 

2735 6525 X-RAY APPARATUS, DENTAL, 15MA FIXED P 

2740 6525 X-RAY APPARATUS, DENTAL, 15MA PORTABLE P 

2745 6525 X-RAY APPAR DENT CYPHALOMETRIC 15MA 

2746 6525 X-RAY APPARATUS, DENTAL, CYPHALOMETRIC (State mA and kVp in 

nomenclature)

P 

2748 6525 X-RAY APPARATUS, DENTAL, 

CYPHALOMETRIC/PANOGRAPHIC 

P 

2750 6525 X-RAY APPARATUS, DENTAL, PANOGRAPH P 
SB 8-75 MEDCASE

(continued) TABLE A-2. STANDARD ITEM DESCRIPTION TABLE – IDC SEQUENCE 

A-12 

IDC FSC STANDARD ITEM DESCRIPTION NOTES

 

 3000-3499 DIAGNOSTIC IMAGING/RADIATION 

THERAPY

 

3000 DIAGNOSTIC IMAGING/THERAPEUTIC RADIATION ITEM G,P 

3001 UPGRADE-MAGNETIC RESONANCE IMAGING 

3002 UPGRADE-X-RAY APPARATUS, TOMOGRAPHY 

3003 UPGRADE-SCANNER, DIAGNOSTIC ULTRASOU 

3004 UPGRADE-CAMERA, GAMMA SCINTILLATION 

3005 6525 CABINET, CASSETTE TRANSFER 

3006 UPGRADE-POSITRON EMISSION TOMOGRAPH 

3008 UPGRADE-X-RAY APPARATUS, MAMMOGRAPH 

3009 UPGRADE-X-RAY APPARATUS, RADIO/FLUO 

3010 UPGRADE-X-RAY APPARATUS RADIO 

3015 6525 CALIBRATOR, ISOTOPE DOSE N,P 

3020 5820 CAMERA, CLOSED-CIRCUIT TV 

3021 6525 CAMERA, GAMMA SCINTILLATION (Specify in nomenclature if 

unit 

is single head, dual head or triple head)

I,N,P,X 

3022 6525 CAMERA UNIT, PHOTO-FLUORO, X-RAY APPARATUS P 

3023 6525 CAMERA, MULTIFORMAT P 

3025 6525 CASSETTE CHANGER 

3026 CASSETTE CHANGER VARIABLE SPEED 

3027 CAMERA, GAMMA SCINTILLATION - TRIPL 

3028 CAMERA, GAMMA SCINTILLATION - DUAL 

3029 IMAGE MGT SYSTEM, NUCLEAR MEDICINE 

3030 COMPUTER, IMAGE PROCESSING (For Gamma Camera) N,X 

3031 6525 COMPUTER, THERAPY PLANNING X 

3040 6525 COOLER/HEATER, X-RAY FILM PROCESS APPARATUS, 

AUTO 

3050 6525 COUNTER, GAMMA AUTO (For nuclear medicine, IDC 3632 is for 

lab use)

N,P 

3060 6665 DETECTOR, SCINTILLATION N,P 

3062 DETECTOR SCINTILLATION 2 CHAN 

3081 6525 DIGITIZER, RADIATION THERAPY P 

3082 6525 DIGITIZER, RADIOGRAPHIC IMAGE 

3083 6525 DIGITAL SUBTRACTION ANGIOGRAPHY SYSTEM (C-Arm 

system is IDC 3225)

H,M,P,R

,X 

3084 6525 DIGITAL SUBTRACTION ANGIOGRAPHY UPGRADE P,R,X 

3086 6525 FILM TRANSPORT SYSTEM X 

3090 6525 INJECTOR, AUTO 

3095 6525 LOADER, FILM, PHOTOGRAPHIC DAY LIGHT 

3096 6525 MAGNETIC RESONANCE IMAGING SYSTEM (Specify field 

strength & whether dedicated extremity sys)

M,P,X 

3100 6525 MONITOR, CLOSED-CIRCUIT TV 

3111 6525 POSITRON EMISSION TOMOGRAPHY SCANNER M,P,X 

3115 6525 PROBE, SCINTILLATION P 

3120 6525 PROCESSING MACHINE, PHOTOGRAPHIC FILM 

3132 X-RAY APPARATUS, MAMMOGRAPHY, DIGITAL SPOT 

STEREO TACTIC BIOPSY ATTACHMENT 
SB 8-75 MEDCASE 

(continued) TABLE A-2. STANDARD ITEM DESCRIPTION TABLE – IDC SEQUENCE 

A-13 

IDC FSC STANDARD ITEM DESCRIPTION NOTES

 

 3000-3499 DIAGNOSTIC IMAGING/RADIATION 

THERAPY (Continued)

 

3133 6525 PROCESSING UNIT X-RAY FILM 

3134 6525 PROCESSING UNIT, X-RAY FILM, TABLETOP 

3135 6525 PROCESSING UNIT, X-RAY FILM (includes Dry laser 

imagers) 

3148 6525 RECORDER, VIDEO TAPE (Radiology use only) 

3150 6525 RADIONUCLITIDE IMAGING SYSTEM G,N,P,X 

3152 6525 SINGLE PHOTON EMISSION COMPUTED TOMOGRAPHY 

(SPECT) 

N,P,X 

3153 SCANNER, ULTRASOUND SYSTEM, NON-DIAGNOSTIC 

3155 6525 SCANNER, RECTILINEAR (Specify Single or Dual Photon) N,P,X 

3156 SCANNER, ULTRASOUND SYSTEM, ECHO-CARDIO 

3157 6525 SCANNER, DIAGNOSTIC ULTRASOUND I,R,X 

3158 SCANNER, ULTRASOUND SYSTEM, OB-GYN 

3159 IMAGE MGT SYSTEM, ECHO-CARDIO ULTRASOUND 

3160 6525 SILVER RECOVERY UNIT, FILM PROCESS M 

3170 6525 STEREOSCOPE X-RAY FILM MOUNTED 

3175 6525 SIMULATOR, RADIATION THERAPY N,P 

3180 SYNCHRONIZER PHYSIOLOGICAL 

3183 6525 TABLE, RADIOGRAPHIC H,X 

3185 6525 TANK, MASTER, X-RAY FILM PROCESS 

3188 6525 COMPUTED RADIOGRAPHY SYSTEM M,X 

3189 6525 DIRECT DIGITL RADIOGRAPHY SYSTEM M,X 

3190 6525 TELERADIOLOGY SYSTEM M,X 

3191 READER, COMPUTED RADIOGRAPHY 

3192 6525 PICTURE ARCHIVING & COMMUNICATION SYSTEM (PACS) M,X 

3193 WORKSTATION, COMPUTED RADIOGRAPHY 

3194 6525 THERAPY UNIT, RADIATION, COBALT M,N,P,X 

3197 6525 TUBEHEAD, X-RAY APPARATUS O 

3198 6525 TUBE, X-RAY APPARATUS O 

3200 6525 VIEWER, X-RAY FILM, AUTOMATIC 

3215 6525 WELL COUNTER 

3220 6525 X-RAY APPARATUS, RADIO PORTABLE (Up to 20 mA, 

specify mA) 

H,P 

3222 X-RAY APPAR SE RADIO PORT 15MA MED 

3223 X-RAY APPAR, R/F PORT 50 MA 

3224 X-RAY APPARATUS, RADIO/FLUORO, MOBILE C-ARM H,P,R,X 

3225 6525 X-RAY APPARATUS, RAD/FLUOR, MOBILE C-ARM W/DIGIT 

SUB 

H,P,R,X 

3226 X-RAY APPARATUS, FLUOROSCOPY, MULTI-PURPOSE 

FIXED C-ARM CONFIGURATION (NOT ANGIO SYSTEM) 

3229 IMAGE MGT SYSTEM, CARDIOLOGY 

3230 6525 X-RAY APPARATUS, MAMMOGRAPHY H,M,P,X 

3231 X-RAY APPAR MAMMOGRAPHY, STEREO TACTIC BIOPSY 

TABLE 

3232 MAMMOGRAPHY, COMPUTER-AIDED DETECTION 
SB 8-75 MEDCASE

(continued) TABLE A-2. STANDARD ITEM DESCRIPTION TABLE – IDC SEQUENCE 

A-14 

IDC FSC STANDARD ITEM DESCRIPTION NOTES

 

 3000-3499 DIAGNOSTIC IMAGING/RADIATION 

THERAPY (Continued)

 

3233 X-RAY APPAR, MAMMOGRAPHY, DIGITAL 

3235 6525 X-RAY APPARATUS, PHOTOFLUORO H,M,P,X 

3236 6525 X-RAY APPARATUS, CARDIAC CATH LAB, SINGLE PLANE H,M,P,X 

3237 6525 X-RAY APPARATUS, CARDIAC CATH LAB, BI-PLANE H,M,P,X 

3238 X-RAY APPAR, ANGIOGRAPHY, SINGLE PLANE 

3239 X-RAY APPAR RADIO 350MA 

3240 X-RAY APPAR RADIO 200MA 

3241 6525 X-RAY APPARATUS, RADIO (Specify mA up to 500 mA) H,M,P,X 

3242 X-RAY APPAR RADIO 500MA 

3243 X-RAY APPAR RADIO 600MA 

3244 X-RAY APPAR RADIO 700MA 

3245 X-RAY APPAR RADIO 800MA 

3246 6525 X-RAY APPARATUS, RADIO (Specify mA above 500 mA 

and if unit has tomographic capability) 

H,M,P,X 

3247 X-RAY APPAR RADIO 1200MA 

3250 X-RAY APPAR RADIO/FLUORO 100MA 

3251 X-RAY APPAR RADIO/FLUORO 200MA 

3252 6525 X-RAY APPARATUS, RADIO/FLUORO (Specify mA up to 

500 mA) 

H,M,P,X 

3253 X-RAY APPAR RADIO/FLUORO 500 MA 

3254 X-RAY APPAR RADIO/FLUORO 600MA 

3255 X-RAY APPAR RADIO/FLUORO 700MA 

3256 X-RAY APPAR RADIO/FLUORO 800MA 

3257 6525 X-RAY APPARATUS, RADIO/FLUORO (Specify mA above 

500 mA, and if unit has tomographic capability) 

H,M,P,X 

3258 X-RAY APPAR RADIO/FLUORO 1200MA 

3260 X-RAY APPAR RADIO MOBILE 50MA 

3261 6525 X-RAY APPARATUS, RADIO MOBILE (Specify mA up to 299 

mA) 

H,M,P,X 

3262 X-RAY APPAR RADIO MOBIL 200MA 

3264 6525 X-RAY APPARATUS, RADIO MOBILE (Specify mA above 

299 mA) 

H,M,P,X 

3265 6525 SCANNER, COMPUTED TOMOGRAPHY, COMPUTED C,M,P,X 

3266 6525 SCANNER, COMPUTED TOMOGRAPHY, HEAD UNIT C,M,P,X 

3267 X-RAY APPAR, TOMO, NON-COMPUTERIZED 

3268 6525 SCANNER, COMPUTED TOMOGRAPHY, MOBILE C,P,X 

3269 POSITRON EMISSION COMPUTED TOMOGRAP 

3270 6525 X-RAY APPARATUS, UROLOGICAL H,M,P,X 

3272 6525 TABLE, RADIO, UROLOGICAL (With or w/out Image 

Intensifier) 

H,X 

3280 6525 X-RAY APPARATUS, THERAPEUTIC GRENTZ RAY M,N,P,X 

3288 6525 LINEAR ACCELERATOR THERAPEUTIC M,N,P,X 

3289 X-RAY IMAGE INTENSIFIER 

 
SB 8-75 MEDCASE 

(continued) TABLE A-2. STANDARD ITEM DESCRIPTION TABLE – IDC SEQUENCE 

A-15 

IDC FSC STANDARD ITEM DESCRIPTION NOTES

 

 3500-3999 LABORATORY SCIENCE

3500 LABORATORY SCIENCE ITEM G 

3505 6630 ANALYZER, BLOOD GAS, SEMI-AUTOMATIC 

3506 6630 ANALYZER, BLOOD GAS, AUTOMATIC 

3507 6630 ANALYZER, BLOOD GAS, W/DATA MANAGEMENT 

3510 6630 ANALYZER, BUN 

3512 6630 ANALYZER, BACT4RIA DETECTION 

3515 6630 ANALYZER, CALCIUM 

3520 6640 ANALYZER, CLINICAL AUTO 

3523 6640 ANALYZER, DRUG IDENTIFICATION (See also IDCs 3601-

3604) 

3524 6630 ANALYZER, ELECTROLYTE 

3525 6630 ANALYZER, ENZYME 

3527 6630 ENZYME IMMUNOASSAY SYSTEM 

3530 4910 ANALYZER, GAS 

3535 6630 ANALYZER, CLUCOSE 

3538 6630 ANALYZER, LABORATORY 

3540 6630 ANALYZER, NITROGEN 

3550 6515 ANALYZER, OXYGEN 

3555 6630 ANALYZER, OZONE 

3565 6630 ANTIBACTERIAL SYSTEM 

3568 6630 BALANCE AND SCALE, DIGITAL 

3570 BATH PARRIFIN LAB 

3572 6640 BATH, WATER, ELECTRIC 

3575 BILIRUBINOMETER 

3585 CABINET CONSTANT TEMP BIOLOGICAL 

3590 6640 CHAIR, BLOOD, COLLECTING 

3594 6640 ULTRACENTRIFUGE (Operating at or above 6000 RPM) 

3595 6640 CENTRIFUGE, LABORATORY, SMALL 

3596 6640 CENTRIFUGE, REFRIGERATED 

3597 6640 CENTRIFUGE, LABORATORY, BENCH TOP 

3598 CENTRIFUGE LABORATORY SIZE 3 

3599 6640 CENTRIFUGE, LABORATORY, FLOOR TYPE 

3600 CENTRIFUGE SLIDE STAINER 

3601 6630 GAS, CHROMATOGRAPH 

3602 6630 GAS, CHROMATOGRAPH/MASS SPECTROMETER 

(Sometimes called GCMS, see also IDC 3807) 

3603 6630 GAS/LIQUID CHROMATOGRAPH (Sometimes called GLC) 

3604 6630 LIQUID CHROMATOGRAPH (Sometimes called HPLC) 

3610 COLORIMETER COMPARATIVE 

3623 CONTROLLER AUTOANALYZER 

3625 COAGULYZER AUOT 

3632 

3635 

 COUNTER, GAMMA RADIOIMMUNOASSAY (IDC 3050 is for 

nuclear medicine) 

COUNTER MICROSCOPIC PARTICLE 

P 

3636 6640 COUNTER, BLOOD CELL (4-7 parameters) 

3637 6640 COUNTER, BLOOD CELL (8 parameters) 
SB 8-75 MEDCASE

(continued) TABLE A-2. STANDARD ITEM DESCRIPTION TABLE – IDC SEQUENCE 

A-16 

IDC FSC STANDARD ITEM DESCRIPTION NOTES

 

 3500-3999 LABORATORY SCIENCE (Continued)

 

3638 6640 HEMATOLOGY ANALYZER (16 or more parameters) 

3642 4610 DEMINERALIZER, WATER 

3643 6760 DESNITOMETER, ELECTROPHORESIS 

3645 DERMATOME 

3647 DETECTOR IMMUNOELECTROPHORESIS 

3650 6630 DILUTER, AUTO 

3655 6640 DISTILLING APPARATUS, LAB 

3657 6640 EMBEDDING MACHINE, TISSUE 

3659 ELECTROPHORESIS DENSITOMETER 

3660 6530 ERGOMETER (Should be received by Physical Medicine 

consultant) 

3662 EVAPORATOR, VACUUM, AUTO CONTROL 

3664 6640 FLOW CELL CYTOMETER (Note P applies if the unit uses a 

laser) 

3665 FLUORONEPHELOMETER 

3670 6640 FREEZER, CELL (For preservation of cells, used in cytology and tissue 

studies)

3671 4110 FREEZER, PLASMA, UPRIGHT (To -85 C) 

3672 4110 FREEZER, PLASMA, CHEST-TYPE (To -85 C) 

3673 4110 FREEZER, ULTRA-LOW TEMP, CHEST-TYPE (Below -85 C) 

3674 4110 FREEZER, ULTRA-LOW TEMP, UPRIGHT (Below -85 C) 

3675 GENERATOR HYDROGEN 

3676 FREEZER, ULTRA-LOW TEMP, HIGH CAP 

3679 6640 HOOD, SAFETY FUME, LAB 

3682 HEMOGLOBINOMETER 

3683 INCINERATOR 

3684 6640 INCUBATOR, MECHANICAL BIOLOGICAL 

3685 6640 HOOD, SAFETY, BACTERIOLOGICAL 

3687 INCUBATOR BACTERIOLOGICAL 

3688 6640 INCUBATOR, BLOOD CULTURE, RECIPROCATING ACTION 

3690 LASER, LABORATORY (See other lasers at IDC 1239, 5600, and 

8026)

P 

3701 6640 MICROSCOPE, ELECTRON 

3702 6650 MICROSCOPE, SPECIAL PURPOSE (State purpose) 

3703 6650 MICROSCOPE, OPTICAL (Specify number of viewing 

positions and whether bright, fluorescent or phase 

contrast) 

3705 MICROSCOPE LAB DUAL VIEW 

3706 MICROSCOPE OPTICAL MULTIVIEW 

3710 6640 MICROTOME 

3715 6640 MIXER, LAB 

3717 NEPHELOMETER LASER 

3720 6630 OSMOMETER, SYSTEM 

3725 6640 OVEN, LABORATORY 

3730 6650 PHOTOMETER, FLAME 

3735 6640 PIPETTE, AUTO 
SB 8-75 MEDCASE 

(continued) TABLE A-2. STANDARD ITEM DESCRIPTION TABLE – IDC SEQUENCE 

A-17 

IDC FSC STANDARD ITEM DESCRIPTION NOTES

 

 3500-3999 LABORATORY SCIENCE (Continued)

 

3739 6640 PROCESSOR, BLOOD PHORESIS 

3740 6640 PROCESSOR, TISSUE, AUTO LAB 

3745 PROGRAMMER CELL 

3755 PULMO-DIGITIZER 

3765 RECORDER 

3767 REFRIGERATOR MECH CENTRIFUGE 

3769 4110 REFRIGERATOR, BLOOD BANK M 

3770 4110 REFRIGERATOR, MECH BIOLOGICAL W/ALARM 

3771 4110 REFRIGERATOR, MECH COMMERCIAL, LAB-TYPE W/O 

ALARM 

3772 4110 REFRIGERATOR, MECH MORTUARY M 

3773 6640 ROTOR, CENTRIFUGE LABORATORY, REFRIGERATED 

3774 ROBOTICS, LAB/PATHOLOGY SYSTEM 

3775 6640 SAMPLER, AUTO 

3790 6640 SHAKING MACHINE, LAB 

3795 SHARPENER, MICROTOME 

3805 SPECTROFLUOROMETER 

3807 6640 SPECTROMETER (Formerly IDC 5679, see also IDC 3602) 

3810 SPECTROPHOTOMETER 

3815 6640 STAINER, SLIDE, AUTO CYTOLOGY 

3816 6640 STAINER, SLIDE, AUTO HEMATOLOGY 

3820 6530 TABLE, AUTOPSY 

3822 TESTER, BLOOD CULTURE, BODY FLUIDS 

3825 THYROID UPTAKE SYSTEM 

3830 6630 TITRATOR 

3840 6640 WASHER, CELL, AUTO HEMATOLOGIC DIFFERENTIAL 

3841 6640 WASHER, CELL, AUTO (Other than IDC 3840) 

3850 6640 WASHING MACHINE, GLASSWARE LAB 

3875 WELL SCINTILLATION DETECTOR 

 

 4000-4499 NURSING

4000 NURSING ITEM G 

4003 6530 AERATOR, GAS (Formerly IDC 1112) 

4005 6530 BASSINET/DRESSING TABLE, COMBO HOSP 

4015 6530 BED, FRACTURE CIRCULAR 

4010 6530 BASSINET, WARMING 

4014 BED FRACTURE 

4015 BED FRACTURE CIRCULAR 

4017 6530 TABLE, EMERGENCY, TRANSPORT/TREAT 

4018 6530 TRANSPORTER, PATIENT 

4020 6530 BED, ADJUSTABLE, MANUAL OR ELECTRIC (State which) 

4021 6530 BED, AIR SUPPORT 

4025 6530 BED, ORTHOPEDIC, TURNING FRAME 

4030 6530 BED/STRETCHER, COMBO INTENSIVE CARE 

 
SB 8-75 MEDCASE

(continued) TABLE A-2. STANDARD ITEM DESCRIPTION TABLE – IDC SEQUENCE 

A-18 

IDC FSC STANDARD ITEM DESCRIPTION NOTES

 

 4000-4499 NURSING (Continued)

 

4035 CABINET, MEDICINE, COMBINATION 

4040 6530 CABINET, SOLUTION WARMING 

4043 6530 HEADWALL SYSTEM 

4045 CLEANER, ULTRASONIC (Use IDC 2550 for dental) 

4055 6530 INCUBATOR, INFANT 

4060 6530 INCUBATOR, INFANT TRANSPORT 

4070 MONITOR, TEMPERATURE 

4072 5830 NURSE CALL SYSTEM M 

4075 6515 PUMP, INFUSION 

4077 6530 SCALE, WEIGHING, PATIENT BED 

4078 6910 SKELETON, HUMAN ADULT 

4080 STERILIZER ELEC 16X24 

4082 STERILIZER ELEC 20X36 

4084 STERILIZER ELEC 16X16X24 

4086 STERILIZER ELEC 20X20X36 

4088 STERILIZER ELEC 6 1/2X12 

4090 STERILIZER ELEC 5X6 1/2X 111/2 

4092 STERILIZER ELEC 16X36 

4094 STERILIZER ELEC 7 1/2X14 1⁄2 

4096 STERILIZER ELEC 24X36X36 

4100 6530 STERILIZER, GAS (Specify type of gas and chamber size) M 

4110 6530 STERILIZER, STEAM (Supplied by steam line, specify chamber size) G,M 

4111 6530 STERILIZER, STEAM (With electrically heated boiler, specify 

chamber size)

G,M 

4112 6530 STERILIZER, STEAM 16X16X26 (Supplied by steam line) M 

4113 6530 STERILIZER, STEAM 16X16X26 (With electrically heated 

boiler) 

M 

4114 6530 STERILIZER, STEAM 24X24X36 (Supplied by steam line) M 

4115 6530 STERILIZER, STEAM 24X24X36 (With electrically heated 

boiler 

M 

4116 6530 STERILIZER, STEAM 24X36X48 (Supplied by steam line) M 

4117 6530 STERILIZER, STEAM 24X36X48 (With electrically heated 

boiler) 

M 

4118 6530 STERILIZER, STEAM 20X20X48 (Supplied by steam line) M 

4119 6530 STERILIZER, STEAM 20X20X38 (With electrically heated 

boiler) 

M 

4120 STERILIZER, PLASMA 

4124 STERILIZER (SPECIFY CHAMBER SIZE) 

4125 STERILIZER STEAM 

4126 STERILIZER STEAM 24X24X36 

4127 STERILIZER STEAM 24X36X48 

4128 STERILIZER STEAM 20X20X38 

4129 6530 STERILIZER, ULTRAVIOLET M 

4150 6515 SUCTION APPARATUS 

4160 6515 SUCTION, PRESSURE APPARATUS 

4165 6530 WASHER, CART M 
SB 8-75 MEDCASE 

(continued) TABLE A-2. STANDARD ITEM DESCRIPTION TABLE – IDC SEQUENCE 

A-19 

IDC FSC STANDARD ITEM DESCRIPTION NOTES

 

 4000-4499 NURSING (Continued)

 

4170 6530 WASHER, BEDPAN/URINAL 

4175 6530 WASHER-STERILIZER, SURGICAL INSTRUMENT (Specify 

chamber size)

M 

 

 4500-4999 OBSTETRICS/GYNECOLOGY

 

4500 OBSTETRICS/GYNECOLOGY ITEM G 

4505 ASPIRATOR UTERINE EVACUATOR 

4515 6530 BED, BIRTHING 

4525 6515 COLPOSCOPE 

4550 6515 CYSTOMETER 

4575 DILATOR/SUCTION APPAR UTERINE EVAC 

4625 INSUFFLATOR UTEROTUBAL 

4650 6515 MONITOR, FETAL HEART 

4700 6530 TABLE OB/GYN, EXAM 

4725 TABLE OB/GYN EXAM TREATMENT 

 

 5000-5499 PHYSICAL THERAPY

5000 PHYSICAL THERAPY ITEM G 

5005 6530 PARALLEL BARS, THERAPY FIXED – USE IDC 5008-5010 

5008 6530 PARALLEL BARS, MANUAL 

5009 6530 PARALLEL BARS, ELECTRIC 

5010 6530 PARALLEL BARS, THERAPY PORTABLE 

5025 6530 BATH, PARAFFIN, PHYS THERAPY 

5035 6530 TRACTION APPARATUS, PHYS THERAPY 

5050 6530 BATH, WHIRLPOOL, ARM 

5052 6530 DIATHERMY APPARATUS 

5054 6530 BATH, WHIRLPOOL, LEG 

5055 6530 BATH, WHIRLPOOL, HIP AND LOWER EXT 

5056 6530 BATH, WHIRLPOOL - HUBBARD 

5057 6530 BATH, WHIRLPOOL - PORTABLE 

5060 6530 CART, WEIGHTS, DISKS 

5061 6530 CART, WEIGHTS, DUMBBELLS 

5062 6530 CART, WEIGHTS, STRAPS 

5065 6530 CHAIR, TRACTION 

5066 6530 CHAIR, WHIRLPOOL 

5067 6530 CHAIR, WHIRLPOOL, MOBILE 

5075 6530 PUMP, EXTREMITY, INTERMIT COMPR 

5076 6530 PUMP, EXTREMITY, COLD COMPR 

5077 6530 PUMP, EXTREMITY, SEQUENT COMPR 

5080 6530 STAIRS, PORTABLE 

5100 6530 DIATHERMY, SHORTWAVE, THERAPEUTIC 

5125 6515 ELECTROMYOGRAPH SPECIFY DIAG/THERAP 

5150 6530 EXERCISE UNIT, ISOKINETIC 

5151 6530 EXER UNIT, ISOKINETIC EXTREMITY 
SB 8-75 MEDCASE

(continued) TABLE A-2. STANDARD ITEM DESCRIPTION TABLE – IDC SEQUENCE 

A-20 

IDC FSC STANDARD ITEM DESCRIPTION NOTES

 

 5000-5499 PHYSICAL THERAPY (Continued)

 

5152 6530 EXER UNIT, ISOKINETIC, W/SPINAL 

5153 6530 EXER UNIT, ARM ERGOMETER 

5154 6530 EXER UNIT, BACK, EVAL, THERAPY 

5155 6530 EXER UNIT, BOARD, VESTIBULAR 

5156 6530 EXER UNIT, CLOSED CHAIN 

5157 6530 EXER UNIT, CONT PASSIVE MOTION 

5158 6530 EXER UNIT, EVAL/THERAPY 

5159 6530 EXER UNIT, FINGER LADDER 

5160 6530 EXER UNIT, LEG ERGOMETER 

5161 6530 EXER UNIT, PRE 

5162 6530 EXER UNIT, PROPRIOCEPTIVE, ELEC 

5163 6530 EXER UNIT, PROPRIOCEPTIVE, MANL 

5164 6530 EXER UNIT, ROWING 

5165 6530 EXER UNIT, SHOULDER WHEEL 

5166 6530 EXER UNIT, SKIING 

5167 6530 EXER UNIT, STAIR STEPPER 

5168 6530 EXER UNIT, TREADMILL 

5169 6530 EXER UNIT, TREADMILL-UNDERWATER 

5170 6530 EXER UNIT, WALL PULLEY SYSTEM 

5175 6515 STIMULATOR, ELEC MUSCLE 

5176 6515 STIMULATOR ELEC, ALT CURRENT 

5177 6515 STIMULATOR ELEC, DIRECT CURRENT 

5178 6515 STIMULATOR ELEC, INTERFERENTIAL 

5179 6515 STIMULATOR ELEC, IONTOPHORESIS 

5180 6515 STIMULATOR ELEC, PULSED CURRENT 

5181 6515 STIMULATOR ELEC, TRANS NERVE 

5182 6515 STIMULATOR ELEC, MUSCLE 

5185 6515 MIRROR, MOBILE, MULTI SECTION 

5186 6515 MIRROR, MOBILE, SINGLE 

5190 6515 MODEL, SKELETON 

5191 6515 MODEL, SPECIFY-BODY PART 

5195 6515 PATIENT LIFT, SPECIFY ELEC OR MANL 

5200 6530 TABLE, EXERCISER PHYS THERAPY 

5201 6530 TABLE, PLINTH, ELECTRIC 

5202 6530 TABLE, EXERCISER PHYS THERAPY 

5203 6530 TABLE, PLINTH, FIXED HEIGHT 

5204 6530 TABLE, PLINTH, MANIPULATION 

5205 6530 TABLE, PLINTH, PORTABLE 

5206 6530 TABLE, PLINTH, TRACTION 

5207 6530 TABLE, HAND THERAPY 

5208 6530 TABLE, MAT, EXERCISE, ADJUSTABLE 

5209 6530 TABLE, MAT, EXERCISE, FIXED HEIGHT 

5210 6530 TABLE, MAT, EXERCISE, FOLDING 

5225 TABLE TILT MAN 

5230 6530 TESTER, ARTHROMETER, KNEE LIGAMENT 

5231 6530 TESTER, HAND GRIP, DYNAMOMETER 
SB 8-75 MEDCASE 

(continued) TABLE A-2. STANDARD ITEM DESCRIPTION TABLE – IDC SEQUENCE 

A-21 

IDC FSC STANDARD ITEM DESCRIPTION NOTES

 

 5000-5499 PHYSICAL THERAPY (Continued)

 

5232 6530 TESTER, INCLINOMETER 

5233 6530 TESTER, KIT, JOINT GONIOMETER 

5234 6530 TESTER, KIT, SKIN SENSITIVITY 

5235 6530 TESTER, MUSCLE, MANUAL 

5236 6530 TESTER, PINCH GRIP, DYNAMOMETER 

5237 6530 TESTER, SKINFOLD CALIPER 

5238 6530 TESTER, VOLUMETER, ARM 

5239 6530 TESTER, VOLUMETER, FOOT 

5240 6530 TESTER, VOLUMETER, FOREARM 

5241 6530 TESTER, VOLUMETER, HAND 

5250 6530 ULTRASONIC APPARATUS, PHYS THERAPY 

 

 5500-5999 PREVENTIVE MEDICINE

5500 PREVENTIVE MEDICINE ITEM G 

5520 6640 ANALYZER, CLINICAL BIOCHROMATIC 

5535 6625 ANALYZER, SOUND 

5550 ANALYZER, TRACE METALS G 

5551 ANALYZER, AMBIENT AIR, PORTABLE 

5565 CONTROL UNIT BULK OXYGEN 

5570 COUNTER, BETA PORTABLE 

5573 COMPACTOR, TRASH 

5583 4540 INCINERATOR, INFECTIOUS WASTE M 

5584 INCINERATOR, PATHOLOGICAL WASTE (See also IDC 

6625) 

M 

5585 INFECTIOUS WASTE DISPOSAL SYSTEM (System shreds, 

sterilizes and packages the waste) 

M 

5600 LASER (See also IDC 1239, 3690 and 8026) G,P 

5610 LIQUID SCINTILLATION SYSTEM 

5620 METER EXPOSURE/EXPOSURE RATE 

5630 6625 METER, SOUND LEVEL 

5650 NOISE CLASSIFIER 

5660 OSCILLOSCOPE RECORDING DUAL TRACE 

5670 OSCILLOSCOPE GEN PURPOSE 

5679 SPECTROMETER 

5680 SPECTROMETER ALPHA 

5682 6530 STERILIZER, INFECTIONS WASTE M 

5685 WATTS METER ULTRASONIC 

5687 TANK, STORAGE, OXYGEN 

5690 X-RAY APPAR RADIO INDUST 5MA 

 

 6000-6499 PHARMACY

6000 PHARMACY ITEM G 

6005 6670 BALANCE, ANALYTICAL 

6025 COUNTER, PILL AND TABLET 
SB 8-75 MEDCASE

(continued) TABLE A-2. STANDARD ITEM DESCRIPTION TABLE – IDC SEQUENCE 

A-22 

IDC FSC STANDARD ITEM DESCRIPTION NOTES

 

 6000-6499 PHARMACY (Continued)

 

6050 FILTER/TANK UNIT PHARM PROCESS 

6075 HOOD, LAMINAR FLOW 

6100 MIXER TANK MASTER FILTER PHARM PROD 

6125 PACKAGER, CAPSULE AND TABLET 

6126 PHARMACY PILL DISPENSING ROBOTICS SYSTEM 

6130 PACKAGING MACHINE UNIT DOSE LIQ 

6150 PUMP AND FILLER PRESCRIP 

6155 3540 SEALING MACHINE ELECTRIC, UNIT DOSE 

6200 PHARMACY ROBOTICS 

6270 4110 REFRIGERATION, PHARMACEUTICAL W/ALARM 

 

 6500-6999 VETERINARY MEDICINE

 

6500 VETERINARY MEDICINE ITEM G 

6550 6515 ANESTHESIA APPARATUS VETERINARY 

6585 3770 CAGE, ANIMAL 

6600 FROZEN FOOD MECH REFRIG 

6625 4540 INCINERATOR, VETERINARY PATHOLOGY (See also IDC 

5584) 

6650 6515 ULTRASONIC PROPHYLAXIS UNIT, VETERINARY 

6675 STERILIZER STEAM VET 

6680 6525 X-RAY APPARATUS, VETERINARY P,X 

6700 6530 TABLE, OPERATING, VETERINARY 

 

 7000-7499 NUTRITION CARE

7000 NUTRITION CARE ITEM G,Y 

7210 4110 ICE MAKER Y 

7221 4110 REFRIGERATOR, MECH COMM Y 

 

 7500-7999 OPTICAL FABRICATION

7500 6540 OPTICAL FABRICATION ITEM G 

7510 BLOCKING UNIT OPHTHAL LENS 

7530 6540 CHEMICAL TEMPERING UNIT, OPHTHAL LENS 

7550 6540 CUTTING MACHINE, OPHTHAL LENS 

7570 DEBLOCKER OPHTHAL LENS 

7590 EDGER HAND OPHTHAL LENS 

7600 6540 EDGING MACHINE, OPHTHAL LENS 

7620 6540 GENERATOR, OPHTHAL LENS 

7630 HEAT TREATING UNIT OPHTHAL LENS 

7660 6540 POLISHING MACHINE, OPHTHAL LENS 

7690 6540 SURFACER, OPHTHAL LENS, AUTO 

 
SB 8-75 MEDCASE 

(continued) TABLE A-2. STANDARD ITEM DESCRIPTION TABLE – IDC SEQUENCE 

A-23 

IDC FSC STANDARD ITEM DESCRIPTION NOTES

 

 8000-8499 OPHTHALMOLOGY/OPTOMETRY 

 

8000 OPTHALMOLOGY/OPTOMETRY ITEM G 

8010 6540 CHAIR, PHOROPTER (Without the PHOROPTER or stand) 

8020 6540 CHAIR AND STAND UNIT, PHOROPTER (Without the 

PHOROPTER) 

8023 6540 KERATOMETER 

8026 LASER, PHOTOCOAGULATION, OPHTHALMOLOGICAL P 

8030 6540 LIGHT, SLIT OPHTHALMOLOGICAL 

8031 6540 LIGHT, SLIT WITH APPLANATION TONOMETER 

8040 MAGNET EYE ELECTRIC 

8050 6540 PERIMETER, OPHTHALMOLOGICAL 

8051 6540 PERMIETER, OPHTHALMOLOGICAL, AUTOMATED U 

8060 6540 PHOROPTER (Without the chair or stand) 

8070 PHOROPTER UNIT WITH STAND AND CHAIR 

8073 6540 PROJECTOR, OPHTHALMOLOGICA, ACUITY TEST 

8075 6540 RADIUSCOPE 

8080 6540 REFRACT9R 

8090 6525 SCANNNER, ULTRASOUND OPHTHALMOLOGICAL (See IDC 

3157) 

8100 6540 STAND, PHOROPTER (Without the PHOROPTER or chair) 

8030 6540 LIGHT, SLIT OPHTHALMOLOGICAL 

8031 6540 LIGHT, SLIT WITH APPLANATION TONOMETER 

8040 MAGNET EYE ELECTRIC 

8050 6540 PERIMETER, OPHTHALMOLOGICAL 

8051 6540 PERMIETER, OPHTHALMOLOGICAL, AUTOMATED U 

8060 6540 PHOROPTER (Without the chair or stand) 

8070 PHOROPTER UNIT WITH STAND AND CHAIR 

8073 6540 PROJECTOR, OPHTHALMOLOGICA, ACUITY TEST 

8075 6540 RADIUSCOPE 

8080 6540 REFRACT9R 

8090 6525 SCANNNER, ULTRASOUND OPHTHALMOLOGICAL (See IDC 

3157) 

8100 6540 STAND, PHOROPTER (Without the PHOROPTER or chair) 

 

8110 6540 STEROSCOPE, VISION TESTING 

8115 6540 TONOMETER OPHTHALMOLOGICAL (See IDC 8031) 

8125 6540 LENS MEASURING INST, OPHTHALMOLOGICAL 

 

 9000-9999 ADMINISTRATIVE/NON-MEDICAL ITEMS 

9500 PRODUCTION ENGINEERING COSTS 

9999 NON-MEDCASE ITEM 
SB 8-75-MEDCASE 

(continued) TABLE A-3. STANDARD ITEM DESCRIPTION TABLE – NOMENCLATURE SEQUENCE 

A-24 

STANDARD ITEM DESCRIPTION IDC FSC NOTES

 

ACOUSTIC METER, COMPLIANCE 1111 6515 

ADAPTER (TMDE) 0251 

ADAPTER CLOS OPE-GASTROSCOPE 0504 

ADMINISTRATIVE ITEM 0000 G 

AERATOR, GAS (Formerly IDC 1112) 4003 6530 

AMBULATORY CARE ITEM 2000 G 

AMMETER A (TMDE) 0252 

AMPLIFER (TMDE) 0256 

AMPLIFIER FOUR TRACE (TMDE) 0262 

ANALGESIA MACH, DENTAL 2515 6520 

ANALYZER, AMBIENT AIR, PORTABLE 5551 

ANALYZER, BACTERIA DETECTION 3512 6630 

ANALYZER, BLOOD GAS, SEMI-AUTOMATIC 3505 6630 

ANALYZER, BLOOD GAS, AUTOMATIC 3506 6630 

ANALYZER, BLOOD GAS, W/DATA MANAGEMENT 3507 6630 

ANALYZER, BUN 3510 6630 

ANALYZER, CALCIUM 3515 6630 

ANALYZER CAP (TMDE) 0272 

ANALYZER CARDIAC OUTPUT 0513 

ANALYZER, CLINICAL AUTO (IDC reserved for future use) 3520 6640 

ANALYZER, CLINICAL AUTO 3521 6640 

ANALYZER, CLINICAL BIOCHROMATIC 5520 6640 

ANALYZER DISTORTION (TMDE) 0274 

ANALYZER, DRUG IDENTIFICATION (See also IDCs 3601-

36040) 

3523 6640 

ANALYZER, ELECTROLYTE 3524 6630 

ANALYZER, ENZYME 3525 6630 

ANALYZER, GAS 3530 4910 

ANALYZER, GLUCOSE 3535 6630 

ANALYZER, HEARING AID 1105 6515 

ANALYZER, LABORATORY 3538 6630 

ANALYZER, NITROGEN 3540 6630 

ANALYZER, OXYGEN 3550 6515 

ANALYZER, OZONE 3555 6630 

ANALYZER, SOUND 5535 6625 

ANALYZER, TRACE METALS 5550 G 

ANESTHESIA APPARATUS (IDC reserved for future use) 1108 6515 

ANESTHESIA APPARATUS (IDC reserved for future use) 1109 6515 

ANESTHESIA APPARATUS 1110 6515 

ANESTHESIA APPARATUS VETERINARY 6550 6515 

ANTIBACTERIAL SYSTEM 3565 6630 

ARTHROSCOPE 1113 6515 

ARTICULATOR DENTAL 2525 

ASPIRATOR UTERINE EVACUATOR 4505 

AUDIOLOGY, ITEM 1100 G 

AUDIOMETER, AUTO OR MANUAL PORTABLE 1114 6515 

AUDIOMETER, DIAGNOSTIC 1115 6515 

AUDIOMETER, SCREENING (Specify number of channels) 1118 6515 
SB 8-75-MEDCASE 

(continued) TABLE A-3. STANDARD ITEM DESCRIPTION TABLE – NOMENCLATURE SEQUENCE 

 A-25 

STANDARD ITEM DESCRIPTION IDC FSC NOTES

 

AUDIOMETER, SCREENING 1 CHANNEL 1116 6515 

AUSCULTATION SYS 0530 

AUTOMATIC DATA PROCESSING EQUIPMENT 0100 A,G,T 

BALANCE AND SCALE, DIGITAL 3568 6630 

BALANCE, ANALYTICAL 6005 6670 

BASE, OPERATIONS (BASOPS) ITEM (Formerly IDC 0001) 0200 G,T 

BASSINET, WARMING 4010 6530 

BASSINET/DRESSING TABLE, COMBO HOSP 4005 6530 

BATH, PARAFFIN, PHYS THERAPY 5025 6530 

BATH, WATER, ELECTRIC 3572 6640 

BAH, WHIRLPOOL (Specify whole body) 5052 6530 

BATH, WHIRLPOOL, ARM 5050 6530 

BATH, WHIRLPOOL, HIP AND LOWER EXT 5055 6530 

BATH, WHIRLPOOL, HUBBARD 5056 6530 

BATH, WHIRLPOOL, LEG 5054 6530 

BATH, WHIRLPOOL, PORTABLE 5057 6530 

BED, ADJUSTABLE, MANUAL OR ELECTRIC (State which) 4020 6530 

BED AIR SUPPORT 4021 6530 

BED, BIRTHING 4515 6530 

BED, FRACTURE 4014 

BED, FRACTURE, CIRCULAR 4015 6530 

BED, ORTHOPEDIC, TURNING FRAME 4025 6530 

BED/STRETCHER, COMBO INTESNIVE CARE 4030 6530 

BILIRUBINOMETER 3575 

BIOFEEDBACK SYSTEM 1510 6515 

BLAST CLEARNING CABINET 2670 6520 M 

BLOCKING UNIT OPHTHAL LENS 7510 

BLOOD CELL WASHING SYSTEM 3841 

BOOTH, AUDIOMETRIC EXAM (Specify number of 

compartments) 

1131 6515 

BRONCHOFIBERSCOPE, BIOPSY 1135 6515 

BRONCHOSCOPE 0543 6515 

CABINET, CASSETTE TRANSFER 3005 6525 

CABINET CONSTANT TEM BIOLOGICAL 3585 

CABINET, FLAMMABLE STORAGE 0014 T 

CABINET, MEDICINE, COMBINATION 4035 6530 

CABINET, SOLUTION WARMING 4040 6530 

CABINET/SINK, DENTAL 2516 6520 

CAGE, ANIMAL 6585 3770 

CALIBRATOR, ISOTOPE DOSE 3015 6525 N,P 

CAMERA UNIT, PHOTO-FJUORO, X-RAY APPARATUS 3022 6525 P 

CAMERA, CLOSED-CIRCUIT TV 3020 5820 

CAMERA, FUNDUS FLASH 1150 6515 

CAMERA, GAMMA SCINTILLATION (Specify in nomenclature if 

unit has SPECT capability)

3021 6525 I,N,P,X 

CAMERA, GAMMA SCINTILLATION – DUAL 3028 

CAMERA, GAMMA SCINTILLATION – TRIPL 3027 

CAMERA, MULTI FORMAT 3023 6525 P 
SB 8-75-MEDCASE 

(continued) TABLE A-3. STANDARD ITEM DESCRIPTION TABLE – NOMENCLATURE SEQUENCE 

A-26 

STANDARD ITEM DESCRIPTION IDC FSC NOTES

 

CAMERA, TELEVISION 0121 5820 D,T,Z 

CAMERA, VIDEO, MEDICAL/SURGICAL SCOPT SET 1155 6515 

CARDIOSCOPE 0545 

CART, EMERGENCY EMSS 2020 6530 

CART, UTILITY 2025 6530 

CART, WEIGHTS, DISKS 5060 6530 

CART, WEIGHTS, DUMBBELLS 5061 6530 

CART, WEIGHTS, STRAPS 5062 6530 

CASSETTE CHANGER 3025 6525 

CENTRAL DICTATION SYSTEM 0052 Q,T,U 

CENTRIFUGE, LABORATORY, BENCH TOP 3597 6640 

CENTRIFUGE, LABORATORY, FLOOR TYPE 3599 6640 

CENTRIFUGE, LABORATORY, SIZE 3 3598 

CENTRIFUGE, LABORATORY, SMALL 3595 6640 

CENTRIFUGE SLIDE STAINER 3600 

CENTRIFUGE, REFRIGERATED 3596 6640 

CEPHALOMETER 2520 

CHAIR AND STAND UNIT, PHOROPTER (Without the 

PHOROPTER) 

8020 6540 

CHAIR, BLOOD COLLECTING 3590 6640 

CHAIR, DENTAL OPERATING (May be a component of IDC 

2647) 

2545 6520 

CHAIR, DENTAL X-RAY 2546 6520 

CHAIR, EXAM/TREATMENT SURGICAL 1165 6530 

CHAIR, PHOROPTER (Without the PHOROPTER or stand) 8010 6540 

CHAIR, PODIATRY 1160 6530 

CHAIR, TRACTION 5065 6530 

CHAIR, WHIRLPOOL 5066 6530 

CHAIR, WHIRLPOOL, MOBILE 5067 6530 

CHAMBER, ACOUSTIC 1170 6515 

CHEMICAL TEMPERING UNIT, OPHTHALMIC LENS 7530 6540 

CLEANER, ULTRASONIC (Use IDC 2550 for dental) 4045 

CLEANER, ULTRASONIC DENTAL 2550 6520 

COAGULYZER AUTO 3625 6625 

COLORIMETER COMPARTIVE 3610 

COLPOSCOPE 4525 6515 

COMPACTOR, TRASH 5573 

COMPRESSION UNIT, INTERMIT PRESSURE 5075 

COMPRESSOR/DEHYDRATOR, DENTAL EQUIP 2565 6520 

COMPUTED RADIOGRAPHY SYSTEM 3188 6525 M,X 

COMPUTER BLOOD VOLUME 1175 

COMPUTER, IMAGE PROCESSING (For Gamma Camera) 3030 N,X 

COMPUTER, THERAPY PLANNING 3031 6525 X 

CONTROL UNIT BULK OXYGEN 5565 

CONTROLLER AUTOANALYZER 3623 

CO-OXIMETER 0673 6515 

COOLER/HEATER, X-RAY FILM PROCESS APPARATUS, AUTO 3040 6525 

COPIER ELECTROSTATIC 0200 
SB 8-75-MEDCASE 

(continued) TABLE A-3. STANDARD ITEM DESCRIPTION TABLE – NOMENCLATURE SEQUENCE 

 A-27 

STANDARD ITEM DESCRIPTION IDC FSC NOTES

 

COPIER ELECTOSTATIC 0160 

COUNTER, BETA PORTABLE 5570 

COUNTER, BLOOD CELL (4-7 parameters) 3636 6640 

COUNTER, BLOOD CELL (8 parameters) 3637 6640 

COUNTER, GAMMA, AUTO (For nuclear medicine, IDC 3632 is 

for lab use) 

3050 6525 N,P 

COUNTER, GAMMA RADIOIMMUNOASSAY (IDC 3050 is for 

nuclear medicine use) 

3632 6640 P 

COUNTER MICROSCOPIC PARTICLE 3635 

COUNTER, PILL AND TABLET 6025 

CYOSURGICAL SYSTEM 1180 6530 

CUTTING MACHINE, OPHTHAL LENS 7550 6540 

CYSTOMETER (Without monitor) 4550 6515 

DEBLOCKER OPHTHAL LENS 7570 

DEFIBRILLATOR, EMSS (Without monitor) 2040 6515 

DEFIBRILLATOR/ECG MONITOR (also see IDC 2060) 0555 6515 

DEFIBRILLATOR/ECG MONITOR (This IDC reserved for future 

use) 

0556 6515 

DEFIBRILLATOR/ MON, PORTABLE (For ambulance use, see 

also IDC 0555) 

2060 6515 

DEHYDRATOR, COMPRESSOR AIR SYSTEM, DENTAL 2575 6520 

DEMINERALIZER, WATER 3642 4610 

DENSITOMETER, ELECTROPHORESIS 3643 6760 

DENTAL OPERATING SYS (Must include a chair and dental 

operating unit) 

2647 6520 

DENTAL OPERATING UNIT (May be a component of IDC 2647) 2645 6520 M 

DENTAL OPERATING UNIT HYGIENIST 2570 

DENTISTRY ITEM 2500 G 

DERMATOME 3645 

DETECTOR, FETAL MONITOR 0560 6515 

DETECTOR, SCINTILLATION 3060 6665 N,P 

DIAGNOSTIC IMAGING/THERAPEUTIC RADIATION ITEM 3000 G,P 

DIALYZER APPARATUS 1200 6515 

DIATHERMY APPARATUS 5100 6530 

DIGITAL SUBTRACTION ANGIOGRAPHY SYSTEM (C-Arm 

system is IDC 3225) 

3083 6525 H,M,P, 

R,X 

DIGITAL SUBTRACTION ANGIOGRAPHY UPGRADE 3084 6525 P,R,X 

DIGITIZER, RADIATION THERAPY 3081 6525 P 

DIGITIZER, RADIOGRAPHIC IMAGE 3082 6525 

DILUTER, AUTO 3650 6635 

DIRECT DIGITAL RADIOGRAPHY SYSTEM 3189 6525 M,X 

DISTILLING APPARATUS, LAG 3655 6640 

DRIER FOR RESPIRATOR THERAPY EQUIPMENT 0562 6530 

DRILL SET, SURGERY 1202 6515 

EDGING MACHINE, OPHTHAL LENS 7600 6540 

ELECTROCARDIOGRAPH SYSTEM 1 CHANNEL 0565 6515 

ELECTROCARDIOGRAPH SYSTEM 3 CHANNEL NON CAPOC 0567 6515 

 
SB 8-75-MEDCASE 

(continued) TABLE A-3. STANDARD ITEM DESCRIPTION TABLE – NOMENCLATURE SEQUENCE 

A-28 

STANDARD ITEM DESCRIPTION IDC FSC NOTES

 

ELECTROCARDIOGRAPH SYSTEM MULTI CHANNEL (Specify 

no. of chan) 

0568 6515 

ELECTROCARDIOGRAPH SYS, MULTI CHAN, CAPOC 

COMPATIBLE 

0569 6515 

ELECTROCARDIOGRAPH 0563 6515 

ELECTROCONVULSIVE THERAPY APPARATUS 1520 6515 

ELECTROMYOGRAPH-SPECIFY DIAG/THERAP 5125 6515 

ELECTRONYSTAGOMOGRAPH 0570 6540 

ELECTROSURGICAL APPARATUS 1215 6515 

ELECTROSURGICAL APPARATUS, DENTAL 2590 6515 

EMBEDDING MACHINE, TISSUE 3657 6640 

EMBOSSER, PLASTIC CARD 0003 7490 T 

EMBOSSER, PLASTIC SIGN 0016 7490 T 

ENDOSCOPE 1535 6515 

ENDOSCOPE TRAINING ATTACHMENT 0572 6515 

ENZYME IMMUNOASSAY SYSTEM 3527 6630 

ERGOMETER (Should be reviewed by Physical Medicine 

consultant) 

3660 6530 

ESOPHAGEAL MOTILITY SYSTEM 0575 6515 

EVACUATOR, ORAL CAVITY, DENTAL 2605 6520 

EVAPORATOR, VACUUM, AUTO CONTROL 3662 

EXER UNIT, ARM ERGOMETER 5153 6530 

EXER UNIT, BACK, EVAL, THERAPY 5154 6530 

EXER UNIT, BOARD, VESTIBULAR 5155 6530 

EXER UNIT, CLOSED CHAIN 5156 6530 

EXER UNIT, CONT PASSIVE MOTION 5157 6530 

EXER UNIT, EVAL/THERAPY 5158 6530 

EXER UNIT, FINGER LADDER 5159 6530 

EXERCISE UNIT, ISOKINETIC 5150 6530 

EXER UNIT, LEG ERGOMETER 5160 6530 

EXER UNIT, PRE 5161 6530 

EXER UNIT, PROPRIOCEPTIVE, ELEC 5162 6530 

EXER UNIT, PROPRIOCEPTIVE, MANL 5163 6530 

EXER UNIT, ROWING 5164 6530 

EXER UNIT, SHOULDER WHEEL 5165 6530 

EXER UNIT, SKIING 5166 6530 

EXER UNIT, STAIR STEPPER 5167 6530 

EXER UNIT, TREADMILL 5168 6530 

EXER UNIT, TREADMILL-UNDERWATER 5169 6530 

EXER UNIT, WALL PULLEY SYSTEM 5170 6530 

FIBERSCOPY 0580 6515 G 

FIBERSCOPE, COLON 0585 6515 

FIBERSCOPE, DUODENAL 0590 6515 

FIBERSCOPE, PHOTO UPPER GI 5095 6515 

FILM TRANSPORT SYSTEM 3086 6525 X 

FLOW CELL CYTOMETER (Note P applies if the unit uses a 

laser) 

3664 6640 

FLUORONEPHELOMETER 3665 
SB 8-75-MEDCASE 

(continued) TABLE A-3. STANDARD ITEM DESCRIPTION TABLE – NOMENCLATURE SEQUENCE 

 A-29 

STANDARD ITEM DESCRIPTION IDC FSC NOTES

 

FREEZER, CELL (For preservation of cells used in cytology and 

tissue studies) 

3670 6640 

FREEZER, PLASMA, CHEST-TYPE (To -85 C) 3672 4110 

FREEZER, PLASMA, UPRIGHT (To -85 C) 3671 4110 

FREEZER, ULTRA-LOW TEMP, CHEST-TYPE (Below -85 C) 3673 4110 

FREEZER, ULTRA-LOW TEMP, UPRIGHT (Below -85 C) 3674 4110 

FURNACE, VACUUM, DENTAL 2625 6520 

FURNITURE AND FURNISHING PACKAGE 0005 F 

GAS, CHROMATOGRAPH 3601 6630 

GAS, CHROMATOGRAPH/MASS SPECTROMETER (Sometimes 

called GCMS, see also IDC 3807) 

3602 6630 

GAS/LIQUID CHROMATOGRAPH (Sometimes called GLC) 3603 6630 

GASTROSCOPE 1218 6515 

GENERATOR, OPHTHAL LENS 7620 6540 

GRAPHIC ARTS PACKAGE 0006 F 

HANDPIECE, BONE SURGICAL 1217 6515 

HEADWALL SYSTEM 4043 6530 

HEATER, DENTAL 2627 6520 

HEMATOLOGY ANALYZER (16 or more parameters) 3638 6640 

HOOD, LAMINAR FLOW 6075 

HOOD, SAFETY FUME, LAB 3679 6640 

HOOD, SAFETY, BACTERIOLOGICAL 3685 6640 

HOSPITAL COMMUNICATIONS SYSTEM (Nurse call system - 

IC 4072) 

0050 G,Q,T 

HOSPITAL INTERCOM SYSTEM 0051 Q,T 

HUMIDIFIER/VOLUME VENTILATOR 1220 6515 

HYPOBARIC CHAMBER 0603 6530 M 

HYPODERMIC INJECTION APPARATUS, JET AUTO 0605 6515 

HYPOTHERMIA APPARATUS, INTRA GASTRIC 1225 6515 

ICE MAKER 7210 4110 Y 

IMAGE MGT SYSTEM, CARDIOLOGY 

IMAGE MGT SYSTEM, ECHO-CARDIO ULTRASOUND 3159 

IMAGE MGT SYSTEM, NUCLEAR MEDICINE 3029 

IMPLANT INSTRUMENT SET (Components must be replaced 

with O&M funds) 

1238 6545 

INCINERATOR, INFECTIOUS WASTE 5583 4540 M 

INCINERATOR, PATHOLOGICAL WASTE (See also IDC 6625) 5584 4540 M 

INCINERATOR, VETERINARY PATHOLOGY (See also IDC 

5584) 

6625 4540 

INCUBATOR, BLOOD CULTURE, RECIPROCATING ACTION 3688 6640 

INCUBATOR, INFANT 4055 6530 

INCUBATOR, INFANT TRANSPORT, EMSS 2070 6530 

INCUBATOR, INFANT TRANSPORT 4060 6530 

INCUBATOR, MECHANICAL BIOLOGICAL 3684 6640 

INFECTIOUS WASTE DISPOSAL SYSTEM ( shreds, sterilizes, 

and packages the waste) 

5585 M 

INJECTOR, ANGIOGRAPHIC 0610 6515 

INJECTOR, AUTO 3090 6525 
SB 8-75-MEDCASE 

(continued) TABLE A-3. STANDARD ITEM DESCRIPTION TABLE – NOMENCLATURE SEQUENCE 

A-30 

STANDARD ITEM DESCRIPTION IDC FSC NOTES

 

INTENSIVE CARE SYSTEM INFANT 0612 6515 

INTENSIVE CARE SYSTEM MED 0615 6515 

INTENSIVE CARE SYSTEM, SURGICAL 1235 6515 

INTERIOR DECORATIVE PLANT PACKAGE 0007 F 

INTERIOR SIGN PACKAGE 0008 F 

INTRACRANIAL PRESSURE MONITOR 1234 6515 

INTRUSION DETECTION SYSTEM 0055 6350 M,T 

KERATOMETER 8023 6543 

KIDNEY MACHINE (Hemodialysis Machine) 0611 6515 

LABORATORY SCIENCE ITEM 3500 G 

LAPAROSCOPE, OPERATIVE 1237 6515 

LASER (Also see IDC 1239, 3690 and 8026) 5600 G,P 

LASER, LABORATORY (See other lasers at IDC 1239, 1246, 

5600 and 8026) 

3690 P 

LASER, LITHOTRIPSY, IRETERAL 1246 6515 

LASER, PHOTOCOAGULATION, OPHTHALMOLOGICAL 8026 P 

LASER, THERAPEUTIC, SURGICAL 1239 6515 P 

LENS MEASURING INST. OPHTHALMOLOGICAL 8125 6540 

LIGHT, BILIRUBIN 0614 6515 

LIGHT, DENTAL OPERATING UNIT (May be a component of 

IDC 2647) 

2630 6520 

LIGHT, DENTAL OPERATING, FIBEROPTIC 2635 6520 

LIGHT, SLIT OPHTHALMOLOGICAL 8030 6540 

LIGHT, SLIT WITH APLICATION TONOMETER 8031 6540 

 

LIGHT, SURGICAL CEILING EMSS 2075 6530 M 

LIGHT, SURGICAL STAND 2077 6530 

LIGHT, OPERATING/EXAM, FIGEROPTIC 1240 6530 

LIGHT, SURGICAL CEILING 1245 6530 M 

LINEAR ACCELERATOR, THERAPEUTIC 3288 6525 M,N,P,X 

LIQUID CHROMATOGRAPH 9Sometimes called HPLC) 3604 6630 

LIQUID SCINTILLATION SYSTEM 5610 

LITHOTRIPTER SYSTEM, EXTRACORPEAL 1247 6515 M,P,X 

LITHOTRIPTER, PERCUTANEOUS ULTRASONIC 1248 6515 

LOADER, FILM, PHOTOGRAPHIC DAY LIGHT 3095 6525 

LOGISTICS ITEM 0010 G,T 

MACHINE, CASTING, AUTOMATIC 2638 6520 

MAGNETIC RESONANCE IMAGING SYSTEM 3096 6525 M,P,X 

MAMMOGRAPHY, COMPUTER-AIDED DETECTION 3232 

MANIKIN, RESUSCITATION TRAINING, RECORDING 0742 6910 

MATERIEL DISTRIBUTION SYSTEM 0011 

MATERIEL HANDLING EQUIPMENT 0012 T 

PICTURE ACHIEVING AND COMMUNICATION (PACS) SYSTEM 3192 6525 M,X 

MEDICINE ITEM 0500 G 

METER, SOUND LEVEL 5630 6625 

MICROGRAPHIC EQUIPMENT 0130 D,G,T 

MICROSCOPE, ELECTRON 3701 6640 

MICROSCOPE, OPERATING ROOM 1255 6515 
SB 8-75-MEDCASE 

(continued) TABLE A-3. STANDARD ITEM DESCRIPTION TABLE – NOMENCLATURE SEQUENCE 

 A-31 

STANDARD ITEM DESCRIPTION IDC FSC NOTES

 

MICROSCOPE, SPECIAL PURPOSE (State purpose) 3702 6650 

MICROSCOPE, OPTICAL (Specify number of viewing positions 

/whether bright field, fluo or phase contrast) 

3703 6650 

MICROTOME 3710 6640 

MIRROR, MOBILE, MULTI SECTION 5185 6530 

MIRROR, MOBILE SINGLE 5186 6530 

MIXER TANK MASTER FILTER PHARM PROD 6100 

MIXER, LAB 3715 6640 

MODEL, ANATOMICAL 0745 6910 

MODEL, SKELETON 5190 6910 

MODEL, SPECIFY-BODY PART 5191 6910 

MONITOR, ANESTHESIA (Specify central or stand alone) 1370 6515 

MONITOR, BLOOD PRES (Specify number of stations) 0621 6515 

MONITOR, BLOOD PRES 1 STATION 0620 6515 

MONITOR, CARBON DIOXIDE 0619 6515 

MONITOR, CARDIAC (Specify number of stations) 0626 6515 

MONITOR, CARDIAC 1 STATION 0625 6515 

MONITOR, CENTRAL OXYGEN SYSTEM 1365 6515 M 

MONITOR, CLOSED-CIRCUIT TV 3100 

MONITOR, COMPUTERIZED 0641 6515 

MONITOR, FETAL HEART 4650 6515 

MONITOR, FETAL HEART (IDC reserved for future use) 4651 6515 

MONITOR, HEART RATE (Specify number of stations) 0636 6515 

MONITOR, HEART RATE 1 STATION 0635 6515 

MONITOR, PHYSIOLOGICAL SYSTEM 1 STATION (Vital signs 

monitor; specify number of stations) 

0645 6515 

MONITR, PHYSIOLOGICAL SYSTEM (Vital signs monitor) 2080 6515 

MONITOR, RESPIRATION (Specify number of stations) 0653 6515 

MONITOR, RESPIRATION 1 STATION 0651 6515 

MONITOR, RESPIRATION INFANT 0650 6515 

MONITOR, SYSTEM, EXERCISE-STRESS (Includes treadmill 

and ECG) 

0630 6515 

MONITOR, TEMPERATURE 0661 6515 

MONITOR, VENTILATION (Specify number of stations) 0661 6515 

MONITOR/RECORDER, COMMUNICATIONS SYSTEM 0053 Q,T 

NEONATAL CARE SYSTEM 0670 6515 

NEW FACILITY PACKAGE (Specify type) 0004 F,G 

NOISE CLASSIFIER 5650 

NURSE CALL SYSTEM 4072 5830 M 

NURSING ITEM 4000 G 

NUTRITION CARE ITEM 7000 G,Y 

OBSTETRICS/GYNECOLOGY ITEM 4500 G 

OPERATING APPARATUS ENT 1207 6515 

OPHTHALMOLOGY/OPTOMETRY ITEM 8000 G 

OPTICAL FABRICATION ITEM 7500 6540 G 

OSCILLOSCOPE (TMDE) 0270 6625 E 

OSMOMETER, SYSTEM 3720 6630 

OVEN, LABORATORY 3725 6640 
SB 8-75-MEDCASE 

(continued) TABLE A-3. STANDARD ITEM DESCRIPTION TABLE – NOMENCLATURE SEQUENCE 

A-32 

STANDARD ITEM DESCRIPTION IDC FSC NOTES

 

OXIMETER 0672 6515 

OXYGEN GENERATION SYSTEM 0020 M 

PACEMAKER 0675 6515 

PACEMAKER, EXTERNAL 0676 6515 

PACKAGER, CAPSULE AND TABLET 6125 

PAGING SYSTEM, RADIO 0111 5830 D,T,Z 

PANENDOSCOPE 0682 6515 

PARALLEL BARS, ELECTRIC 5009 6530 

PARALLEL BARS, MANUAL 5008 6530 

PARALLEL BARS, PHYS THERAPY FIXED 5005 6530 

PARALLEL BARS THERAPY PORTABLE 5010 6530 

PATIENT LIFT, SPECIFY ELEC OR MANL 5195 6530 

PERIMETER, OPHTHALMOLOGICAL 8050 6540 

PERIMETER, OPHTHALMOLOGICAL, AUTOMATED 8051 6540 U 

PERITONEOSCOPE 0681 6515 

PHANTOM, NUCLEAR 0449 6625 E 

PHANTOM, RADIOGRAPHIC (Changed from PHANTOM) 0450 6625 E 

PHANTOM, ULTRASONIC 0451 6625 E 

PHARMACY ITEM 6000 G 

PHARMACY PILL DISPENSING ROBOTICS SYSTEM 6126 

PHOROPTER (Without the chair or stand) 8060 6540 

PHOROPTER UNIT WITH STAND CHAIR 8070 6540 

PHOTOMETER, FLAME 3730 6650 

PHYSICAL MEDICINE ITEM 5000 G 

PIPETTE, AUTO 3735 6640 

PNEUMO-PLETHYSMOGRAPHY 0680 6515 

POINT OF USE 0151 

POLISHING MACHINE, OPHTHAL LENS 7660 6540 

POSITRON EMISSION TOMOGRAPHY SCANNER 3111 6525 M,P,X 

POWER SUPPLY, UNINTERRUPTED (UPS) 0025 M,T 

PREVENTIVE MEDICINE ITEM 5500 G 

PRINTING AND BINDING EQUIPMENT 0150 D,G,T,Z 

PROBE, SCINTILLATION 3115 6525 P 

PROCESSING MACHINE, PHOTOGRAPHIC FILM 3120 6525 

PROCESSING MACHINE, X-RAY FILM, AUTO DENTAL 2650 6525 

PROCESSING UNIT, X-RAY FILM, TABLETOP 3134 6525 

PROCESSING UNIT, X-RAY FILM 3135 6525 

PROCESSOR, BLOOD PHORESIS 3739 6640 

PROCESSOR, TISSUE, AUTO LAB 3740 6640 

PROJECTOR, OPHTHALMOLOGICAL, ACUITY TEST 8073 6540 

PSYCHIATRY/NEUROLOGY ITEM 1500 G 

PUMP, CARDIAC ASSIST 1270 6515 

PUMP, EXTREMITY, COLD COMPR 5076 6515 

PUMP, EXTREMITY, INTERMIT COMPR 5075 6515 

PUMP, EXTREMITY, SEQUENT COMPR 5077 6515 

PUMP, INFUSION 4075 6515 

RADIO NUCLIDE IMAGING SYSTEM 3150 6525 G,M,N,P 

 
SB 8-75-MEDCASE 

(continued) TABLE A-3. STANDARD ITEM DESCRIPTION TABLE – NOMENCLATURE SEQUENCE 

 A-33 

STANDARD ITEM DESCRIPTION IDC FSC NOTES

 

SINGLE PHOTON EMISSION COMPUTED TOMOGRAPHY 

(SPECT) SYS 

3152 6525 N,P,X 

RADIOTELEPHONE SYSTEM 0115 6540 D,T,Z 

RADIOSCOPE 8075 6540 

READER, BAR CODE LABEL 0015 T 

READER, MICROFICHE 0131 6730 D,T,Z 

READER-PRINTER, MICROFICHE 0132 6730 D,T,Z 

RECEIVER - TRANSMITTER, EMSS 2100 5805 D,T 

RECEIVER - TRANSMITTER, TELEMETRY 2120 5805 D,T 

RECORDER, ELECTROCARDIOGRAM PORTABLE 0683 6515 

RECORDER, PHYSIOLOGIC MULTI-CHANNEL 0597 6515 

RECORDER, VIDEO TAPE (Radiology use only) 3148 6525 

RECORDS MANAGEMENT EQUIPMENT 0140 D,G,T 

REFRACTOR 8080 6540 

REFRIGERATOR, BLOOD BANK 3769 4110 M 

FEFRIGERATOR, MECH BIOLOGICAL W/ALARM 3770 4110 

REFRIGERATOR, MECH COMM 7221 4110 Y 

REFRIGERATOR, MECH COMMERCIAL, LAB-TYPE W/O ALARM 3771 4110 

REFRIGERATOR, MECH MORTUARY 3772 4110 M 

REFRIGERATOR, PHARMACEUTICAL W/ALARM 6270 4110 

RESPIRATOR, PORTABLE 0697 6530 

RESUSCITATOR, HEART-LUNG 0705 6515 

RESUSCITATOR, OXYGEN-POWERED, PRESSURE CYCLED 0700 6515 

RESUSCITATOR-INHALATOR, PORTABLE 0710 6515 

RESUSCITATOR/ASPIRATOR, EMSS 2140 6515 

ROBOTICS, LAB/PATHOLOGY SYSTEM 3774 

ROTOR, CENTRIFUGE, LABORATORY, REFRIGERATED 3773 6640 

SAMPLER, AUTO 3775 6640 

SCALE, WEIGHING, PATIENT BED 4077 6530 

SCANNER, DIAGNOSTIC 0725 6515 

SCANNER, DIAGNOSTIC ULTRASOUND 3157 6525 I,R,X 

SCANNER, RECTILINEAR (Specify Single or Dual Photon) 3155 6525 N,P,X 

SCANNER, ULTRASOUND OPHTHALMOLOGICAL (See also IDC 

3157) 

8090 6525 X 

SCANNER, ULTRASOUND SYSTEM, ECHO-CARDIO 3156 

SCANNER, ULTRASOUND SYSTEM, NON-DIAGNOSTIC 3153 

SCANNER, ULTRASOUND SYSTEM, OB-GYN 3158 

SCRUBBING MACHINE, FLOOR 0018 7910 T 

SEALER, HEAT (For hospital linen packaging) 0017 3540 T 

SEALING MACHINE ELECTRIC, UNIT DOSE 6155 3540 

SHAKING MACHINE, LAB 3790 6640 

SHAMPOOING MACHINE, CARPET 0019 7910 T 

SHARPENER, MICROTOME 3795 

SHELVING SYSTEM, TRACK-MOUNTED (Often called "spacesaver shelving") 0013 

SILVER RECOVERY UNIT, FILM PROCESS 3160 6525 M 

SIMULATOR, RADIATION THERAPY 3175 6525 N,P 

SIMULATOR, VISUALLY KEYED 1550 6515 
SB 8-75-MEDCASE 

(continued) TABLE A-3. STANDARD ITEM DESCRIPTION TABLE – NOMENCLATURE SEQUENCE 

A-34 

STANDARD ITEM DESCRIPTION IDC FSC NOTES

 

SINK, SURGICAL SCRUB 1292 6515 M 

SKELETON, HUMAN ADULT 4078 6910 

SPECTROFLUOROMETER 3805 

SPECTROMETER (Formerly IDC 5679; see also IDC 3602) 3807 6640 

SPECTROPHOTOMETER 3810 

SPHYGMOMANOMETER, ELECTRIC-ULTRASONIC 1295 6515 

SPIROMETER, DIAGNOSTIC 0727 6515 

SPIROMETER, MONITORING 0728 6515 

STAINER, SLIDE, AUTO CYTOLOGY 3815 6640 

STAINER, SLIDE, AUTO HEMATOLOGY 3816 6640 

STAIRS, PORTABLE 5080 6530 

STAND, PHOROPTER (Without the PHOROPTER or chair) 8100 6540 

STERILIZER, ELECTRIC, DENTAL (Specify Bench or Floor 

Mounted) 

2686 6530 M 

STERILIZER, GAS (Specify type of gas and chamber size) 4100 6530 M 

STERILIZER, INFECTIOUS WASTE 5682 6530 M 

STERILIZER, PLASMA 4120 

STERILIZER, STEAM (Supplied by steam line, specify chamber 

size) 

4110 6530 G,M 

STERILIZER, STEAM (With electrically heated boiler; specify 

chamber size) 

4111 6530 G,M 

STERILIZER, STEAM 16X16X26 (Supplied by steam) 4112 6530 M 

STERILIZER, STEAM 16X16X26 (With electrically heated 

boiler) 

4113 6530 M 

STERILIZER, STEAM 20X20X38 (Supplied by steam line) 4118 6530 M 

STERILIZER, STEAM 20X20X38 (With electrically heated 

boiler) 

4119 6530 M 

STERILIZER, STEAM 24X24X36 (Supplied by steam line) 4114 6530 M 

STERILIZER, STEAM 24X24X36 (With electrically heated 

boiler) 

4115 6530 M 

STERILIZER, STEAM 24X36X48 (Supplied by steam line) 4116 6530 M 

STERILIZER, STEAM 24X36X48 (With electrically heated 

boiler) 

4117 6530 M 

STERILIZER, ULTRAVIOLET 4129 6530 M 

STEREOSCROPE, VISION TESTING 8110 6540 

STIMULATOR, ELEC, ALT CURRENT 5176 6515 

STIMULATOR, ELEC, DIRECT CURRENT 5177 6515 

STIMULATOR, ELEC, INTERFERENTIAL 5178 6515 

STIMULATOR, ELEC, IONTOPHORESSIS 5179 6515 

STIMULATOR, ELEC, MUSCLE 5175 6515 

STIMULATOR, ELEC, PULSED CURRENT 5180 6515 

STIMULATOR, ELEC, TRANS NERVE 5181 6515 

SUCTION APPARATUS 4150 6515 

SUCTION, PRESSURE, APPARATUS 4160 6515 

SURFACER, OPHTHAL LENS, AUTO 7690 6540 

SURGICAL ITEM 1000 G 

TABLE, AUTOPSY 3820 6530 

TABLE, EMERGENCY, TRANSPORT/TREAT 4017 6530 
SB 8-75-MEDCASE 

(continued) TABLE A-3. STANDARD ITEM DESCRIPTION TABLE – NOMENCLATURE SEQUENCE 

 A-35 

STANDARD ITEM DESCRIPTION IDC FSC NOTES

 

TABLE, EXAM 0730 6530 

TABLE, EXAM, UROLOGICAL 1315 6530 

TABLE, EXERCISER PHYS THERAPY 5202 6530 

TABLE, HAND THERAPY 5207 6530 

TABLE, MAT, EXERCISE, ADJUSTABLE 5208 6530 

TABLE, MAT, EXERCISE, FIXED HEIGHT 5209 6530 

TABLE, MAT, EXERCISE, FOLDING 5210 6530 

TABLE, OB/GYN, DELIVERY 4700 6530 

TABLE, OB/GYN, EXAM TREATMENT 4725 6530 

TABLE, OPERATING, HOSPITAL (IDC reserved for future use) 1310 6530 

TABLE, OPERATING, HOSPITAL 1311 6530 

RADIO TRANSLUCENT (For use with mobile C-Arm, IDC 

3224/3225) 

1312 6530 

TABLE, OPERATING, VETERINARY 6700 6530 

TABLE, ORTHOPEDIC 1305 6530 

TABLE, PROCTOSCOPE 0735 6530 

TABLE, RADIO, UROLOGICAL 3272 6525 H,X 

TABLE, RADIOGRAPHIC (Specify whether unit is with or w/o 

image intensifier) 

3183 6525 H,X 

TABLE, TILT, MAN 5225 6530 

TABLE, TILT, MANUAL OR ELECTRIC (State which) 5200 6530 

TABLE, PLINTH, ELECTRIC 5201 6530 

TABLE, EXERCISER PHYS THERAPY 5202 6530 

TABLE, PLINTH, FIXED HEIGHT 5203 6530 

TABLE, PLINTH, MANIPULATION 5204 6530 

TABLE, PLINTH, PORTABLE 5205 6530 

TABLE, PLINTH, TRACTION 5206 6530 

TANK, MASTER, X-RAY FILM PROCESS DENTAL 2705 6525 

TANK, MASTER, X-RAY FILM PROCESS 3185 6525 

TANK, STORAGE, OXYGEN 5687 

TELECOMMUNICATIONS EQUIPMENT 0110 D,G,T,Z 

TELERADIOLOGY SYSTEM 3190 6525 M,X 

TEST EQUIPMENT GENERAL (TMDE) 0250 G,E 

TEST SET, DIGITAL (TMDE) 0280 6625 E 

TESTER, BLOOD CULTURE, BODG FLUIDS 3822 

TESTER, ARTHROMETER, KNEE LIGAMENT 5230 

TESTER, HAND GRIP, DYNAMOMETER 5231 

TESTER, INCLINOMETER 5232 

TESTER, KIT, JOINT GONIOMETER 5233 

TESTER, KIT, SKIN SENSITIVITY 5234 

TESTER, MUSCLE, MANUAL 5235 

TESTER, PINCH GRIP, DYNAMOMETER 5236 

TESTER, SKINFOLD CALIPER 5237 

TESTER, VOLUMETER, ARM 5238 

TESTER, VOLUMETER, FOOT 5239 

TESTER, VOLUMETER, FOREARM 5240 

TESTER, VOLUMETER, HAND 5241 

THERAPY UNIT, RADIATION COBALT 3194 6525 M,N,P,X 
SB 8-75-MEDCASE 

(continued) TABLE A-3. STANDARD ITEM DESCRIPTION TABLE – NOMENCLATURE SEQUENCE 

A-36 

STANDARD ITEM DESCRIPTION IDC FSC NOTES

 

THERMOREGULATOR, PATIENT 1360 6530 

THYROID UPTAKE SYSTEM 3825 

TITRATOR 3830 6630 

TONOMETER OPHTHALMOLOGICAL 8115 6540 

TRACTION APPARATUS 5035 6530 

TRAINER, ARRHYTHMIA 0740 6515 

TRANSPORTER, PATIENT 4018 6530 

TREADMILL (The monitor or entire system is IDC 0630) 0750 6530 

TUBE, X-RAY APPARATUS 3198 6525 O 

TUBEHEAD, X-RAY APPARATUS 3197 6525 O 

ULTRACENTRIFUGE (Operates at or above 6,000 RPM) 3594 6640 

ULTRASONIC APPARATUS, PHYS THERAPY 5250 6530 

ULTRASONIC PROPHYLAXIS UNIT, DENTAL RESINS 2660 6520 

ULTRASONIC PROPHYLAXIS UNIT, VETERINARY 6650 6515 

VACUUM SYSTEM, DENTAL 2715 6520 M 

VENTILATOR, AUTOMATIC-MANUAL, ADULT 1380 6515 

VENTILTOR, AUTOMATIC-MANUAL, INFANT 1381 6515 

VETERINARY MEDICINE ITEM 6500 G 

VIEWER, X-RAY FILM, AUTOMATIC 3200 6525 

VISULA INFORMATION EQUIPMENT (Formerly Audiovisual 

Equipment) 

0120 D,G,T,Z 

WASHER, BEDPAN/URINAL 4170 6530 

WASHER, CART 4165 6530 M 

WASHER, CELL, AUTO 3841 6540 

WASHER, CELL, AUTO HEMATOLOGIC DIFFERENTIAL 3840 6640 

WASHER-STERILIZER, SURGICAL INSTRUMENT (Specify 

chamber size) 

4175 6530 M 

WASHING MACHINE, GLASSWARE LAB 3850 6640 

WELL COUNTER 3215 6525 

WELL SCINTILLATION DETECTOR 3875 P 

WINDOW COVERING PACKAGE 0009 F 

X-RAY APPARATUS VETERINARY 6680 6525 P,X 

X-RAY APPARATUD, ANGIOGRAPHY, SINGLE PLANE 3238 

X-RAY APPARATUS, CARDIAC CATH LAB, BI-PLANE 3237 6525 H,M,P,X 

X-RAY APPARATUS, CARDIAC CATH LAB, SINGLE PLANE 3236 6525 H,M,P,X 

X-RAY APPARATUS, DENTAL, 7MA FIXED 2725 6525 P 

X-RAY APPARATUS, DENTAL, 7MA PORTABLE 2730 6525 P 

X-RAY APPARATUS, DENTAL, 15MA FIXED 2735 6525 P 

X-RAY APPARATUS, DENTAL, 15MA PORTABLE 2740 6525 P 

X-RAY APPARATUS, DENTAL, CYPHALOMETRIC (State mA and 

kVp in nomenclature) 

2746 6525 P 

X-RAY APPARATUS, DENTAL, 

CYPHALOMETRIC/PANOGRAPHIC 

2748 6525 P 

X-RAY APPARATUS, DENTAL, PANOGRAPH 2750 6525 P 

X-RAY APPARATUS, FLUOROSCOPY, MULTI-PURPOSE FIXED 

C-ARM CONFIGURATION (NOT ANGIO SYSTEM 

3226 
SB 8-75-MEDCASE 

(continued) TABLE A-3. STANDARD ITEM DESCRIPTION TABLE – NOMENCLATURE SEQUENCE 

A-37 (A-38 blank) 

STANDARD ITEM DESCRIPTION IDC FSC NOTES

 

X-RAY APPARATUS, MAMMOGRAPHY 3230 6525 H,M,P,X 

X-RAY APPARATUS, MAMMOGRAPHY, DIGITAL 3233 

X-RAY APPARATUS, MAMMOGRAPHY, DIGITAL SPOT STEREO 

TACTIC BIOPSY ATTACHMENT 

3132 

X-RAY APPARATUS MAMMOGRAPHY, STEREO TACTIC BIOPSY 

TABLE 

3231 

X-RAY APPARATUS, PHOTOFLUORO 3235 6525 H,M,P,X 

X-RAY APPARATUS, RADIO (Specify mA up to 500 mA) 3241 6525 H,M,P,X 

X-RAY APPARATUS, RADIO (Specify mA above 500 mA and if 

unit has tomographic capability) 

3246 6525 H,M,P,X 

X-RAY APPARATUS, RADIO MOBILE (Specify mA up to 299 

mA) 

3261 6525 H,M,P,X 

X-RAY APPARATUS, RADIO MOBILE (Specify mA above 299 

mA) 

3264 6525 H,M,P,X 

X-RAY APPARATUS, RADIO PORTABLE (Up to 20 mA, specify 

mA) 

3220 6525 H,P 

X-RAY APPARATUS, RADIO/FLUORO, MOBILE C-ARM 3224 6525 H,P,R,X 

X-RAY APPARATUS, RADIO/FLUOR, MOBILE C-ARM W/DIGSUB 3225 6525 H,P,R,X 

X-RAY APPARATUS, RADIO/FLUORO (Specify mA up to 500 

mA) 

3252 6525 H,M,P,X 

X-RAY APPARATUS, RADIO FLUORO (Specify mA above 500 

mA and if unit has tomographic capability) 

3257 6525 H,M,P,X 

X-RAY APPARATUS, THERAPEUTIC GRENTZ RAY 3280 6525 M,N,P,X 

X-RAY APPARATUS, TOMOGRAPHY COMPUTED 3265 6525 C,M,P,X 

X-RAY APPARATUS, TOMOGRAPHY, COMPUTED, HEAD UNIT 3266 6525 C,M,P,X 

X-RAY APPARATUS, TOMOGRAPHY, COMPUTED, MOBILE 3268 6525 C,P,X 

X-RAY APPARATUS, UROLOGICAL 3270 6525 H,M,P,X 

X-RAY CALIBRATION/VERIFICATION SYSTEM TOMO (TMDE) 0260 6625 E 
SB 8-75 MEDCASE 

B-1 

APPENDIX B. MEDCASE/SUPERCEEP FORMS: 

DA FORM 5027-R (MPR), DA FORM 5028-R (MSTF) 

B-1. INTRODUCTION 

The basic MEDCASE/SuperCEEP forms, DA Form 5027-R (MPR) and DA Form 5028-R 

(MSTF) are the primary forms used to identify and obtain approval for 

MEDCASE/SuperCEEP eligible equipment items. 

B-2. GENERAL 

A MEDCASE/SuperCEEP requirement is initiated by the preparation and processing of 

DA Form 5027-R and DA Form 5028-R. Together they provide an auditable record 

that documents the need, coordination, and approval of a MEDCASE/SuperCEEP 

requirement. Chapter 3 contains guidance concerning the development and staffing 

of these forms. 

B-3. REPRODUCTION 

DA Form 5027-R and DA Form 5028-R will be locally reproduced on 81⁄2 by 11 inchpaper. Copies for reproduction purposes are located at the back of this publication. 

B-4. ELECTRONIC FORMS 

DA Forms 5027-R and 5028-R are available electronically through the electronics 

forms library of the U.S. Army Publishing Directorate, Alexandria, VA. 

B-5. PREPARATION 

A DA Form 5027-R/5028-R must be prepared for each MEDCASE/SuperCEEP 

requirement, not recommended by the TARA, i.e., one DA Form 5027-R/5028-R for 

each end item, set, or system requested. Exceptions are discussed in chapter 3, of 

this bulletin. Provide the number of copies prescribed by command guidance. Forward 

complete copies of the DA Form 5027-R/5028-R with all enclosures to the address 

below. 

U.S. Army Medical Materiel Agency 

ATTN: MCMR-MMO-AT 

1423 Sultan Drive, Suite 100 

Fort Detrick MD 21702-5001 

Copies that are forwarded should bear original signatures. 
SB 8-75 MEDCASE 

B-2 

B-6. INSTRUCTIONS FOR COMPLETING DA FORM 5027-R, MEDCASE 

PROGRAM REQUIREMENT 
SB 8-75 MEDCASE 

B-3 

Item 1 - Self-explanatory 

Item 2 - Enter requesting activity name and address 

Item 3 - Enter requesting Division, Department or Service 

Item 4 - Enter appropriate Asset Control Number (see chapter 3) 

Item 5 - Enter requesting activity TDA Unit Identification Code (UIC) 

Item 6 - Self-explanatory 

Item 7 - Enter applicable Budget Line Item Code (see chapter 3) 

Items 8, 9 and 10 - Self-explanatory 

Item 11 - Enter Standard Item Description (see appendix A) 

Items 12, 13, and 14 - Self-explanatory 

Items 15 and 16 - Self explanatory; continuation sheets may be used where 

necessary and it is acceptable to leave this item blank with a reference to "see 

attached sheet." 

Items 17, 18, 19, 20, 21, 22, 23, and 24 - Self-explanatory 

Items 25, and 26 - Self-explanatory. The initiator and the chief of the requesting 

department or service must sign this form to certify the requirement described is 

valid and that the justification provided is accurate to the best of their knowledge. 

Their signatures also certify that consideration has been given to the availability of 

existing and excess assets to satisfy the requirement. 
SB 8-75 MEDCASE 

B-4 

B-7. INSTRUCTIONS FOR COMPLETING DA FORM 5028-R, MEDCASE 

SUPPORT AND TRANSMITTAL FORM 

Items 1 and 2 - Self-explanatory (perpetuated from associated DA Form 5027-R) 

Items 3 through 41 - Self-explanatory
SB 8-75-MEDCASE 

C-1 

APPENDIX C. LETTERS OF AUTHORITY (LOAs) 

C-1. GENERAL 

The LOA grants authority to cite funds and incur obligations for MEDCASE/SuperCEEP 

equipment. Chapter 7 provides detailed information pertaining to the use of LOAs. 

C-2. EXAMPLES 

a. Figure C-1 is a sample of an E-mail LOA with data elements. 

b. Figure C-2 is a sample of an Amendment to an E-Mail LOA. 

c. The circled numbers in each figure designate the data elements. 

d. An explanation of these circled numbers for Figure C-1 follows: 
SB 8-75-MEDCASE 

C-2 

FIGURE C-1. E-mail Letter of Authority with Data Elements as Marked 

TO: margie_medcase@amedd.army.mil -- 1 

CC: usammamedcasemgr@det.amedd.army.mil 

Subject: LOA P061110 

FROM: MCMR-MMO-AS 31 October 2005 2 

RETURN LOA TO E-MAIL ADDRESS: 

USAMMAMEDCASEMGR@DET.AMEDD.ARMY.MIL 

ACN(S): 010006997-- 3 

EXPIRATION DATE: 28 FEB 2006 -- 4 

DOLLAR AMOUNT: $164,125.00 5 LOA: P061110 -- 6 

1. DIRECT FUND CITATION AUTHORITY: THIS MESSAGE PROVIDES AUTHORITY TO INCUR 

OBLIGATIONS UNDER THE FOLLOWING ACCOUNTING CLASSIFICATION FOR THE PURCHASE 

OF THE ACN AND THE AMOUNT SHOWN ABOVE. 

 

7 - 9760130.1871 074-8027 847721.00000 31E5 P1XXXX (14-POS DOC #) XXXXP1

018126 P061110 

 8 

2. EXECUTION INSTRUCTIONS: 

A. FURNISH A COPY OF THIS AUTHORITY TO THE SERVICING FINANCE AND ACCOUNTING 

OFFICE. 

B. ALL OBLIGATION DOCUMENTS MUST SHOW THE FUND CITE PROVIDED ABOVE. 

C. MAINTAIN AN OBLIGATION RECORD AS SHOWN BELOW. 

D. SUBMIT ALL OBLIGATION DOCUMENTS TO COMMANDER, USAMMA ATTN: MCMR-MMO-AS 

FORT DETRICK, MD 21702-5001, VIA MAIL OR FAX 301-619-4480/DSN 343-4480 WHEN 

THE CONTRACTS ARE AWARDED. A COPY OF RECEIVING REPORTS SHOULD BE FORWARDED 

TO THE USAMMA WHEN THE ITEM IS RECEIVED. 

3. THE PAYING OFFICE FOR CONTRACTS ISSUED UNDER THE AUTHORITY OF THIS LOA IS: 

DFAS-SA/FPA 

500 MCCULLOUGH AVE 

SAN ANTONIO TX 78215-2100 

PHONE DSN 448-4061; COMM 210-527-8061 

OBLIGATION DATE -- 9 REQUISITION NUMBER-- -10 DOLLAR AMOUNT OBLIGATED- 11 

 _______________ __________________ _______________________ 

_______________ __________________ _______________________ 

_______________ __________________ _______________________ 

 ADDITIONAL OBLIGATION LINES MAY BE ADDED TO THIS LOA. 
SB 8-75-MEDCASE 

C-3 

ITEM 1. ISSUE TO - The activity’s e-mail address that the LOA is sent. 

ITEM 2. DATE ISSUED - This is the date the LOA was generated by the USAMMA. 

Funds are available as of that date for execution of the LOA. In no case should a 

contract, purchase/delivery order be awarded prior to that date. 

ITEM 3. ACN - The ACN(s) to be purchased with the LOA. In no case should other 

requirements be purchased with this LOA. 

ITEM 4. EXPIRATION DATE - The LOA is valid for a specific number of days ending 

on the expiration date. In no case should a contract, purchase/delivery order be 

awarded past this date without amendment to the LOA. 

ITEM 5. AMOUNT AUTHORIZED - Total dollar allocated on this LOA. Obligations 

incurred shall not exceed this amount without amendment to the LOA. 

ITEM 6. LOA NUMBER – This seven-digit field is assigned by the USAMMA for LOA 

transaction control. The Advice number is unique to an LOA and is used only once 

within a FY. All references to an LOA use this number. 

ITEM 7. ACCOUNTING CLASS - The accounting classification cited on this LOA must 

be reflected on the contract, purchase/delivery order exactly as on the LOA. If funds 

are controlled by a project code, the project code is incorporated in this line. 

ITEM 8. BUDGET LINE ITEM - Identifies the program category within the Defense 

Health Program-Procurement appropriation. 

ITEM 9. OBLIGATION DATE - Calendar date the obligation occurred. 

ITEM 10. REQUISITION NUMBER - Requisition Number obligated for this LOA. 

ITEM 11. DOLLAR AMOUNT OBLIGATED - Dollar value of the contract, 

purchase/delivery order number obligated against this LOA. 
SB 8-75-MEDCASE 

C-4 

 

FIGURE C-2. Amendment to an E-mail Letter of Authority 

TO: margie_medcase@amedd.army.mil -- 1 

CC: usammamedcasemgr@det.amedd.army.mil 

Subject: AMENDMENT TO LOA P061108 

FROM: MCMR-MMO-AS 

RETURN AMENDMENT TO E-MAIL ADDRESS: 

USAMMAMEDCASEMGR@DET.AMEDD.ARMY.MIL 

 2 

1. INFORMATION CITED ON LOA P061108 IS CHANGED AS FOLLOWS: 

A. EXPIRATION DATE IS EXTENDED TO: NO CHANGE -- 3 

B. FUNDING AUTHORITY IS INCREASED BY $ 164,125.00. TOTAL 

OBLIGATIONS SHALL NOT EXCEED $1,412,875.00. -- 4 

2. THE ACCOUNTING CLASSIFICATION AND EXECUTION INSTRUCTIONS ON 

THE ORIGINAL LOA REMAIN UNCHANGED. RETURN THE AMENDMENT WITH 

THE ORIGINAL SIGNATURE WITH THE OBLIGATIONS PACKAGE. 

 5 

3. THIS AMENDMENT IS CHANGE NUMBER 01 TO SUBJECT LOA. 

4. ACN(S): 010006995 

ITEM 1. ISSUE TO - Address of the activity to which the LOA was issued. 

ITEM 2. LOA NUMBER - Seven-digit field assigned by the USAMMA for a specific LOA. 

ITEM 3. EXPIRATION DATE - This reflects the new expiration date of the LOA. If no 

change occurred it will read "NO CHANGE". 

ITEM 4. AMOUNT AUTHORIZED - Total dollars allocated on the LOA. Obligations 

incurred shall not exceed this amount without another amendment to the LOA. If no 

change occurred to the amount it will read "NO CHANGE". 

ITEM 5. CHANGE NUMBER - Identifies the number of LOA amendments. 
SB 8-75 MEDCASE 

D-1 (D-2 blank) 

APPENDIX D. MEDCASE/SUPERCEEP REQUISITION (EXAMPLE) 

D-1. GENERAL 

This appendix provides an example of a DD Form 1348-6 (see figure D-1) to use in 

preparing requisitions for MEDCASE/SuperCEEP requirements. The DD Form 1348-6 

is used for equipment acquisitions through the wholesale supply system or 

independent contracting agencies. This requisition form is used for standard, nonstocked (AAC "L"), Shared Procurement and non-standard items. 

D-2. COPIES 

The USAMMA must receive three complete legible copies of each requisition with 

attachments. 

FIGURE D-1. DD Form 1348-6, DOD Non-NSN Requisition (Manual) 
SB 8-75-MEDCASE 

E-1 

APPENDIX E. DIAGNOSTIC IMAGING AND RADIATION THERAPY 

EQUIPMENT 

E-1. INTRODUCTION 

This appendix explains documents associated with the acquisition and acceptance of 

diagnostic imaging and radiation therapy equipment. It also provides a detailed 

explanation of the responsibilities and procedures involved in the acceptance of 

diagnostic imaging equipment acquired through contracts administered by the DSCP. 

E-2. CONTENTS 

Reproducible copies of documents for use in preparing MPRs may be obtained from 

the USAMMA. 

E-3. DIAGNOSTIC IMAGING ACCEPTANCE 

a. General. Upon completion of installation, the vendor is required to notify 

DSCP contracting office, in writing that the system is ready for acceptance inspection. 

The inspection must occur within 30 working days following the DSCP receipt of the 

notification. Initial or first-time inspection costs are at government expense, any and 

all re-inspections are paid for by the vendor. 

b. USAMMA X-ray Acceptance Program. X-ray acceptance inspections are 

performed by one of the following methods. 

(1) CONUS. DSCP notifies the Force Sustainment Directorate, 

Maintenance Operations Division of the USAMMA that the system is ready for 

acceptance testing. 

 

(a) The USAMMA contacts and informs the activity that the 

government has received an official notification that the installation is complete and 

ready for inspection. If the local Medical Maintenance staff is unable to perform the 

required testing, they should request assistance in writing from the USAMMA, with an 

explanation as to why they are unable to perform the testing, i.e., lack of qualified 

technicians or Test, Measurement, and Diagnostic Equipment (TMDE). 

(b) Technicians from the using organization or one of the USAMMA’s 

maintenance operations (Tobyhanna, PA, or Tracy, CA) will be assigned to perform 

the tests. The activity is responsible for coordinating the testing schedule with the 

vendor service engineer, who must be there to perform the testing with the 

Government representative. 

(c) The technician provides the results of the acceptance testing 

with a copy of the FDA 2579 to the DSCP contracting officer and the USAMMA. When 

testing is performed by the USAMMA, they provide an electronic or printed copy of 

the acceptance test document to the activity. The customer and the USAMMA are to 

retain a copy of the acceptance test information. The USAMMA also provides a copy 

to the Contracting Officer with a recommendation on the warranty start date. 
SB 8-75-MEDCASE 

E-2 

(2) OCONUS. DSCP notifies the USAMMA that the system is ready for 

acceptance testing. The Medical Maintenance Operations Division notifies the 

appropriate OCONUS maintenance activity, who conducts the tests. Upon completion 

of the testing, the OCONUS maintenance activity sends copies of the results to DSCP 

and the USAMMA. 

(3) Local Acceptance. Certain types of diagnostic imaging systems, such 

as mobile radiographic or fluoroscopic units, dental x-ray systems, conventional 

radiographic or fluoroscopic systems, or other systems which do not require 

extensive testing may be inspected locally by Biomedical Equipment Maintenance 

personnel. Local inspection is dependent upon the availability of qualified personnel 

and the necessary TMDE. 

c. Acceptance Test Failure. The failure of an x-ray system to meet 

acceptance test protocols and federal regulations is a determination that may be 

made only by the contracting officer. Once the vendor has been notified with 

rejection letter, he is required to reimburse the government for all expenses related 

to the re-inspection. The contracting officer determines the warranty start date. If the 

system passes the initial acceptance testing, the date that DSCP receives the notice 

from the vendor that the system is ready for acceptance testing becomes the 

warranty start date. If the system fails the initial inspection, the warranty start date 

is the date that the system passes the re-inspection testing. 
SB 8-75-MEDCASE 

F-1 

APPENDIX F. TOTAL CASE ANALYSIS (TCA) FORMAT 

F-1. GENERAL INSTRUCTIONS 

a. A Total Cost Analysis must accompany the initial submission (nonreplacement requirements/new technology) of items or systems with a total cost of 

$100,000 or more. This requirement does not apply to TARA-generated 

requirements, since the TARA report already includes a TCA. If your request is for a 

non-medical item, answer as many questions as are applicable. 

b. The TCA must be worded in concise language, responding to each question 

in the format shown below. The submission will be understandable without the reader 

having to refer to this format. For medical items, do not use the term “not 

applicable.” The submission will state why a question is not applicable. Workload 

data cited in the submission will pertain only to the equipment or system being 

requested. The cost analysis section must be complete. Data on cost per procedure 

and annual costs where services are provided by other facilities must relate to 

workload and cost for performing these same services in-house. 

F-2. EQUIPMENT DESCRIPTION 

a. Provide a functional description. Describe what the unit does and its 

intended use (i.e., generic description and types and number of procedures). 

b. Give a complete description of the item or system. (Include all major 

attachments or accessories, models, and manufacturer.) A quote is acceptable. 

c. Describe how these procedures are accomplished now. 

F-3. BASIS FOR REQUIREMENT 

a. The MEDCASE/SuperCEEP submission, DA Form 5027 and 5028 should 

answer the following questions: 

(1) What will the equipment be used for and why is it required? 

(2) How will the equipment be used with other equipment? 

(3) What are the advantages of the requested item over equipment 

currently in use or available on the market and why are these advantages needed? 

(4) What will be the impact upon mission accomplishment if the 

requested item is not acquired? 

(5) Will patient care be improved? How? 

(6) Has consideration been given to the use of available excess assets? 

(7) What technological advantages are gained? 
SB 8-75-MEDCASE 

F-2 

(8) How does the equipment support (if applicable) the assigned 

physician-training program? 

(9) How many qualified personnel are required to operate the equipment 

versus the number of qualified personnel currently available? 

(10) Operator training requirements. 

(a) How many personnel need to be trained? 

(b) How is the training to be accomplished? 

(11) How will the equipment be maintained? 

(12) Maintenance training requirements. 

(a) How many maintenance personnel need to be trained? 

(b) How will training be accomplished? 

(13) What building modifications (structural and utilities) are required? 

Include a written cost estimate. 

(14) What other health care facilities (DOD, Veterans Administration and 

civilian health care facilities are near your facility? Provide name, location, and 

distance from your activity. 

(a) Based on workload, what is the cost per procedure at each 

location? List procedures by type and number. Provide projected annual workload for 

the equipment being requested. Explain any differences between current and planned 

workload. (For multiple procedures use average costs.) List separately for each 

facility. 

(b) What are the patient transportation, travel, and per diem 

costs? Also, identify other costs such as technical or professional personnel required 

to accompany patients. 

(c) What are the annual costs, if workload is purchased from 

available Federal or civilian sources? 

(d) Explain why each facility can or cannot satisfy your 

requirement. 

F-4. COST ANALYSIS

a. Acquisition costs: 

(1) Equipment: $__________________ 

(2) Transportation: $__________________ 

(3) Installation: $__________________ 

(4) Facility modification (structural and utilities): 

 $__________________ 

(5) Training (maintenance and operator personnel): 

 $__________________ 

(6) Total fixed cost: $__________________ 
SB 8-75-MEDCASE 

F-3 (F-4 blank) 

b. Anticipated life expectancy of the item or system (include rationale used in 

establishing the life expectancy) (Reference TB-MED-7.) 

Annual allocation of fixed cost (total fixed cost divided by life expectancy) 

c. Annual operating costs (must be based on workload) 

(1) Consumable supplies: $_______ 

(2) Maintenance: $_______ 

(3) Personnel: $_______ 

(Include all personnel costs using appropriate standard services tables. If personnel 

costs will be reduced, the cost savings should be subtracted from operating costs.) 

(4) Total annual operating costs: $_______ 

(5) Total life cycle sustainment costs: $_______ 

(Annual allocation of fixed cost plus total annual operating costs) 

F-5. NON-MEDICAL ITEM

Is it more cost effective to lease this item versus purchase? 
SB 8-75-MEDCASE 

G-1 

APPENDIX G. WEBMRE ACCESS – USER-ID REQUEST FORM (MM260) 

G-1. GENERAL

The USAMMA User-ID Request Form MM260 is the primary form used to request 

access for the WebMRE. 

G-2. REPRODUCTION 

USAMMA Form MM260 will be locally reproduced on 81⁄2 by 11 inch-paper. Copies for 

reproduction purposes are located at the back of this publication. 

G-3. PREPARATION

Form MM260 must be prepared for each individual requesting access to the WebMRE 

system. Fax complete copies of the MM260 to the USAMMA MEDCASE Manager at 

(301) 619-4480 or via e-mail to medcasemgr@amedd.army.mil. Copies that are 

forwarded to the commands and to the USAMEDCOM should bear original signatures. 

G-4. INSTRUCTIONS FOR COMPLETING FORM MM260 
SB 8-75-MEDCASE 

G-2 

ITEM 1 Name. Write name of person requesting access and check whether 

civilian, Military, Student Hire, or Contractor. If contractor, note the 

Company and ending date of your contract. 

ITEM 2 Name of location where you work. 

ITEM 3 Office Information. Telephone Number, Office Symbol, Check YES or 

NO if the User is replacing someone else and if the user is moving 

from another office, Check No to the user needing access to the 

USAMMA LAN, disregard Additional LAN Options. 

ITEM 4 Blank 

ITEM 5 Click NO to user needing access to the Mainframe IBM Computer, 

Check MEDCASE Requirement & Execution, input DODAAC, Command 

Code, and TDA/UIC. 

ITEM 6 Check YES if off-post user, input address (to include building number), 

DSN/commercial phone number, email address, and fax number. 

ITEM 7 Supervisor’s Approval, Signature, and Date. 

ITEM 8 Your site’s Security Officer should fill out this info. Provide Security 

Investigation Type and Date, Security Officer’s Name, Signature, Date 

of Signature, and Phone number. (User must have a NACI Background 

on file at their site) 
SB 8-75-MEDCASE 

SB 8-75 MEDCASE Glossary - 2006 

Abbreviation/Acronym Definition

GL-1 

A 

AAC .......................................................................................................Acquisition Advice Code 

ACN(s) ................................................................................................. Asset Control Number(s) 

ADPE ................................................................................Automated Data Processing Equipment 

AMEDD............................................................................................... Army Medical Department 

AP ................................................................................................................. Accounts Payable 

AKO ...................................................................................................... Army Knowledge Online 

AVF ..............................................................................................................Asset Visibility File 

B 

BASOPS ...........................................................................................................Base Operations 

BCE ........................................................................................Base Level Commercial Equipment 

BLIC .......................................................................................................Budget Line Item Code 

C 

CCP ......................................................................................Consolidation Containerization Point 

CEEP.................................................................................... Capital Expense Equipment Program 

CFO ......................................................................................................... Chief Financial Officer 

CICA ............................................................................................ Competition in Contracting Act 

CLIN ............................................................................................................ Contract Line Item 

CONUS................................................................................................ Continental United States 

CT ......................................................................................................... Computed Tomography 

D 

DA........................................................................................................Department of the Army 

DCSIE&FM ................... Deputy Chief of Staff for Installations, Environment, and Facility Management 

DFARS ....................................................................... Defense Acquisition Regulation Supplement 

DHP ......................................................................................................Defense Health Program

DIRS..............................................................Diagnostic Imaging and Radiotherapy Subcommittee 

DLA .................................................................................................... Defense Logistics Agency

DMFO......................................................................................... Defense Medical Facilities Office 

DMLSS ....................................................................... Defense Medical Logistics Standard Support 

DMS .................................................................................................Defense Messaging System 

DOD ...................................................................................................... Department of Defense 

DSCP .................................................................................... Defense Supply Center Philadelphia 

E 

EMSS ................................................................................... Emergency Medical Services System 

F 

FAR ..............................................................................................Federal Acquisition Regulation

FOB ................................................................................................................... Free On Board 

FSR .......................................................................................................Facilities Survey Report 

FY ...........................................................................................................................Fiscal Year 
SB 8-75-MEDCASE 

(con’t) SB 8-75 MEDCASE Glossary - 2006 

Abbreviation/Acronym Definition

GL-2 

G 

GFE ........................................................................................ Government Furnished Equipment 

H 

HA .......................................................................................................................Health Affairs 

HFPO .............................................................................................. Health Facility Project Office 

HPO ......................................................................................................... Health Physics Officer 

I 

IAW ............................................................................................................ In Accordance With 

IDC......................................................................................................... Item Description Code 

IFT ............................................................................................................... Interfund Transfer 

IMA .....................................................................................................Information Mission Area 

IMAE.................................................................................... Information Mission Area Equipment 

IMO .......................................................................................... Information Management Officer 

IMP...............................................................................................Information Management Plan 

J 

JMAR ............................................................................................Joint Medical Asset Repository 

JSN........................................................................................................... Joint Service Number 

J&A..................................................................................................... Justification and Approval 

L 

LAN .............................................................................................................Local Area Network 

LIN ............................................................................................................... Line Item Number 

LOAs........................................................................................................... Letters of Authority 

LOGCAT ....................................................................................................... Logistical Category 

M 

MEDCASE .................................................................................. Medical Care Support Equipment 

MIL-STD ..........................................................................................................Military Standard 

MILCON......................................................................................................Military Construction 

MIPR........................................................................... Military Interdepartment Purchase Request 

MPR ......................................................................................... MEDCASE Program Requirements 

MRI ............................................................................................... Magnetic Resonance Imaging 

MSC............................................................................................... Major Subordinate Command 

MSTF ............................................................................. MEDCASE Support and Transmittal Form 

MTF(s) ......................................................................................... Medical Treatment Facility(ies) 

O 

OASD......................................................................... Office of the Assistant Secretary of Defense 

OCONUS............................................................................. Outside the Continental United States 

OMD .................................................................................. Operations and Maintenance, Defense 

OTSG ............................................................................................ Office of the Surgeon General 
SB 8-75-MEDCASE 

(con’t) SB 8-75 MEDCASE Glossary - 2006 

Abbreviation/Acronym Definition

GL-3 (GL-4 blank) 

P 

PAC ....................................................................................................... Participant Action Code 

PACS ........................................................................... Picture Archiving Communications System 

PASS ................................................................................................Pre-Acquisition Site Survey

PBAC .................................................................................. Program Budget Advisory Committee 

PBO ..........................................................................................................Property Book Officer 

PET.............................................................................................. Positron Emission Tomography 

PFD ............................................................................................................ Program For Design 

POC ................................................................................................................. Point of Contact 

POM.......................................................................................... Program Objective Memorandum 

PRR ......................................................................................................... Project Rooms Report 

R 

RDD....................................................................................................... Required Delivery Date 

RDTE ....................................................................... Research, Development, Test and Evaluation 

RMC................................................................................................. Regional Medical Command 

ROD.........................................................................................................Report of Discrepancy 

S 

SEQ .............................................................................................................. Sequence Number 

SICC ................................................................................................Service Item Control Center

SIDPERS ..............................................................Standard Installation/Division Personnel System 

SOP ............................................................................................. Standard Operating Procedure 

SPECT ................................................................... Single Photon Emission Computed Tomography 

STANFINS....................................................................................Standard Army Finance System 

STCPC.......................................................................Strategic Technology/Clinical Policies Council 

SuperCEEP......................................................................Super Capital Expense Equipment Program 

T 

TARA .................................................................... Technology Assessment/Requirements Analysis 

TDA ..................................................................................... Table of Distribution and Allowances 

TEWLS .......................................................................... Theater Enterprise Wide Logistics System 

TMDE ..................................................................... Test, Measurement, and Diagnostic Equipment 

U 

UIC........................................................................................................Unit Identification Code 

USACE-HNC ................................................................ U. S. Army Engineering and Support Center 

USAHFPA ...................................................................... U.S. Army Health Facility Planning Agency 

USAMEDCOM .................................................................................. U.S. Army Medical Command 

USAMMA................................................................................. U.S. Army Medical Materiel Agency 

W 

WAN ............................................................................................................Wide Area Network 

WebMRE .................................................................... Web MEDCASE Requirements and Execution 

WRAMC ....................................................................................Walter Reed Army Medical Center 
SB 8-75-MEDCASE 

IN-1 

SB 8-75-MEDCASE INDEX - 2006

Subject Page

Activity/RMC/MSC Commander Review and Approval ................................................4-2 

Administrative and Information Management Introduction .......................................13-1 

Alternate Acquisition Activity Introduction ...............................................................8-1 

Approval of MEDCASE/SuperCEEP Requirements Introduction ....................................4-1 

Assignment of a BLIC...........................................................................................3-4 

Assignment of a MEDCASE/SuperCEEP ACN.............................................................3-3 

Award and Acceptance .......................................................................................12-4 

Base Level Commercial Equipment (BCE) ..............................................................13-5 

Basic Procedures for Local Purchase .......................................................................7-4 

Basic Requisitioning Procedures .............................................................................6-1 

Central Requirements ........................................................................................3-12 

Centrally Managed Systems ................................................................................13-4 

CICA ...............................................................................................................14-2 

Communication/Automation Data Processing Equipment Acquisition .........................13-3 

Competition in Contracting Requirements Introduction............................................14-1 

Development of MEDCASE/SuperCEEP Requirements Introduction ..............................3-1 

Deviations ..........................................................................................................1-3 

Diagnostic Imaging and Radiation Therapy Requirements ........................................12-1 

Diagnostic Imaging and Radiation Therapy Requirements Introduction ......................12-1 

Diagnostic Imaging and Radiation Therapy Requirements Scope...............................12-1 

DMLSS System ...................................................................................................3-6 

Equipment Replacement .......................................................................................2-5 

Equipment Replacement Report ...........................................................................16-1 

Equipment Replacement Reports General ..............................................................16-1 

Equipment Replacement Reports Introduction........................................................16-1 

Execution and Acquisition Source.........................................................................12-2 

Execution of BLIC “MB” Requirements ....................................................................5-2 

Execution of MEDCASE/SuperCEEP Requirements Introduction ...................................5-1 

Expiration of Unfunded MEDCASE/SuperCEEP Requirements .....................................4-3 

Extended Installation .........................................................................................12-3 

Financial Management..........................................................................................2-6 

Funding MEDCASE/SuperCEEP Requirements...........................................................5-1 

Funds Management at the Station..........................................................................5-2 

Identification of Requirements...............................................................................3-2 

Information Mission Area (IMA) Software and Hardware..........................................13-2 

Initiation of BLIC “NF” and BLIC “MB” Requirements ...............................................3-11 

Justification for Other-Than-Full-and-Open Competition ..........................................14-3 

Justification of Requirements.................................................................................3-5 

Leased Equipment .............................................................................................15-4 

LOA Management ................................................................................................7-2 

Local Area Network (LAN) and Wide Area Network (WAN) .......................................13-3 

Local Purchase and Letters of Authority (LOA) Introduction........................................7-1 

LOGCAT Codes ..................................................................................................11-2 
SB 8-75-MEDCASE 

IN-2 

(con’t) SB 8-75-MEDCASE INDEX - 2006 

 Subject Page

Management of Requisitions..................................................................................6-5 

MEDCASE and SuperCEEP General Information Introduction ......................................1-1 

MEDCASE and SuperCEEP General Information Responsibilities ..................................1-1 

MEDCASE/SuperCEEP Action Codes........................................................................4-3 

MEDCASE/SuperCEEP Eligibility of Costs Other Than Unit Price.................................15-2 

MEDCASE/SuperCEEP Program Eligibility.................................................................2-1 

MEDCASE/SuperCEEP Program Policies Introduction .................................................2-1 

Medical MILCON Projects (BLIC “NF” and “MB” Requirements) Introduction ................11-1 

Methods of Describing MEDCASE/SuperCEEP Requirements .....................................14-2 

MILCON Project Requirements Management (BLIC “NF” and “MB”)..............................3-9 

MIPR Requests ....................................................................................................8-1 

MTF or RMC Initiation of Requirements ...................................................................3-2 

Noncompetitive Acquisition ...................................................................................2-7 

Objectives for MEDCASE/SuperCEEP Program Submissions ........................................3-7 

Overview of a Medical MILCON Project..................................................................11-1 

Overview of Requisition Processing ........................................................................6-2 

Overview of the Local Procurement Process .............................................................7-1 

Overview of the MIPR Process ...............................................................................8-1 

Price Estimates .................................................................................................15-1 

Processing of Urgent and Emergency MEDCASE/SuperCEEP Requirements 

 Introduction.....................................................................................................9-1 

Property Accountability ........................................................................................2-6 

Purpose and Applicability ......................................................................................1-1 

Receipt Processing...............................................................................................5-3 

Receipt Processing...............................................................................................6-5 

Recommending Changes to the WebMRE System ...................................................10-2 

References and Resources ..................................................................................11-3 

Relocatable Buildings .........................................................................................15-1 

Reporting Discrepancies .....................................................................................15-5 

Responsibilities During the Project .......................................................................11-4 

Shipment of MEDCASE/SuperCEEP Items ................................................................6-4 

Special Eligibility Criteria ......................................................................................2-2 

Special MEDCASE/SuperCEEP Program Considerations Introduction ..........................15-1 

Special Procedures ............................................................................................12-5 

Special Requirements for Submission and Approval (Routine) ..................................12-2 

Submission of Requirements .................................................................................3-7 

TDA Approval and Type Classification Exemption....................................................13-1 

Technology Assessment and Requirements Analysis (TARA) Accountability ................17-3 

Technology Assessment and Requirements Analysis (TARA) Confidentiality ................17-3 

Technology Assessment and Requirements Analysis (TARA) Coordination ..................17-1 

Technology Assessment and Requirements Analysis (TARA) Integration ....................17-3 

Technology Assessment and Requirements Analysis (TARA) Introduction ...................17-1 

Technology Assessment and Requirements Analysis (TARA) Methodology ..................17-1 

Technology Assessment and Requirements Analysis (TARA) Mission..........................17-1 

Technology Assessment and Requirements Analysis (TARA) Program Review .............17-3 

Telecommunications Equipment...........................................................................13-4 

Turnkey Acquisition ...........................................................................................13-4 

Types of MIPRs ...................................................................................................8-1 
SB 8-75-MEDCASE 

IN-3 (IN-4 blank)

(con’t) SB 8-75-MEDCASE INDEX – 2006 

 Subject Page

Urgent MEDCASE/SuperCEEP Requirements ............................................................9-1 

USAMEDCOM/OTSG Consultant Review and Approval................................................4-2 

Utilization of Excess Equipment .............................................................................2-6 

Warranties .......................................................................................................15-4 

Web MEDCASE Requirements and Execution (WebMRE) System Introduction .............10-1 

WebMRE Access Form ........................................................................................10-1 

WebMRE/Theater Enterprise Wide Logistics System (TEWLS) ...................................10-1 

Wholesale Supply Source Actions...........................................................................6-3 

Wholesale Supply System (Requisitions) Introduction ...............................................6-1 


SB 8-75-MEDCASE 

By Order of the Secretary of the Army: 

PETER J. SCHOOMAKER 

General, United States Army 

Chief of Staff 

By Order of the Secretary of the Army: 

SANDRA R. RILEY 

Administrative Assistant to the 

Secretary of the Army

Distribution:

To be distributed in accordance with initial distribution number (IDN) 340005, 

requirements for SB 8-75 MEDCASE. 
PIN: 050307-000